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Abstract 
With the sequencing of the human genome effectively complete, the development of high 
throughput and rapid biomarker assays has become a major focus of research as the biomedical 
community seeks to translate genomic insight into clinical improvements in patient care.  One class of 
molecules that has attracted considerable attention is microRNAs (miRNAs).  miRNAs are 19-24 
nucleotide, short post-transcriptional regulators, involved in a number of cellular processes 
including proliferation, apoptosis, and development.  They are also implicated in a variety of 
diseases, such as cancer, neurodegenerative disorders, and diabetes. 
Despite their importance in a variety of cellular functions as well as their potential for 
disease diagnostics, miRNAs are incredibly difficult to detect.  Their short length makes it 
difficult to attach any label (fluorescent or radioactive) without introducing a signal bias to the 
measurement.  Additionally, traditional PCR-based methods for RNA detection cannot be 
utilized, as the primers themselves are often the lengths of the miRNAs.  To further complicate 
matters, miRNAs act in highly complex fashion.  A single gene can be regulated by multiple 
miRNAs, and a single miRNA can regulate multiple genes.  In order to fully understand the role 
miRNAs play, as well as utilize their potential as informative biomarkers, a multiplexed analysis 
is necessary.  
We have developed a sensing platform based on arrays of silicon photonic microring 
resonators that is highly amenable for the quantitative, multiplexed detection of nucleic acids, in 
particular, miRNAs.  We begin by demonstrating a label-free method for the quantitative, 
multiplexed detection of miRNAs.  We further extend this technique by utilizing S9.6, an unique 
antibody against DNA:RNA heteroduplexes, that significantly improves both our sensitivity and 
specificity without the introduction of a signal bias.  Furthermore, we present an incredibly 
simple but elegant, method for distinguish single-nucleotide polymorphisms based on isothermal 
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desorption.  This not only offers potential applications for screening genomic SNPs, but more 
importantly, provides a framework to begin to distinguish closely related miRNAs.  Future work 
will focus on the development of new amplification schemes to further increase the sensitivity of 
the microring resonator platform towards miRNAs, as well as applying this work towards a 
variety of interesting biological systems and clinical situations. 
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Chapter 1 – Label-free technologies for quantitative multiparameter biological analysis 
 
This chapter has been reproduced from the original paper, titled “Label-free technologies for 
quantitative multiparameter biological analysis” (Qavi, A.J.; Washburn, A.L.; Byeon, J.-Y.; 
Bailey, R.C.; Anal. Bioanal. Chem.; 2009, 394, 121-135). It has been reproduced here with 
permission from Springer Science and Business Media. The original document can be accessed 
online at <http://www.springerlink.com/content/bm0013m627j4558n/>. 
We acknowledge financial support for our own efforts in developing new quantitative, 
label-free multiparameter biomolecular analysis methods from the following agencies: the NIH 
Director’s New Innovator Award Program, part of the NIH Roadmap for Medical Research, 
through grant number 1-DP2-OD002190–01; the Camille and Henry Dreyfus Foundation, 
through a New Faculty Award; and the US National Science Foundation through the Science and 
Technology Center of Advanced Materials for the Purification of Water with Systems 
(WaterCAMPWS, CTS-0120978). A.L.W. acknowledges support via a National Science 
Foundation Graduate Research Fellowship. 
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1.1 Abstract   
In the postgenomic era, information is king and information-rich technologies are critically 
important drivers in both fundamental biology and medicine. It is now known that single-
parameter measurements provide only limited detail and that quantitation of multiple 
biomolecular signatures can more fully illuminate complex biological function. Label-free 
technologies have recently attracted significant interest for sensitive and quantitative 
multiparameter analysis of biological systems. There are several different classes of label-free 
sensors that are currently being developed both in academia and in industry. In this critical 
review, we highlight, compare, and contrast some of the more promising approaches. We 
describe the fundamental principles of these different methods and discuss advantages and 
disadvantages that might potentially help one in selecting the appropriate technology for a given 
bioanalytical application. 
1.2 Introduction 
High-information-content genomic and proteomic technologies, such as capillary sequencing, 
complementary DNA microarrays, two-dimensional polyacrylamide gel electrophoresis, and 
mass spectrometry, have greatly increased the level of molecular clarity with which we now 
understand human biology. Perhaps the most critical insight gleaned from these continued efforts 
is the vast interconnectivity of gene and protein regulatory networks. This in turn leads to the 
realization that biological systems are more completely characterized as an increasing number of 
molecular expression profiles are obtained from a single analysis. Coupled with immortalized 
cell lines and modern molecular and cell biology techniques, the aforementioned genomic and 
proteomic tools are well suited and established in research laboratories. Unfortunately, many of 
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the same measurement approaches are not rigorously quantitative and also are not ideal for use in 
the clinic, where sample sizes and specialized training in analytical methods are more limited.  
The greatest challenges in quantitative clinical bioanalysis arise because of the 
requirement of a label—usually fluorescent or enzymatic. This label may be directly tethered 
either to the biomolecule under interrogation or to a secondary or tertiary recognition element 
such as in a sandwich assay configuration. In the case of antibody-based sandwich assays, such 
as conventional enzyme-linked immunosorbent assays, the requirement for a secondary protein 
capture agent adds significant cost and development time as generation of multiple, high-
binding-affinity antibodies that recognize distinct and nonoverlapping target epitopes can be very 
difficult. Direct labeling has its own challenges. Label incorporation itself can be highly 
heterogeneous, making any resulting measurement inherently nonquantitative.1 Furthermore, Sun 
et al.2 recently demonstrated that the presence of a fluorescent label can have detrimental effects 
on the affinity of an antigen–antibody interaction. Since almost all biosensing methods 
essentially provide a measure of surface-receptor occupancy, which is dictated by the binding 
affinity between the capture agent and the antigen, this report validates the quite obvious fact that 
labels can, in many cases, negatively impact the limit of detection of an assay.  
For these reasons, among others, there is great interest in developing label-free methods 
of biomolecular analysis. There are many different classes of label-free biosensors, but all are 
based upon the measurement of an inherent molecular property such as refractive index or mass. 
In this review, we focus on examples of label-free biosensors in which multiple target analytes 
are assayed simultaneously from within the same sample. These transduction methods, which are 
often based upon micro- and nanotechnologies, therefore also have an advantage of relatively 
low sample consumption, since multiple sample volumes are not required for multiple assays.  
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Clearly it would be impossible to discuss every technology that fits the label-free 
multiplexed sensing criteria; therefore, in this review we have attempted to highlight some of the 
technologies that we feel are the most promising at present to make an impact in this rapidly 
developing field. We have chosen to break the review down into sections according to the 
manner in which the presence of the biological moiety is transduced: plasmonic, photonic, 
electronic, and mechanical methods. In each section we briefly introduce the key aspects of 
sensor operation, highlight notable research to date, and comment on the advantages and/or 
disadvantages of each technology as it applies to the direct, multiplexed analysis of complex 
biological samples. In some cases we will discuss applicability to detection of different classes of 
biomolecules and/or cells. Furthermore, while this review is mainly focused on detection 
(quantitation), we will also highlight several instances where label-free techniques have been 
used in multiplexed molecular library (chemical and biological) screening applications, since 
many of these demonstrations are highly relevant and potentially amenable to multiparameter 
quantitation.  
We have intentionally chosen not to discuss other valuable analytical metrics such as 
time-to-result and specificity. Our reasoning is that while these metrics are critically important to 
sensor utility, they can be severely complicated by other factors that are not related to the 
fundamental physical performance of the device. Properties such as the dimensions of the sample 
chamber surrounding the sensor or the quality of the capture agent can dominate the observed 
time response and specificity (and sensitivity, for that matter). 3,4 We recognize that these are 
vitally important facts to consider, but it is not practical to qualify each literature report in terms 
of the many peripheral factors that affect these performance attributes.  
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1.3  Plasmonic methods 
One promising technique for the multiplexed, label-free detection of biomolecules is surface 
plasmon resonance imaging (SPRI), also referred to as “surface plasmon resonance microscopy.” 
SPRI is based upon the same fundamental principles as conventional surface plasmon resonance 
(SPR) spectroscopy; light is coupled to the interface of a thin metallic film (typically gold for 
biosensing applications) via total internal reflection where propagating surface plasmon modes 
are excited, if the photons are of a particular frequency and incident angle. The evanescent field 
associated with the plasmon resonance samples the proximal optical dielectric environment and 
is highly sensitive to local changes in refractive index, including those associated with the 
binding of biomolecules to receptors presented by the surface.5 When biomolecules bind to 
specific receptors anchored to the metallic film, the corresponding changes in the refractive 
index modulate the intensity of light reflected off the surface, which in turn is measured by the 
detector.6  
SPR spectroscopy was first demonstrated for biosensing applications by Lundstrom in 
1983,7 and was further developed throughout the mid-1980s as a method to monitor 
immunochemical reactions.8 SPRI, which allows multiple binding events to be monitored 
simultaneously, was introduced by Yeatman and Ash9 in 1987 and further developed by Corn 
and colleagues through and mid- to late-1990s.10-12 In a typical SPRI experiment, shown 
schematically in Figure 1.1, a CCD detector is used to image the intensity of light reflected off 
the surface, which directly corresponds to the amount of material bound to the metal film at a 
given image position. In this arrangement, changes in reflected light intensity can be measured 
down to a resolution of approximately 4 µm, allowing for highly multiplexed measurements of a 
variety of biological binding events.13 However, multiplexing comes with a cost; SPRI typically 
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has limits of detection 10–100 times higher (worse) than standard, nonimaging SPR 
spectroscopy.6  
One major application of SPRI is the readout of massive protein microarrays. Work by 
Shumaker-Parry et al. demonstrated that the change in intensity of reflected light in an SPRI 
array could be correlated to a change in mass per unit area for proteins.14 They successfully 
utilized this method to detect the binding of streptavidin to a biotinylated-DNA substrate, with a 
limit of detection of approximately 0.5 pg per 200-µm spot.15 In later work, highlighted in 
Figure 1.2, the same group demonstrated quantitative measurement of the sequence-specific 
binding of the transcription factor Gal4 to double-stranded DNA sequences in a 120-component 
array with similar sensitivity.16 
An incredible breadth of SPRI applications in proteomics have been described over the 
past decade. This literature is far too broad to cover in its entirety here, and we direct those 
interested to two outstanding reviews on SPRI technologies for biomolecular interaction 
monitoring.5,13 Though many screening demonstrations have focused on only a limited number 
of components, SPRI systems are capable of higher levels of multiplexing—perhaps allowing for 
10,000 or more parallel measurements.17  
There has also been significant effort focused on utilizing SPRI for quantitative nucleic 
acid analysis; work pioneered by the group of Corn. Nelson et al. monitored hybridization of 
DNA and RNA onto microarrays at concentrations as low as 10 nM for short oligonucleotides 
(18-mers) and down to 2 nM for longer oligonucleotides (1,500 bases).18 Goodrich and 
coworkers used an enzymatic approach to further extend the detection limit to approximately 
1 fM.19,20 These reports took advantage of the ability of RNase H to selectively cleave RNA from 
DNA:RNA heteroduplexes—allowing the rate of duplex hydrolysis to be correlated to the 
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amount of bound target DNA. Lee et al. developed a related enzymatic amplification scheme 
using Exonuclease III, an enzyme that selectively cleaves DNA:DNA homoduplexes.21 In this 
work, the authors were able to detect down to 10 pM target DNA. Wolf et al. demonstrated the 
use of SPRI as a tool for screening small molecule–DNA interactions by observing the 
interaction between actinomycin D with a multitude of DNA sequences.22 While all of the 
aforementioned demonstrations of nucleic acid analysis used a limited number of array 
components, this technology clearly could be scaled to much higher levels of multiplexing.  
Two variations to the traditional prism-based SPR techniques that have attracted 
considerable attention for multiplexed biosensing are grating-coupled SPR (GCSPR) and 
waveguide-coupled SPR (WCSPR). GCSPR utilizes an optical grating incorporated into the 
sensor surface to generate high diffracted orders that couple photons to the surface and in turn 
launch propagating surface plasmons.23-25 This technique provides a number of advantages over 
traditional methods of SPRI. Prisms or index-matching fluids are not required for the generation 
of surface plasmons, providing flexibility in the experimental layouts. Furthermore, the sensors 
can be mass produced with relative ease and low cost. However, the sensitivity of GCSPR is 
generally lower than that of prism-based SPR measurements.6 WCSPR involves the 
incorporation of an optical fiber or other waveguide into the sensor as a means to generate 
surface plasmons. While the incorporation of a waveguide allows for miniaturization of the 
sensor, the coupling of the light from the waveguide to the surface plasmons is heavily 
dependent on the polarization of the incident light, which is sensitive to deformations in the 
waveguide geometry, thus limiting the general utility of the technique.  
The widespread utility of SPRI as a biomolecular transduction technology is, in part, 
reflected in the number of companies offering commercial instrumentation. Biacore, owned by 
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GE Healthcare, is the largest maker of SPRI instruments, offering a variety of models for 
different scales of analysis.26 GWC Technologies currently manufactures an SPRI instrument 
with the ability to screen over 25 different analytes simultaneously.27 IBIS Technologies offers a 
versatile SPRI system that provides both fixed and scanning angle measurements for increased 
sensitivity.28 Toyobo, manufacturerof the MultiSPRinter, packages a microarray spotter with its 
SPR imager, integrating the entire fabrication process within a single product. 29 GenOptics has 
developed commercial SPRI instruments capable of interrogating arrays having more than 1,000 
different components.30  
SPRI is a robust technology that has proven to be a valuable tool for the label-free 
detection and analyses of biomolecules. The technique possesses the ability to sensitively detect 
a wide range of biomolecules, including nucleic acids, proteins, and carbohydrates. On account 
of the relatively large area of individual sensing elements, SPRI has a relatively poor limit of 
detection in terms of absolute bound mass, which might be a drawback in some sample-limited 
applications. While SPRI has not been widely utilized for multiparameter quantitation (examples 
focused almost exclusively on nucleic acid detection), the many successful demonstrations of 
multiplexed interaction screening make it a promising technology for such applications.  
Another plasmonic-based biosensing platform that has recently emerged is based on the 
phenomenon of extraordinary optical transmission through periodic, subwavelength nanoholes in 
metallic thin films.31 The intensity of light transmitted through these substrates is significantly 
higher than predicted by classical theory and has been shown to be mediated by surface 
plasmons.32 The periodic holes act as a high-order diffraction grating that launches propagating 
plasmons linking the front and back sides of the metal thin film. The propagating plasmons then 
decouple from the substrate by emission of a new photon from the back side of the film.33 Since 
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propagating plasmons are sensitive to changes in the local refractive index, similar to SPR, 
nanohole arrays are responsive to biomolecular surface binding events. However, in this system 
biomolecular binding is transduced as a shift in the wavelength of light maximally transmitted by 
the nanohole array. Several recent reports of nanohole-based biosensors have emerged out of the 
Larson group.34,35 The authors have rigorously defined the factors that affect device sensitivity 
and demonstrated the sensitive detection of anti-glutathione S-transferase antibodies down to 
concentrations as low as 10 nM on arrays that are capable of supporting at least 25 simultaneous 
measurements, as shown in Figure 1.3. Advantages of nanohole arrays for biomolecular 
detection include the extremely small footprint of the active sensing area (down to 1 µm2) and 
the batch fabrication potential of the substrates, both of which should greatly facilitate high 
levels of sensor multiplexing (yet to be demonstrated).  
1.4 Photonic techniques 
In addition to SPRI and nanohole arrays, several nonplasmonic optical biosensors currently show 
promise for high-throughput, multiparameter analysis—we term these “photonic techniques.” 
Photonic-based, label-free biosensing is not a new concept. As early as 1937, Langmuir and 
Schaefer described a method for evaluating the thickness of adsorbed monolayers of 
biomolecules on a metal surface by observing the colors generated by reflective interference.36 In 
the late-1960s, Vroman and Adams demonstrated the use of ellipsometry for measuring 
immunoadsorbed molecules on a surface.37 Following a timeline similar to that for SPR 
spectroscopy, optical biosensors based on technologies such as optical waveguides and reflective 
interferometry began to emerge in the 1990s.38,39 Examples that we will discuss here include 
photonic crystals, optical microcavity resonators, reflective interferometry, and imaging 
ellipsometry. Typically, these methods take advantage of microscale fabrication methods and 
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incorporate imaging or rapid scanning to interrogate a large number of sensors simultaneously or 
in near real time.  
Cunningham et al. have pioneered a novel photonic crystal biosensing platform that has 
proven to be effective for multiplexed screening and detection.40 Photonic crystals are 
engineered to selectively reflect a narrow bandwidth of light, and the wavelength at which this 
maximal reflection occurs is sensitive to the refractive index environment surrounding the 
substrate. As a result, bound biomolecules cause a measurable shift in the reflected wavelength 
(see Figure 1.4).40,41 The wavelength shift directly corresponds to the amount of bound 
biomolecule, and thus can be used for quantitation. With use of this principle of detection, 
photonic crystal biosensors have demonstrated the ability to detect adsorbed protein down to 
approximately 1 pg/mm2 on the surface.42  
For performing multiplexed measurements, plastic-molded photonic crystal structures 
have been incorporated into a microplate format for use with conventional biological assays, and 
multiple wells can be analyzed simultaneously using optical imaging techniques. Photonic 
crystal sensors are well suited for multiparameter detection and quantitation of biological 
analytes;40,42,43 however, many of the most relevant demonstrations to date have focused on 
multiplexed biomolecular interaction screening. For example, by monitoring the density of cells 
within a microplate well, Chan et al. have demonstrated the ability to rapidly screen compounds 
for effects on rates of cancer cell proliferation and apoptosis.44,45 They have also recently shown 
that a microplate photonic crystal format can be used to screen thousands of compounds for their 
ability to inhibit specific protein–DNA interactions.46 Choi and Cunningham incorporated 11 
different microfluidic channels onto a 96-well microplate system to allow parallel determination 
11 
 
of relative binding affinities between protein A and seven different IgGs using a single photonic 
crystal substrate.47  
Photonic crystal biosensors have enabled rapid, label-free monitoring of protein binding 
and cell growth, demonstrating the utility of these sensors for high-throughput screening 
applications. Scalable manufacturing methods have facilitated the commercialization of this 
technology, as it is currently available from SRU Biosystems.48 To date, photonic crystal 
biosensors have not been rigorously utilized for quantitative concentration determination in 
complex solutions; however, their promise for multiplexed detection points towards future 
applications in these areas.  
Optical microcavity sensors of various geometries have also shown promise for highly 
sensitive label-free detection.49 These sensors are based on the refractive index sensitivity of 
cavity modes supported by microfabricated waveguide structures that satisfy the constructive 
interference condition: 
λ = 2 
where m is a non-zero integer value, λ is the wavelength of light, r is the radius of the cavity, and 
n eff is the effective refractive index that is sampled by the optical mode. The wavelength at 
which resonance occurs is extremely narrow owing to precise fabrication of the optical cavity 
(high-Q cavities). Because the resonant wavelength is a function of the refractive index 
environment surrounding the optical cavity, sensing is accomplished by measuring the change in 
resonant wavelength in response to biomolecular binding at the microcavity surface. The narrow 
resonance bandwidth of high-Q microcavities, amongst other factors, helps make small shifts 
resolvable, which translates into low detection limits for biomolecular binding events.  
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Using microtoroidal resonators, Armani et al. demonstrated single-molecule detection of 
the cytokine interleukin-2 binding to an antibody-modified microcavity.50 Suter et al. utilized 
liquid-core optical ring resonators (LCORRs) to detect DNA at a surface density of 4 pg/mm2,51 
and Zhu et al. demonstrated virus detection with LCORRs at 2.3 × 10–3 pfu/mL.52 White et al. 
also introduced a multiplexed LCORR array incorporating up to eight anti-resonant reflecting 
optical waveguides coupled to a glass capillary allowing interrogation of multiple optical 
cavities.53,54 In addition to containing multiple sensing elements, the active resonator element, 
the capillary, integrates fluid handling into the sensing system.  
Using silicon-on-insulator (SOI) microring resonators, Ramachandran et al. measured 
bacteria down to concentrations of 105 cfu/mL.55 Mandal et al. demonstrated an optofluidic 
system based on microfabricated photonic crystal cavities that are coupled to a waveguide bus on 
a patterned SOI substrate.56,57 Though they have demonstrated a 20-component-capable chip, 
they have not yet performed actual biosensing with their system.  
Work by De Vos et al.58 and Ramachandran et al.55 has illustrated the potential for using 
SOI microring resonators for multiplexed biosensors. Notably, standard semiconductor 
processing should allow multiple sensors to be integrated onto a single chip, as shown in 
Figure 1.5. Furthermore, fabrication of both waveguides and microcavities on the same SOI 
substrate may offer significant advantages in terms of baseline noise, compared with coupling 
via even the most efficient free-standing extruded optical fiber approaches.59 Our own 
unpublished work has demonstrated that biomolecular binding to arrays of 24 30-µm-diameter 
SOI microring resonators can be simultaneously monitored with a sensitivity to surface-bound 
protein of approximately 1 pg/mm2 (A.L. Washburn and R.C. Bailey, unpublished results). 
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Given the very small total surface area of SOI microring structures, this corresponds to detection 
limits of less than 100 ag of total bound protein.  
Thus far, optical microcavity resonators have shown promise for highly sensitive, label-
free biosensing. In addition, the small size of the microcavities makes these biosensors more 
sensitive to the absolute mass of surface-adsorbed biomolecules compared with techniques 
which use larger sensing elements or surface areas. Multiplexed sensing with optical microcavity 
resonators appears promising, and literature demonstrations are expected in the near future.  
Other photonic detection techniques such as ellipsometry and reflective interferometry 
are also candidates for label-free multiplexed biosensing applications. In general, these 
techniques sensitively measure small changes in optical thickness on a surface. In 1995, Jin et al. 
first demonstrated that imaging ellipsometry could be used to measure arrays of adsorbed 
biomolecules on a surface.60 The technique is identical to traditional ellipsometry—the 
measurement of polarization changes in light reflected off a surface—except that a CCD imaging 
detector is utilized to simultaneously interrogate thousands of discrete locations on a 
functionalized surface. Standard imaging ellipsometry can measure coatings of biomolecules 
approximately 0.1 nm thick (average optical thickness) on a surface.61 Using oblique-incidence 
reflectivity difference microscopes, Landry et al.62 reported sensitivity down to optical 
thicknesses of approximately 0.01 nm for adsorbed protein on a surface and Wang and Jin63 
reported a simple array-based multiplexed analysis of common proteins (bovine serum albumin, 
human serum albumin, IgG, and fibrinogen). Subsequent examples have demonstrated 48-
element arrays with the ability to simultaneously detect human IgG, fibrinogen, and five protein 
markers for hepatitis.61 Landry et al. have also shown that oblique-incidence reflectivity 
difference microscopy can be used to analyze large arrays having hundreds of sensing 
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elements.62,64 However, these spots were largely redundant, containing only one or two unique 
types of capture probes such as antibodies against IgG and albumin or nucleic acid arrays 
presenting only complements to a single DNA target sequence.  
Currently, imaging ellipsometry allows measurement of large arrays of biomolecular 
interactions on a single surface with sensitivity comparable to that of SPRI.64,65 Recent 
applications of the technique have shown the ability of imaging ellipsometry to detect multiple 
biomolecules simultaneously from complex samples. Though it is not as fully developed as 
SPRI, recent refinements and improvements making the technique more “user friendly” (see the 
review by Jin61) may lead to an increased application of the technique for multiparameter 
analyses.  
Reflective interferometric platforms have also shown the ability to measure small 
changes in optical thickness of a biomolecular layer on a surface. Rather than measuring changes 
in polarization, as in the case of ellipsometry, reflective interferometric techniques utilize optical 
interference between incident photons reflecting off a thin film. Changes in reflectance can thus 
be correlated with differential interference that occurs as biomolecules attach to a reflective 
surface. The sensitivity of reflective interferometric techniques enables measurement of changes 
in surface thickness of about 1 pm, corresponding to approximately 1 pg/mm2 of adsorbed 
biomolecule on the surface.66,67 Gauglitz and coworkers have applied reflective interferometric 
spectroscopy (RIfS) to the multiplexed measurement of biomolecules in 96- and 384-well 
plates.68-70 Using a backlit configuration with CCD imaging, the authors were able to perform 
real-time analyses of biological binding events. This technology has been demonstrated for 
multiplexed assays aimed at screening antibodies against triazine libraries (four antibodies 
against 36 different compounds)69 as well as for epitope mapping of the enzyme 
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transglutamase.70 The same group has also utilized RIfS for measuring nucleic acid duplex 
melting71 and cell binding.72 A commercial RIfS platform is currently being developed by 
Biametrics.73  
Özkumur et al. have demonstrated a spectral reflectance imaging biosensor that measures 
small changes in interference due to the change in optical pathlength from surface-adsorbed 
molecules.67 With use of a CCD camera, 200 different spots can be measured simultaneously, 
allowing real-time kinetic measurements to be made by monitoring the binding regions through a 
glass microfluidic substrate. To date, they have demonstrated the interaction of a protein with a 
surface-bound capture agent at a detection limit of 19 ng/mL. A commercialized version of this 
technology is being developed by Zoiray Technologies.74  
Zhao et al.75 reported a similar reflectometric system for immunosensing applications 
called the “biological compact disc” (commercialized by Quadraspec76). This technique has been 
expanded for parallel analyses and is referred to as “molecular interferometric imaging” (MI2). 
MI2 has been used to measure prostate-specific antigen (PSA) as well as interleukin-5 (IL-5) 
with detection limits of 60 and 50 pg/mL, respectively, on a surface presenting 128 
functionalized areas.77,78 Currently, however, MI2 has only demonstrated the ability to measure 
the concentrations of two different proteins simultaneously. Mace et al. recently utilized an 
array-based sensor for measuring three different cytokines simultaneously and demonstrated a 
limit of detection of 25 pg/mL for interferon-γ; however, the sensitivity and reproducibility was 
limited by large variation in spot morphology as a result of needing a dry surface for analysis.79  
Though they are widely variable in experimental setup (front- versus back-illuminated, 
fluid handling, etc.), reflective interferometric techniques have proven to be extremely sensitive 
to biomolecules adsorbed on a surface. Quantitative multiplexed assays based upon 
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reflectometric techniques are still at an early stage of development, but molecular library 
screening applications are more mature. Future efforts in multiplexed analyses will likely lead to 
improvements in limits of detection for proteins and broaden the classes of target analytes to 
which the technology can be applied.  
1.5 Electrical Detection 
Electrical detection methods have been suggested as attractive alternatives to optical readouts 
owing to their low cost, low power consumption, ease of miniaturization, and potential 
multiplexing capability.80,81 The basis of these detection systems stems from a binding-induced 
change in some electrical property of the circuit, of which the sensor is a vital component. 
Electronic biosensing platforms that we will discuss here include semiconducting silicon 
nanowires (SiNWs), carbon nanotubes (CNTs), and electrochemical impedance spectroscopy 
(EIS).  
The most common mode of biomolecular detection using semiconductor nanowires is 
based on the principles of the field effect transistor (FET). In normal transistor operation, a 
semiconducting element is attached to a source and a drain electrode, and current flowing 
through the element is modulated by changing the voltage applied to a gate electrode.82 In a 
FET-based nanowire biosensor configuration, the SiNW, functionalized with appropriate 
receptors such as single-stranded DNA oligomers or antibodies, is connected to a source and 
drain electrode. Binding of target biomolecules changes the dielectric environment around the 
nanowires and plays a role similar to that of the gate electrode. Thus, molecular binding can be 
directly quantitated as a change in the conductivity of the nanowires (see Figure 1.6).83 
Compared with the relatively large dimensions of earlier planar FET sensors, the small size of 
nanowires means that individual binding events result in a more significant change in the 
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electrical properties of the circuit.84 This unique feature of nanowire FETs provides ultrahigh 
sensitivity down to the single-molecule level.85 Since the first report of biosensing applications,86 
SiNWs have been shown to be broadly applicable to a wealth of analytical challenges, including 
the label-free detection of ions,86 small molecules,87 proteins,86,88,89 nucleic acids,90-92 viruses,85 
and neuronal signals.93  
The first example of a multiplexed array of SiNW sensors was reported in 2004 by 
Patolsky et al.85 Surfaces of two p-type SiNWs were modified with monoclonal antibodies 
specific for influenza A and adenovirus particles, and selective binding and unbinding responses 
for each virus were detected in parallel at the single-particle level. In 2005, Zheng et al. 
demonstrated the multiplexed detection of three cancer marker proteins, free PSA, 
carcinoembryonic antigen, and mucin-1, in undiluted serum at femtomolar concentrations.88 
Notably, in this work the serum sample was desalted to reduce the solution ionic strength.  
Nanowire sensing technology holds much promise for multiparameter biological detection; 
however, there are some significant challenges to be addressed before routine operation of 
higher-order multiplexed analyses can be realized. One challenge that is inherent to FET-based 
detection systems is that they suffer reduced sensitivity when operated at physiological ionic 
strengths (approximately 0.15 M). Ions in solution gate the FET similarly to the biomolecular 
target, and thus the device can experience a much diminished response to the binding event.94 
This can be avoided by desalting the sample prior to analysis, but introduces an additional 
preparative step prior to analysis.82,92 Though it is only partially related to the absolute mass 
sensitivity of an individual nano-FET, the nanometer-size regime of these sensing elements also 
makes their response highly dependent upon sample cell geometry and related parameters.3,4  
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A second significant challenge relates to the integration of nanowires on substrates with 
reproducibility and uniformity.95 Most SiNW biosensors reported to date have used nanowires 
fabricated via the vapor–liquid–solid (VLS) method, which gives high yields of uniform 
nanowires that have very advantageous properties for electronic and bioelectronic applications. 
Large numbers of VLS nanowires are grown simultaneously from individual catalyst particles 
and subsequent positioning and alignment on a sensor surface represents a significant hurdle. 
Recently, Fan et al. introduced a novel method that addresses this challenge, achieving 
approximately 95% directional alignment of VLS nanowires via contact printing, which may 
greatly help facilitate integration of high-density VLS nanowire sensing arrays.95  
An alternative method of preparing SiNW arrays was reported—originally for 
nonanalytical applications —by Melosh et al. in 2003.96 This technique, termed “superlattice 
nanowire pattern transfer” (SNAP), utilizes a novel template and shadow mask approach to 
create ultrahigh density arrays of precisely aligned SiNWs on standard SOI substrates. Using 
these SNAP nanowires, shown in Figure 1.7, Bunimovich et al. demonstrated label-free 
detection of subnanomolar (approximately 100 pM) DNA concentrations.92 Stern et al. have used 
CMOS-compatible SiNWs, though fabricated at considerably lower densities, for the detection 
of proteins (antibodies) below 100 fM.89 A combination of the described scalable fabrication 
methods and ultrasensitive device operation may provide an attractive method for measuring the 
concentrations of many different biomolecules simultaneously.  
CNT-based devices have also been widely investigated as biosensors owing to their 
unique structure-dependent electronic and mechanical properties.97 In particular, single-walled 
CNTs can be metallic, semiconducting, or semimetallic depending on the tube diameter and the 
chirality.98-100 As a result, they have been used in a wide range of applications, including, but not 
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limited to, the FET transduction principle. CNT-based biosensors have been demonstrated for 
detection of small molecules,101,102 DNA (approximately 50 nM),100,103,104 hepatitis C viral RNA 
(0.5 pM),105 and IgE (250 pM).106 Multiparameter detection of biomolecules using a FET 
operation modality has yet to be realized, but reports of multiplexed gas detection point towards 
the possibility.107 Using AC voltammetry and multiwalled CNT arrays, Koehne et al. 
demonstrated a readily scalable approach to DNA detection. A novel electrochemical etching 
and surface passivation scheme that should allow multiplexing was described, but it was only 
applied to single-parameter detection at moderate sensitivity (approximately 100 nM).104 CNT 
arrays have shown potential for biological detection; however, widespread utility has been 
limited to date by difficulties in controlling the physical parameters relevant to biosensing: 
length, diameter, and chirality.98 These issues are particularly significant for multiplexed sensing, 
in which uniform and reproducible performance of each sensor element is essential.  
Another electrical transduction method that has shown promise for multiparameter 
biological detection is EIS. In EIS, sensing is accomplished by measuring changes in the 
resistance and/or capacitance of the electrode–solution interface upon binding of a target 
molecule to a receptor-functionalized surface.80,81 Compared with other electrical measurements, 
such as amperometry and voltammetry, EIS does not require the use of enzymes to amplify 
binding events by generating faradaic readout signals. This is very significant because sensor 
crosstalk due to diffusion of enzymatic products would be a fatal problem for multiplexed 
detection applications.108 Improvements to basic EIS operation have been reported that utilize 
alternative electrode materials such as polymers109,110 and nanoparticles.111,112 Furthermore, 
electrode geometry has been shown to be extremely important, with arrays of interdigitated 
electrodes providing greater device sensitivity.81,113,114 Various types of biological species have 
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been detected using EIS, including nucleic acids113,115,116 down to 10 fM117 and bacteria114,118 as 
low as 10 cfu/mL.119 Impedance-based sensing systems have also been applied to monitor 
protein–carbohydrate120 and protein–protein interactions.121,122 Recently, a demonstration of 
multiplexed protein interaction monitoring was reported by Yu et al. where an array of gold 
electrodes was used to probe for four antibodies that recognized proteins immobilized on the 
electrodes.108  
At this stage, EIS appears to be promising for multiplexed biosensing and several 
commercialized systems are already available for cell-based screening123 (from ACEA 
Bioscience124 and Applied BioPhysics125). In these systems, cells grown in electrode-containing 
wells can be assayed for proliferation,126 adhesion and spreading,127,128 and cytotoxicity.126,128-130 
As the technology continues to mature, it will be necessary to develop a greater understanding of 
the exact mechanisms underlying the binding-induced change in impedance. This insight will 
then allow for better a priori design of experimental conditions, circuit modeling, and fitting of 
the resulting data.81  
1.6  Mechanical sensors 
Mechanical sensors are another promising tool for the multiplexed, label-free detection of 
biomolecules. Like other label-free sensing methods, the specificity of these sensors is 
determined by the topmost coating layer, which can range from a modified gold surface to a 
variety of polymers.131-133 One key advantage of this class of sensors is that it is amenable to a 
wide range of surface coatings.  
Well-known acoustic wave biosensors, including quartz crystal microbalance and 
integrated surface acoustic wave technologies, are based on mechanical transduction and thus do 
not require labels. Both approaches utilize a piezoelectric quartz crystal connected to an 
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oscillating external circuit that is able to measure the resonant oscillatory frequency of the 
system. Binding of molecules to the surface of the sensor is measured as a shift in the resonance 
frequency of the device.134 These sensors have been utilized to detect a wide range of 
biomolecules, including nucleic acids,135-137 proteins,138-140 and lipids.141 While acoustic wave 
devices are extremely sensitive towards binding events, there are a number of factors that limit 
their effective utilization for quantitative, multiplexed biosensing.142,143 Most importantly, 
considerations such as viscoelasticity and hydration lead to nonlinearities in frequency shifts 
accompanying biomolecular binding to the quartz crystal microbalance surface.144-146  
A second class of mechanical sensors that has recently attracted considerable attention as 
a multiplexed, label-free biosensing platform is microcantilevers, as highlighted in Figure 1.8. 
Binding events on the cantilever surface are transduced via one of three methods: deflection of 
the cantilever,147 a change in the resonance frequency of the cantilevers,148 or a change in the 
stress exerted on the cantilever, which in turn generates an electric current in an attached 
piezoelectric element.133  
The simplest transduction event to monitor is the change in deflection, measured by 
reflecting a laser beam off the back of a cantilever and measuring the position with a split 
photodiode. The binding of an analyte to the surface of the cantilever exerts a torque, meaning 
that the location on the cantilever at which the molecule binds affects the amount of deflection. 
Because each molecule does not generate the same amount of deflection, the position of bound 
molecules must be considered during deflection measurements (particularly important for large 
molecules). Furthermore, the required number of molecules bound to a surface to exert a 
detectable deflection is significantly higher than with the other two transduction methods 
(discussed below).149 
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Owing to its ease of implementation, cantilever deflection has resulted in a wide range of 
biological molecules and even entire microorganisms being detected, illustrated schematically in 
Figure 1.9. In 2000, Fritz et al. demonstrated the detection of a single base-pair mismatch within 
a 12-mer sequence of DNA.150 Following this, McKendry et al. demonstrated the detection of 
DNA to concentrations as low as 75 nM with an eight-component array.151 A number of protein 
systems have also been studied with this technique.152-154 Of special interest is the work by Wu  
et al. in which PSA was detected at clinically relevant levels as low as 0.2 ng/mL in serum 
containing 1 mg/mL albumin and plasminogen.155 Recently, an interesting report out of the same 
laboratory demonstrated sensitive protein detection using very large arrays of up to 960 
individually readable microcantilevers.156 Notably, though only a single protein was detected, 
PSA, the sensitivity was quite good, 1 ng/mL, and the sensor array was shown to have minimal 
response to nonspecific proteins at much higher concentration.  
Resonance-based transduction of microcantilevers involves monitoring the change in the 
resonance frequency upon binding of an analyte.148 This is typically accomplished using one of a 
number of interferometric schemes. While the readout equipment for this method is significantly 
more complex than that for deflection-based methods, it is by far the most sensitive.147 One 
limitation of resonance-based sensing is that the oscillations of microcantilevers are highly 
susceptible to dampening effects in liquids, which vary with solution composition.  
Using the more sensitive resonance-based measurement strategy, involving the 
measurement of cantilever resonance frequency shifts, Ilic et al. demonstrated the detection of a 
single strand of DNA 1,587 base pairs in length, having a mass of 1.7 ag.157 A number of protein 
systems have also been explored, with detection limits as low as 10 pg/mL for PSA.158,159 Studies 
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focusing on the detection of microbes have also pushed the limits of detection down to single 
cells and virus particles.160-162  
The incorporation of piezoelectric materials into microcantilevers can also be used to 
probe the presence of biomolecules.133 In the piezoelectric method, the binding of an analyte 
causes the cantilever to deflect, subsequently depolarizing the material and generating a current. 
It should also be noted that piezoelectric-modified microcantilevers can be used for both 
deflection-based and resonance-based measurements. While the piezoelectric method is less 
sensitive than the resonance method, it does not require the extensive optical layouts used in the 
other techniques and allows for incorporation of additional electronic components in the sensor. 
Even though detection systems have been demonstrated utilizing the piezoelectric readout 
method, including examples of nucleic acid (limit of detection 10 nM for a 12-mer) and protein 
(limit of detection 5 ng/mL) analysis,163-165 significant advances are still needed to lower the 
limits of detection to compete with resonance-based methods.  
Microcantilever-based sensors currently represent an attractive method for sensitive, 
label-free detection of biomolecules. The detection limits are comparable if not better than those 
for SPRI and the flexibility of operation and ease with which the cantilevers can be 
functionalized allows for virtually any system to be studied. Currently, several companies are 
developing commercial microcantilever-based systems, including Cantion166, BioScale,167 and 
Concentris.168 The advances stemming from both industry and several academic groups are 
rapidly advancing microcantilever technology for multiparameter bioanalytical applications.  
1.7 Conclusions and Outlook 
Taking values from a selection of literature sources and discussions with experts in the respective 
fields, we have compiled a table comparing many of the label-free biosensing technologies 
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discussed in this review (Table 1.1), highlighting reported limits of detection, degree of 
multiplexing demonstrated in the literature, and status of commercialization. This is not meant to 
be a standalone selection guide, as the specific requirements of the assay(s) should play a critical 
role in which technology best suits the application at hand. For example, absolute mass 
sensitivity may be of extreme importance in sample-limited applications and therefore a smaller 
surface area sensor, provided there is no loss in “bulk” sensitivity, might be advantageous.  
 Another application might require very immediate analysis because of sample 
degradation, for example. In this situation, nanowire sensors requiring sample desalting might 
not be the best choice. Having small sensing features may allow for construction of higher-
density sensor arrays for more highly multiplexed applications. However, a significant 
discrepancy may exist between theoretical and “functional” sensor densities, which may be 
limited more by the method of sensor derivitization than the dimensions of the sensing elements 
themselves. While it is certain that each technology will have specific advantages and 
disadvantages for a given application, each of the modalities described may be the best option for 
a targeted multiparameter bioanalysis situation.  
There are more specific applications and many additional compelling reasons that 
motivate the development of new and improvement of current label-free multiparameter 
biodetection technologies. The next several years promise to be an exciting time in this rapidly 
advancing field, which is poised to impact clinical diagnosis and disease management in the very 
near future.  
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1.8 Tables and Figures 
Table 1.1. Comparison of several promising label-free, multiparameter biosensing technologiesa  
Technology 
Reported limit of 
detection (lowest 
values found in the 
literature) 
Multiplexing Commercial product? 
Plasmonic 
Surface plasmon 
resonance imaging 
∼1 fM for nucleic 
acids19,20  1,000+ elements 
demonstrated17 Yes
26-30
  
0.5 pg per element for 
proteins15,16 
Nanohole arrays 10 nM for proteins35  25 measurements demonstrated35 No 
Photonic 
Photonic crystals 1 pg/mm2 [40]  1,536-well plate 
assays48 Yes
48
  
High-Q 
microcavities  
Microtoroids: single-
molecule (zeptogram)50 Two-component169, 
larger arrays 
possible  
No 
Silicon-on-insulator 
microrings: 80 agb  
Imaging ellipsometry <1 ng/mL for protein61 
∼10-component 
assays 
demonstrated61 
No 
Reflective 
interferometry 1 pg/mm
2 [66,67]
  
384-well plate 
assays68 Yes
74,75
 
Electronic 
Silicon nanowires 10 fM for DNA
90,91
, 
∼3 pM for protein88 
3 parameters 
demonstrated88 No 
Carbon nanotubes 
0.5 pM for RNA 
strand105 Single parameter 
demonstrated Yes
170
 
250 pM for a protein106  
Electrochemical 
impedance 
spectroscopy 
∼25 pM for protein123 4 proteins detected108 Yes
124,125
 
Mechanical Microcantilevers 1.7 ag157 320+ demonstrated156 Yes
166-168
  
 
aCompiled to the best of the authors’ knowledge at the time of submission. In addition to our 
own expertise and searching, additional information was sought from experts in the respective 
fields. The authors apologize for any unintentional oversights.  
bA.L. Washburn and R.C. Bailey, unpublished results. 
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Figure 1.1. A surface plasmon resonance imaging (SPRI) instrumental configuration. 
Biomolecular binding events are transduced as a change in reflected light intensity, and 
multiplexing is accomplished by imaging a large portion of the substrate using the CCD. 
(Adapted from reference 5) 
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Figure 1.2.  (a) SPRI image of a 120-element double-stranded DNA array. (b) Difference image 
and c line scan after incubation of the array from (a) with the transcription factor Gal4. Specific 
protein binding is observed as a positive change in the reflected light image. (Adapted from 
reference 16)  
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Figure 1.3.  (a) Sample introduction onto a nanohole array biosensor. (b) Nanohole array 
instrumental setup. (c) CCD image of 30 sets of nanohole arrays having different geometries. (d, 
e) Scanning electron micrographs showing a top and a side view of a 9 × 9 nanohole array. 
(Adapted from reference 34) 
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Figure 1.4.  (a)  Photonic crystal biosensors transduce biomolecular binding events by 
measuring the shift in wavelength of light reflected by the substrate.  (b) Shown here is a 384-
well-plate configuration of a photonic crystal sensing platform, which can be interrogated using a 
light-emitting diode and a simple spectrometer.  (c) This example demonstrates the screening of 
small-molecule libraries for inhibiting a specific DNA–protein binding event. (Adapted from 
reference 46) 
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Figure 1.5.  Photograph of a five-ringed silicon-on-insulator microring resonator array used to 
detect biological binding events. In this example, the microrings are accessed by on-chip 
waveguides that are tapered off-chip to conventional fiber optics. (From reference 55)  
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Figure 1.6.  (a) A silicon nanowire-based field effect transistor device configured as a sensor 
with antibody receptors (green), where binding of a protein with net positive charge (red) yields 
a decrease in the conductance. (b) Cross-sectional diagram and scanning electron microscopy 
image of a single silicon nanowire sensor device, grown via the vapor–liquid–solid method, and 
a photograph of a prototype nanowire sensor biochip with integrated microfluidic sample 
delivery. (Adapted from reference 83) 
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Figure 1.7. A diagram (a) and a scanning electron micrograph (b) of three groups of ten, 20-nm-
wide silicon nanowires used for label-free DNA detection. With use of the superlattice nanowire 
patterning scheme, large numbers of precisely aligned nanowires can be fabricated for use as 
biosensors. (From reference 92) 
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Figure 1.8. Two-dimensional microcantilever array chip used to monitor protein–protein 
interactions. (a) A reaction well. There were multiple cantilevers in each reaction well. Laser 
light reflected off a cantilever’s end pad was used to monitor the deflection of cantilevers. (b) A 
chip soaked in deionized water. (c) A scanning electron micrograph of three cantilevers in a 
reaction well. (Adapted from reference 156) 
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Figure 1.9. The principle of deflection-based microcantilever biosensing. (From reference 155) 
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2.1 Abstract 
In less than 20 years, our appreciation for micro-RNA molecules (miRNAs) has grown from an 
original, curious observation in worms to their current status as incredibly important global 
regulators of gene expression that play key roles in many transformative biological processes. As 
our understanding of these small, non-coding transcripts continues to evolve, new approaches for 
their analysis are emerging. In this critical review we describe recent improvements to classical 
methods of detection as well as innovative new technologies that are poised to help shape the 
future landscape of miRNA analysis. 
2.2 Introduction 
MicroRNAs (miRNAs) constitute a critically important class of non-translated, small RNAs 
which post-transcriptionally regulate gene expression via one of multiple mechanisms.1 First 
reported in 1993 as a curious anomaly in Caenorhabditis elegans,2 thousands of miRNAs have 
now been identified and shown to play key roles in many transformative biological processes, 
including developmental timing,3-5 stem cell differentiation,6-8 and disease development.9,10 
Although the complete functional role that miRNAs play still remains to be fully elucidated, 
their conservation throughout Archaea,11 bacteria,12 plants,13 and animals14 indicate their 
importance as key regulatory control elements during both normal and transformative biological 
processes. In contrast to small interfering RNAs (siRNAs),15 miRNAs are endogenously encoded 
into the genome and are initially transcribed as long primary transcripts ( ≥1 kb; pri-miRNAs), 
which are then enzymatically processed in the nucleus by Drosha into ~70 nucleotide stem loop 
structures (pre-miRNAs). Pre-miRNAs are exported into the cytoplasm and processed by the 
enzyme Dicer into the mature 19-24 nucleotide duplexes.  
44 
 
As opposed to siRNAs, which operate almost exclusively via mRNA cleavage at regions 
having perfect sequence complementarity, miRNAs can modulate gene expression via one of 
three distinct mechanisms and do not necessarily require perfect base pairing to act upon a 
target.1 In the cytoplasm, the single strands form the mature miRNA duplexes are incorporated 
into the RNA-induced silencing complex (RISC). Guided by the miRNA, the RISC complex can 
then act on mRNAs through one of three distinct mechanisms: 1) cleavage of the targeted 
mRNA, a mechanism commonly observed in plants that often requires perfect complementarity 
between miRNA and mRNA, 2) translational repression, whereby miRNA/RISCs bind to 3′ 
untranslated regions of mRNAs preventing translation by the ribosome, and 3) the recently 
discovered enhancement of translation, in which a miRNA binds to the 5′-terminal 
oligopyrimidine tract (5′-TOP) and relaxes a cis-element in the 5′ UTR that inhibits translation.16 
There are over 15,000 mature miRNA sequences listed in the recently released miRBase 
15.0 database, with ~1000 identified as human miRNAs.17 Through one or more of the 
aforementioned mechanisms, each miRNA can potentially regulate the expression of multiple 
mRNAs, meaning that downstream production of many gene products, ultimately proteins, can 
be tremendously influenced by alterations in the expression of a single miRNA.18 In fact, it is 
known that a majority of human mRNAs are regulated by one (or more) miRNAs.19 
Furthermore, it has recently been experimentally demonstrated that multiple miRNAs, many of 
which are expressed as clusters that are encoded in close genomic proximity to one another, can 
target the same mRNA,20 adding further complexity to the mechanisms through which miRNAs 
regulate gene expression. 
Given the prominent role that miRNAs play in “normal” gene expression and organismal 
function, it is not surprising that the aberrant expression of miRNAs can lead to a wide range of 
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human diseases and disorders, including: cancer,21,22 neurodegenerative diseases,23,24 diabetes,25 
heart diseases,26 kidney diseases,27,28 liver diseases,29 and altered immune system function,30,31 
amongst others. In addition to contributing to the underlying cause of a particular disease, 
miRNAs can also represent potential therapeutic targets32-34  and diagnostic biomarkers.35 
Particularly exciting are the discovery of circulating miRNAs, which are promising biomarker 
candidates since they can be detected from readily attainable blood samples.36-38 
Almost entirely due to their short size, the analysis of miRNAs is considerably more 
difficult than it is for much longer mRNAs. In particular, the small size of miRNAs greatly 
complicates the use of standard molecular biology methods based upon the polymerase chain 
reaction (PCR), as detailed below. Furthermore, the short size also makes hybridization-based 
assays difficult as the melting temperature and binding dynamics of complementary probes 
toward their target miRNAs vary significantly with the identity of the target miRNA. 
Furthermore, experimental parameters, such as the buffer composition, the hybridization 
temperature, and incubation time all can contribute to significant assay-to-assay variation.39-43 
So, what are desirable attributes for existing and emerging miRNA analysis methods? 
Clearly the most appropriate technique for a given measurement challenge varies tremendously 
based upon the application and setting. For example, in an academic laboratory setting well-
established techniques that rely upon the tools of traditional molecular biology might find favor, 
whereas emerging micro- or nanotechnology-based methods might eventually be most well-
suited for point-of-care diagnostic applications. Two other important considerations when 
selecting an existing or designing a new method for miRNA analysis include dynamic range and 
multiplexing capability. The expression level of miRNAs, as determined via intracellular copy 
number, can vary from sequence to sequence by up to a factor of 105 within a single sample. 
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Furthermore, the recent discoveries of multiple miRNAs targeting a single mRNA and regulated 
expression amongst entire families of miRNAs provide motivation for global miRNA analyses, 
which will require methods wherein multiple miRNAs, and perhaps the entire “miRNA-ome”, is 
simultaneously detected in parallel in order to fully elucidate the important and complex function 
of these tiny regulators. 
On account of the critical biological role that miRNAs play in biological function and the 
diverse range of applications in which miRNA analysis is of value, significant effort has been 
invested over the past decade to develop new detection methods. In this critical review we 
highlight a selection of existing and emerging tools for miRNA analysis, with a particular 
emphasis on the current state-of-the-art and important developments in this fast moving field, as 
reported in the primary literature in the past four years. 
2.3 Computational approaches for miRNA target prediction 
While the major focus of the review article lies in existing and emerging miRNA detection 
methods, it is worthwhile to briefly mention computational methods for predicting miRNA 
targets.44 Given that the number of potential mRNA targets and the fact that miRNAs can 
regulate mRNAs that are not perfectly complementary in sequence, the experimental 
identification and validation of miRNA regulatory sites is a vast challenge. For this reason, 
extensive effort has been invested in developing computational methods for predicting the 
mRNA targets of miRNAs. 
One general class of computational methods for the prediction of miRNA targets utilizes 
perfect or imperfect complementarity via Watson-Crick base-pairing between the miRNA and 
possible target candidates.45  Most of these approaches focus on the complimentary at seed 
sequences, 5-8mers at the 5’ end of an miRNA that are often highly conserved.46-48 PicTar, 
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utilizes the sequence complementarity to target sites with emphasis on perfect base-pairing in the 
seed region,47,49,50  while TargetScan, one of more established computational tools, accounts for 
both complementarity as well as evolutionary conservation  to provide a relatively likelihood that 
a given sequence is a miRNA target.48,51   
Another general framework for prediction of miRNA targets involves energetic 
calculations.  DIANA-microT, developed by Kiriakidou et al., is an algorithm that identifies 
miRNA targets based on the binding energies between two imperfectly paired RNAs 52-54 and 
RNAHybrid predicts miRNA targets by finding the most energetically favorable hybridization 
sites of a small RNA in a larger RNA sequence.55,56  The miRNanda prediction algorithm 
includes contributions from the interaction binding energy, sequence complementarity between a 
set of mature miRNAs and a given mRNA, and also weights the conservation of the target site 
across various species.57,58  In contrast to other energetic calculations, STarMIR, models the 
secondary structure of an mRNA to determine the likelihood of miRNA binding.59  
The past few years has seen incredible growth in the area of computational prediction of 
miRNA targets. However, continued progress remains to be achieved as many of the 
aforementioned tools offer too many false positive target sites. Furthermore, many of the 
approaches have been developed using experimentally validated miRNA:mRNA systems, 
therefore introducing bias against miRNAs having and unusual or uncommon sequence.  
Nonetheless, the continued evolution of miRNA target prediction methodologies will, along with 
emerging detection methods, play a key role in fully elucidating the mechanisms by which 
miRNAs regulate normal and potentiate abnormal organismal function – providing a link 
between diagnostic insight and potential therapeutic opportunities.  
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2.4 Molecular biology-based analysis methods 
Early reports featuring miRNA measurements were fueled by what was already available in the 
laboratories of researchers at the forefront of the field—traditional molecular biology techniques 
such as cloning and enzymatic ligation assays. As timing would have it, miRNA research began 
to gather momentum directly on the heels of the genome technology explosion, and thus 
technologies such as RT-PCR and cDNA microarrays were rapidly adapted to accommodate the 
needs of the miRNA researcher. This section details the current state-of-the-art for miRNA 
detection. Based upon well-established methodologies, but with the recent incorporation of 
several very important innovations, these techniques represent the most commonly utilized 
methods for miRNA analysis in the research biology laboratory setting.  
Cloning 
Cloning was one of the first techniques utilized to detect and discover miRNAs.60-62 Although 
slow and laborious, cloning is still at times used for miRNA detection. A more recent 
development that has been developed for the discovery of miRNAs is miRAGE – miRNA serial 
analysis of gene expression.63 Similar to cloning, small RNAs are extracted and amplified via the 
reverse-transcriptase polymerase chain reaction (RT-PCR) into complementary DNAs (cDNAs). 
In this application, biotinylated primers are utilized in the PCR step allowing the cDNA products 
to be purified via affinity chromatography with streptavidin-coated beads. The cDNAs are 
enzymatically cleaved from the beads and the eluted products can be cloned and sequenced. 
miRAGE is advantageous in that it can identify up to 35 tags in a single iteration, versus about 
five using conventional cloning.63  However, this technique is extremely labor intensive, requires 
hundreds of µg of total RNA, and only provides information as to the presence or absence of a 
particular miRNA from within a sample.64 While cloning still remains a powerful technique for 
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the validation and discovery of novel miRNAs, the associated shortcomings of the technique 
make it impractical for high-throughput miRNA detection and expression profiling.37 
Northern Blotting 
At present, the most standard method for the detection of miRNAs is Northern blotting.65-67 
Northern blotting offers a number of advantages for miRNA analysis including a number of well 
established protocols and amenability to equipment readily available in most molecular biology 
laboratories. Additionally, since Northern blotting involves a size-based separation step, it can be 
used to detect both mature and precursor forms of a miRNA, which is appealing for studies 
which focus on the mechanisms of miRNA processing.  
Common protocols for Northern blotting involve miRNA isolation, polyacrylamide gel 
electrophoresis, transfer of the separated sample to the blotting membrane, and visualization via 
hybridization with a radioactively labeled DNA strand complementary to the miRNA of interest. 
Despite its widespread use, traditional Northern blotting is, in general, plagued by a lack of 
sensitivity (up to 20 µg of total RNA required per blot) and a laborious and time consuming 
protocols (often taking several days for complete analysis), which limits its utility in a clinical 
setting.68 Furthermore, the technique often displays a limited dynamic range (2-3 orders of 
magnitude depending on the visualization method) and the reliance on a radioactive tag 
(typically 32P) can be disadvantageous in some settings.69 Northern blots do allow for multiple 
samples to be analyzed in a side-by-side format, but only one miRNA can be assayed for at a 
given time, a drawback which is of increasing importance as researchers strive towards global 
analyses for a systems level understanding of miRNA function. 
A number of improvements have been made to traditional Northern blotting protocols 
that help assuage several of the aforementioned problems. Of particular significance is the 
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incorporation of locked nucleic acid (LNA) hybridization probes.70-72 LNAs are based upon 
DNA bases but feature the addition of a methylene bridge connecting the 2′-oxygen of the ribose 
to the 4′-carbon, effectively rigidifying the strand by inducing organization of the phosphate 
backbone.73 As a result, oligonucleotide strands that incorporate LNAs have been shown to bind 
complementary RNA strands with considerably higher affinity and target specificity compared to 
their DNA-only analogues. Furthermore, RNA:LNA duplexes are unique from RNA:DNA or 
RNA:RNA duplexes in that they have altered interactions with several nucleic acid recognizing 
proteins, including some enzymes. In order to avoid the necessity for a radioactive tag, 
Ramkissoon et al. demonstrated that digoxigenin (DIG), a steroid hapten, could be incorporated 
into complementary RNA strands used to visualize Northern blots for three different miRNAs.74 
Their incorporation of DIG and the accompanying chemiluminescent readout reduced the time-
to-result from days to hours, and increased the shelf-life of the probes, compared to radioactively 
labeled strands. 
Reverse-Transcriptase Polymerase Chain Reaction 
Similarly to its use in conventional studies of RNA expression, RT-PCR can also be applied to 
the analysis of miRNAs. Reverse transcription is first utilized to convert the target RNA into its 
cDNA, which is then subsequently amplified and quantified via one of several conventional PCR 
methods. However, the simple translation of these methods to miRNAs is complicated by the 
short size of the target, as the length of the primers normally used in the PCR step are as long as 
mature miRNAs themselves. Shorter primers are typically not useful as their low duplex melting 
temperature with the miRNA can introduce signal bias. To avoid these challenges, researchers 
have developed an array of creative approaches based upon enzymatic modification of 
conventional primers or altogether new primers for mature miRNA.  
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 One of the first applications of RT-PCR for the detection of miRNA was reported by 
Schmittgen et. al, who examined pre-miRNA expression.75 Because the study did not examine 
mature miRNAs, shortened primers were not necessary and the researchers were able to 
successfully detect amplicons using a fluorescent readout. However, the assumption that the 
amount of pre-miRNA is strictly representative of mature miRNA expression does not rigorously 
hold and thus the most straight-forward application of RT-PCR is of limited utility. 
As a method to analyze mature miRNAs without modifying the target strand itself, 
Raymond and coworkers utilized miRNA-specific reverse transcription primers that featured an 
overhanging 5′ tail so that the resulting cDNA was extended in length from that of the original 
target.76 Following reverse transcription (RT), a LNA-containing PCR primer was added which, 
together with a universal primer contained within the 5′ tail, enabled sensitive quantitation of 
miRNAs. 
There has also been significant effort in applying enzymatic methods to the elongation of 
the miRNA itself by ligation of oligo sequences. The addition of these flanking sequences allows 
for longer primer sequences to be utilized, increasing the efficiency of RT-PCR. Separate reports 
by Miska et al. and Barad et al. utilized the addition 3′ and 5′ adapter oligos to the target 
miRNAs via T4 ligase prior to reverse transcription.77,78 A limitation of many of the ligation 
based RT-PCR techniques, however, is that the sensitivity and specificity of the method is 
ultimately dependent on the efficiency of ligation. In particular, the kinetics of T4 ligase has 
been shown to vary with substrate sequence, and the incorporation of the ligation step can 
potentially introduce a signal bias into the measurements.79,80 
An alternative method for RT-PCR analysis was developed by Shi and Chiang, who used 
poly(A) polymerase to add poly(A) tails to the 3′ end of target miRNAs in solution.81 The 
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corresponding RT primers included poly(T) tails to increase the Tm of the heteroduplex and 
promote reverse transcription. This method was further adapted by Andreasen et al. at Exiqon to 
include two microRNA-specific, LNA primers during the PCR amplification, drastically 
increasing the specificity and sensitivity of the assay.82 An advantage of poly(A) polymerase is 
that the enzyme shows no sequence preference in its activity and thus it should be a useful tool 
for high throughput miRNA analysis applications. Similar technologies are available 
commercially from Agilent and Invitrogen. 
 A recently developed approach for RT-PCR-based miRNA expression profiling that 
eliminates the need for enzymatic extension is based upon the hybridization of stem-loop RT 
primers. The stem-loops are designed so that they are complementary to the 3′ end of the miRNA 
while at the same time having a 5′ end that is derived from the pre-miRNA sequence that 
composes the antisense half of a hairpin loop, as shown in Figure 2.1. These primers offer 
heightened specificity and sensitivity for miRNAs as compared to linear RT primers, largely on 
account of the increased base stacking and steric limitations imposed by the stem loop structure. 
By incorporating stem-loop primers into their assays, Chen and co-workers were able to 
quantitatively monitor the expression profile of mature miRNAs.83 This procedure was further 
adapted by Varkonyi-Gasic et al., who incorporated an additional 5-7 nucleotide extension of the 
primer to further increase the melting temperature.84 Applied Biosystems offers a commercial 
miRNA analysis method based upon stem-loop primer RT-PCR with TaqMan quantitation. 
 Li and colleagues developed a clever alternative to this general stem-loop procedure by 
using T4 ligase to attach two DNA stem-loop probes to one another, using the target miRNA as a 
template, as shown in Figure 2.2.85 The two separate stem loop probes were designed to each 
contain one half of the miRNA complementary sequence masked within the hairpin structure of 
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the stem-loop. Only in the presence of the target miRNA are the stem-loops extended and 
accessible to the ligase. The resulting long DNA strand can then be detected via standard PCR 
techniques. A major advantage of this approach is that increased specificity is achieved 
compared to methods that only utilize the 3′ specificity of a primer. 
A significant limitation of the previously mentioned RT-PCR based methods is a 
restricted ability to simultaneously quantitate multiple miRNAs from a single sample. While 
multiple RT-PCR analyses can be run in parallel, the increased sample required for such assays 
is a motivation for the development of multiplexed miRNA analysis methods. However, there 
are two factors that generally complicate the application of RT-PCR for monitoring multiple 
miRNAs within a single volume: 1) multiple, sequence specific primers (or primer sets) will be 
necessary, placing an impetus on detection specificity, and 2) the presence of each strand must 
be uniquely encoded by a sequence-specific read-out mechanism, such as an independent 
fluorophore signal in a qPCR experiment. 
To tackle the first issue, Lao et al. proposed a pseudo-multiplexed RT-PCR method for 
the high-throughput detection of miRNAs in which carefully designed stem-loop primers 
allowed the simultaneous RT and PCR amplification of all of the target miRNAs. 86 The 
sequence-specific cDNAs were then split into six aliquots and quantitation was performed in 
parallel using separate single-plex TaqMan PCR reactions for each target miRNAs. 
Unfortunately, the many PCR cycles needed between the separate amplification and quantitation 
steps compromises the quantitative utility of the approach. 
 In the previous example, multiplexed quantitative PCR (qPCR) cannot be performed 
because there are a limited number of spectrally unique probes that can encode for cDNAs 
derived from each of the target miRNAs. Furthermore, spectral overlap is in general a significant 
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challenge in the translation of many single-plex biomolecular techniques/assays multiplexed 
formats. For these reasons, amongst others, there has been a significant effort invested in 
demonstrating spatial rather than spectral multiplexing schemes, and several of these approaches 
will be described in more detail below as they apply to miRNA analysis. 
Microarrays 
Helping to fuel the enormous growth of genomics, and to some extent proteomics, microarray 
analysis technologies are well-suited to massively multiplexed biomolecular detection on 
account of spatial, rather than spectral, multiplexing. Not surprisingly, microarrays have been 
extensively applied to the high-throughput detection of miRNAs as they are capable of 
simultaneously screening hundreds of target sequences within a single sample volume. 
Moreover, with proper design of capture probes, microarrays can be used to identify both 
precursor and mature miRNAs.  In general, microarrays are not particularly well-suited for 
quantitative detection or copy number determination, but rather are very good tools to examine 
the relative expression of miRNAs between two different biological samples. 
 As with all miRNA analysis methods, specificity is of utmost importance for microarray 
methods as cross hybridization can lead to false positive signals. Similarly to Northern blotting, 
the incorporation of LNA capture probes significantly increases the specificity of a microarray 
towards target miRNAs.87 However, even more importantly, is the ability to normalize the 
melting temperature across all of the capture probe-target duplexes through selective integration 
of LNAs, an approach that has been led commercially by Exiqon in their miRCURY line of 
miRNA analysis products. This adjustment allows for uniform stringency rinses to be used with 
the microarray, and helps accounts for differences in binding kinetics normally observed for 
cDNA-only capture probes.  
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 In addition to prudent design of capture probes, conventional microarray analysis 
methods require the target miRNAs be labeled, most commonly with a fluorescent tag. This 
labeling is often performed prior to hybridization and can be accomplished via a number of 
methods including the attachment of a pre-labeled oligo via T4 ligase, 88-91 poly(A) extension 
from the 3′ end via poly(A) polymerase,92 and covalent modification with mono-reactive and 
fluorescently tagged cisplatin derivatives that can complex with guanine nucleotides.93,94 
Another popular method for labeling a miRNA-containing sample, prior to microarray 
analysis, involves the incorporation of fluorescent tags (often Cy3 and Cy5) during the process 
of RT-PCR.64,77,78 This approach, which borrows from conventional mRNA transcript profiling, 
provides a convenient method of labeling the total cDNA derived from the miRNA targets in a 
sample, but also increases the amount of available target via the PCR amplification. However, 
many of the same challenges faced by stand alone RT-PCR analysis such as sequence bias and 
run-to-run reproducibility are still encountered when analyzing on a microarray platform. 
Furthermore, additional complications can be encountered since the presence of a fluorescent tag 
can significantly perturb duplex stability, an effect that is particularly significant when 
considering the short lengths of the strands analyzed in miRNA hybridization assays. 
As an alternative to labeling miRNAs prior to hybridization, there have been a number of 
recently developed techniques that focus on introducing labels to the target miRNA after it has 
been bound to the microarray surface. This approach may, in some cases, help to avoid label-
induced perturbations to the duplex hybridization. Liang et al. developed an interesting hybrid 
scheme by which the vicinal diol at the 3′ of a hybridized miRNA was converted to two aldehyde 
groups via oxidation with sodium periodate and subsequently conjugated to biotin in solution.95 
The biotinylated miRNAs were then hybridized to the microarray and detected with streptavidin 
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coated quantum dots, giving a 0.4 fmol limit of detection. While this method does involve pre-
labeling of the miRNA, it is thought that biotin represents a very small and thus non-disruptive 
tag, compared with larger labels, such as the conventional Cy3 and Cy5 dyes. 
A notable purely post-hybridization strand modification scheme that actually allows read 
out without any covalent modification of the bound miRNA is the RNA-Assisted-Klenow-
Enzyme (RAKE) assay, developed by Nelson and co-workers and illustrated in Figure 2.3.96 In 
this methodology, DNA capture probes, which are linked to the surface via its 5′ end, are 
carefully designed to have a spacer sequence presenting three thymidine bases directly adjacent 
to the region complementary to specific miRNA targets. Following hybridization, the entire 
microarray is exposed to DNA exonuclease I, which enzymatically degrades the capture probes 
that are not duplexed with miRNA. The Klenow fragment of DNA polymerase I, an enzyme that 
can act as an RNA-primed DNA polymerase, is then added with biotinylated dATP, which is 
incorporated complementary to the three thymidines in the capture probe template. The amount 
of bound target miRNA can then be determined after incubation with fluorescently labeled 
streptavidin. Because both polymerase I and the Klenow enzyme fragment are sequence 
independent, the assay is not susceptible to any intrinsic signal bias and a detection limit of 10 pg 
was reported. However, one limitation of the technique is that the Klenow enzyme is specific 
only towards the 3′ end of the bound miRNA and thus certain isoforms may elicit unwanted 
cross-hybridization. Nevertheless, similar approaches have been successfully adapted by a 
number of other researchers.97-99 
2.5  Emerging methods of miRNA analysis 
While the previously described techniques were based upon more conventional tools and 
methods in molecular biology, there is increasing interest in developing completely new 
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analytical approaches to analyzing miRNA expression. Many of these emerging methods take 
advantage of micro or nanotechnologies and aim to address one or more of the shortcomings 
associated with the previously mentioned techniques including a minimization of sample size, 
increases in measurement sensitivity, precision, and dynamic range, and reduction in sequence 
dependent bias, cost, and time-to-result. Furthermore, a goal of many of these new technologies 
is to allow very high levels of multiplexing, ideally without sacrificing other key performance 
metrics, with cost and assay simplicity being a major driver for clinical diagnostic applications. 
Among the many miRNA analysis methods currently under investigation for miRNA biomarker 
based diagnostics, some of the most promising advances have involved new detection schemes 
based on electronic and optical signal transduction, and many already excel in key performance 
benchmarks. Given their current rapid rate of development, these techniques appear to be 
promising candidates to provide solutions for emerging miRNA analysis applications.  
Electrical Detection 
Electrical detection methods are based on changes in circuit properties that occur upon target 
miRNA hybridization. Signal amplification, often made possible through redox reporters and 
chemical ligation, can confer ultra-high sensitivity to these devices. However, sometimes this 
increase in sensitivity is accompanied by a loss of dynamic range. Here we discuss a selection of 
recently described methodologies, categorized broadly as either direct or indirect based 
according to their reliance on chemical modification of the target miRNA. Indirect methods 
usually involve a chemical ligation step which provides an amplified electrical signal following 
specific target miRNA-DNA hybridization. Though successful, these approaches are being 
challenged by label free technologies which offer equivalent or superior performance with a 
simpler assay, amongst other advantages100. At first glance, direct methods appear to be the most 
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attractive owing to a reduced number of error-introducing sample preparation steps and thus the 
potential for faster analysis times, providing that they are able to provide adequate sensitivities 
for the given bioanalytical challenge. 
A good example of a direct miRNA detection method is the use of nanoscale field effect 
transistors to monitor binding in a completely label free assay motif. Peptide nucleic acid (PNA) 
functionalized silicon nanowires can be incubated with complementary miRNA targets and 
changes in the resistivity of the nanowires is monitored before and after the binding events. 
PNAs are DNA analogues in which the deoxyribose and phosphate backbone is replaced by a 
peptide bonding motif. The resulting oligomer is devoid of charge and displays increased 
specificity and sensitivity for hybridization assays, similarly to LNAs.101,102 Using an array of 
PNA-functionalized silicon nanowires, Zhang et al. demonstrated a 1 fM detection limit and 
single base pair mismatch discrimination capability in the detection of let-7b.103 In this scheme, 
the negative charges brought to the surface upon miRNA hybridization (phosphate groups in the 
backbone) act as a gate and locally deplete charge carriers in the semiconducting nanowire, 
resulting in a decrease in conductivity. One of the most promising aspects of this technology is 
the ability to fabricate sensor arrays, as shown in Figure 2.4, via conventional semiconductor 
processing techniques, which might enable multiplexed miRNA detection. However, this 
technology still requires further refinement as field effect transistor based biosensor are 
notoriously prone to variations in sample ionic strength, and cost and fabrication challenges 
might complicate the use of PNAs and silicon nanowires, respectively, for high throughput 
miRNA detection applications. 
Fan and coworkers reported a method for detecting miRNA based upon changes in 
conductance accompanying hybridization to PNA-functionalized gaps between a CMOS-based 
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array of microelectrodes.104 After hybridization, a solution containing aniline, horseradish 
peroxidase (HRP), and hydrogen peroxide were added, which led to polymerization of the 
aniline that had associated with the phosphate backbone of the miRNAs via electrostatic 
interactions. The amount of conductive polyaniline deposited was proportional to the amount of 
hybridized target and thus the conduction across the microelectrode gap, which drops 
significantly as the target concentration is increased, could be used for quantitation over a 
dynamic range of 20 pM to 10 fM, as shown in Figure 2.5.  
Another scheme utilizes a four-component hybridization for sensitive and specific 
miRNA detection.105 A capture probe is designed with a gap complementary to the miRNA 
target of interest. Only upon target binding can a reporter enzyme linked to a further DNA 
complement then hybridize to the end of the probe. This is due to the additional stabilization 
conferred by continuous base pair stacking. A hydrolysable substrate is then added and the 
resulting current monitored. This method benefits from the amplification inherent to enzyme-
substrate turnover, as well as electrochemical recycling of the substrate product, p-aminophenol. 
This system was shown capable of a 2 attomole detection limit and diagnostic capabilities in 
total RNA extracts from human breast adenocarcinoma MCF-7 cells. Like other direct 
electrochemical approaches this method does not require chemical modification of the target 
miRNA. 
Ultrasensitive detection down to 10 aM concentration of miRNA was recently 
demonstrated by Yang et al. who utilized a Fe-Ru redox pair as a reporter and amplification 
scheme on a novel nanostructured electrode platform, as shown in Figure 2.6.106 Ru3+ 
accumulates and is reduced at the nanoelectrode surface after miRNA binding to complementary 
PNA capture probes and a ferricyanide solution phase redox couple chemically regenerates Ru3+ 
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from Ru2+ leading to incredible signal amplification—hundreds of electrons can be generated 
from a single binding event.107 In addition to high sensitivity, the sensor shows specificity for 
mature miRNA over pre-miRNA, and is capable of single base pair mismatch detection. Even 
more significant, the sensor was used to detect the upregulation of miR-21 and miR-205 in total 
RNA samples from three human head and neck cancer cell lines. The high surface area of the 
nanoelectrode is extremely important in this approach as it increases target binding and retention, 
which is essential to reaching the attomolar regime where there may be only hundreds or 
thousands of molecules in a sample. 
A direct approach to miRNA quantitation based on guanine oxidation was demonstrated 
by Lusi and co-workers based upon the oxidation of guanine bases in the hybridized target 
strands.108 While this technique does not require any additional reagents and utilizes less 
expensive DNA capture probes, as opposed to PNAs, it does require that all of the guanine bases 
in the capture probe be replaced with inosines. Furthermore, the amount of oxidation current 
observed is proportional to the number of guanines in the target sequence, complicating the 
application of this technique for highly multiplexed analyses.  
A common type of indirect electrical detection method for miRNAs involves the ligation 
of an electrocatalytic tag or other nanoparticle to the target, which upon hybridization provides a 
sequence specific signal.109-112 The strength of this amplified chemical ligation strategy is its 
generality, as an extensive number of catalytic or enzymatic moieties can be exploited for 
improved sensor performance. Several examples of this approach have been reported by Gao and 
coworkers, who have used inorganic nanoparticle catalysts.110-112 In one such example, the 3′ 
ends of target miRNAs were first oxidized with sodium periodate and then hybridized to DNA 
capture probes on an electrode surface. Amine modified OsO2 nanoparticles were then attached 
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to the 3′ aldehydes of the immobilized miRNA and the current measured from the catalytic 
degradation of hydrazine, which had been added to the solution. This approach allowed detection 
of miRNA over a 0.3 pM to 200 pM dynamic range. Notably, a five-fold difference in signal was 
observed between sequences that had only a single base pair mismatch. 
Optical Detection 
In addition to electrical signals, optical transduction methods have recently been successfully 
applied for miRNA detection. Several different classes of optical biosensors have been used to 
detect miRNAs and here we highlight several innovative examples of fluorescence, 
bioluminescence, spectroscopic, and refractive index based detection platforms. Optical 
fluorescence from labeled oligomers (miRNA or cDNA) is the basis for most of the microarray 
measurements mentioned earlier. However, novel approaches and materials have recently been 
developed that hold promise to significantly improve fluorescence based miRNA analysis 
methods. 
For example, Li et al. demonstrated a very sensitive method for miRNA analysis using 
hairpin probes, T4 ligase, and the fluorescent detection of Cd2+ ions. 113 Target miRNAs bind to 
carefully designed stem hairpin probes which are then subsequently hybridized with 
complementary CdSe nanoparticle-labeled DNA. T4 ligase is then added to stabilize the 
extended duplex structure before Ag+ is added in order to cation exchange the Cd2+ ions out of 
the nanocrystals and into solution. The authors state that thousands of Cd2+ ions can be liberated 
from each nanocrystal; a mechanism that provides signal amplification when using a fluorescent 
assay for Cd2+, allowing miRNA detection down to 35 fM. Sequence specificity is achieved by 
the use of T4 ligase in two ways: 1) the ligation has a much lower yield if the two strands are not 
bound with perfect complementarity, and 2) the resulting long duplex has a higher Tm, which 
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allows aggressive stringency washes to be utilized. However, several potential limitations still 
exist, including the use of CdSe nanoparticles that present an unknown toxicity risk, significant 
cross reactivity of the Cd2+-sensitive fluorescent dye with Ca2+, meaning that the sample must be 
rigorously purified prior to analysis, and assay complexity, since multiple reagents and 
incubation steps are required. 
Neely et al. employed a single molecule fluorescence detection method and dual tagged 
miRNA-DNA duplexes to detect down to 500 fM miRNA.114 Importantly, this work established 
the robust nature of this technique as the authors impressively demonstrated the expression 
profiling of 45 different miRNA targets in 16 different human tissues, including detection of the 
key cancer biomarkers mir-16, mir-22, mir-145, and mir-191 from as little as 50 ng of total 
RNA. 
Cissell and coworkers developed a hybridization assay for miRNA detection based on the 
displacement of the bioluminescent enzyme, Renilla luciferase (Rluc).115 The Rluc enzyme was 
conjugated to a synthetic oligonucleotide with a miR-21 sequence was hybridized to an 
appropriate capture probe and used in a competitive assay. miR-21 in the sample displaced the 
Rluc-conjugated strand resulting in a decrease in fluorescence that was used to achieve a 
detection limit of 40 pM with a greater than 3-order of magnitude dynamic range. An assay time 
of just 90 minutes and potential for integration into a 96 or 384 well plate format makes this an 
attractive technology for high throughput miRNA analyses.  
Surface enhanced Raman spectroscopy (SERS) has been extensively used in the detection 
of biomolecules,116-118 but has not generally achieved widespread use due to poor substrate 
reproducibility. Using the method of oblique angle vapor deposition to generate sufficiently 
reproducible substrates, Driskell et al. were able to detect and differentiate between miRNAs of 
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unrelated sequence based upon the different spectral fingerprints with an incredibly short 
acquisition time of only 10 seconds!119 However, due to the subtle differences in peak intensity 
as a function of distinct, but related, sequence composition, identification of specific sequences 
requires extensive multivariate analysis. Furthermore, the chemical specificity of SERS may 
complicate detection in complex samples due to high background signals. Nevertheless, this 
methodology is intriguing for applications in multiplexed miRNA detection. 
Surface plasmon resonance imaging (SPRI) has been shown to be an incredibly versatile 
and effective platform for biomolecule sensing.120-123 The technique is based on coupling light to 
the interface of a thin metallic film (typically gold) to excite surface plasmons, which are highly 
sensitive to changes in the refractive index of the local environment. Properly functionalized 
with an appropriate capture agent, desired biomolecules can be selectively detected by 
monitoring changes in reflectivity. While standard SPRI methods would be highly amenable to 
direct miRNA analysis, an impressive amplification technique incorporating enzymatic strand 
extension and nanoparticle labeling was developed by Fang and coworkers to achieve an 
incredible 5 attomole detection limit!124 LNA capture probes immobilized on a gold SPRi 
substrate were designed so that they were complementary to a targeted miRNA, but left a 6 
nucleotide extension of the miRNA beyond the LNA after hybridization. This 3′ overhang can be 
recognized by poly(A) polymerase, which then enzymatically grows a poly(A) tail at locations 
where miRNA is localized. Further amplification is achieved by subsequent hybridization of 
poly(T30) coated Au nanoparticles, which bind to the appended poly(A) tails. The presence of the 
nanoparticle labels greatly enhances the change in the SPRI reflectivity image, facilitating 
extremely low limits of detection and a dynamic range from 10-500 fM. Importantly, the 
dynamic range can be extended to higher concentrations by eliminating the nanoparticle 
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amplification step, if required for the application. Given these developments, and the existing 
widespread use of this technology for biomolecular measurements, SPRI seems to be a very 
promising techniques for miRNA expression profiling based on its sensitivity, scalability, 
dynamic range, and potential for quantitative detection.  
Recently, our group has developed a label free and modularly multiplexable biomolecular 
detection technology based upon arrays of silicon photonic microring resonators.125-127 These 
optical structures, which are fabricated via conventional semiconductor processing methods, are 
incredibly sensitive to binding induced changes in refractive index accompanying the binding of 
a target analyte to the microring surface, observed as a shift in the resonance wavelength 
supported by the microcavity. As a demonstration of the applicability of this platform to 
multiplexed miRNA detection, we recently covalently immobilized DNA capture probes onto the 
surface of an array of microrings and used it to detect four different disease-relevant miRNAs 
from a cell line model of brain cancer via a direct hybridization assay.128 Using this approach we 
demonstrated a detection limit of 150 fmol after only a 10 minute detection period and a linear 
dynamic range of over 2 orders of magnitude. We also reported an isothermal method for the 
discrimination of single base polymorphisms by including stringency-inducing chemical agents 
directly into the hybridization buffer. 
We are currently developing mechanisms for further extending detection limits for the 
microring resonator technology, and it is worthwhile to point out that many of the enzymatic 
strand extension or ligation techniques described earlier (poly(A) polymerase, T4 ligase, RAKE, 
etc.) could be integrated onto the platform in a straightforward fashion. While this technology is 
still relatively immature in comparison to well-developed methodologies such as RT-PCR and 
SPRi, the prospects for extremely high level multiplexing and the intrinsic manufacturability of 
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the platform make this an promising technique for many emerging miRNA analysis applications, 
particularly those related to clinical diagnostics where metrics such as sample size, time to result, 
and assay cost are of considerable importance. 
2.6 Conclusions and Outlook 
Over the past 17 years, our understanding of miRNAs has exploded. As the incredible 
importance of these small, non-coding transcripts has become increasingly elucidated, the 
number of tools for their analysis has grown. Still in place today are the original miRNA 
measurement approaches, many of which are based upon the tried and true tools of molecular 
biology. More recent adaptations of enabling enzymatic processes have greatly improved many 
aspects of these classical techniques and allowed higher throughput measurements to be made 
using RT-PCR or microarray techniques. The introduction of alternative capture probes, 
incorporating DNA analogues such as LNA and PNA, has been transformative for many of these 
methods as it in increases the melting temperature for short duplexes. 
In the past five years, physical scientists and engineers have become increasingly 
interested in miRNAs and have intensified efforts to apply emerging detection tools to this 
important bioanalytical challenge. Some of these approaches incorporate novel materials and 
reagents, such as metallic nanoparticles, semiconductor quantum dots, and bioluminescent 
proteins while others utilize the interesting electrical or optical properties of micro- and 
nanostructures. These emerging approaches all strive to offer one or more advantages over 
traditional methods, such as of high sensitivity, assay simplicity and reproducibility, 
multiplexing capability, and device manufacturability.  
In the next decade the appetite for enabling miRNA analysis technologies will certainly 
continue to grow. Recent biological discoveries of correlated expression and action on gene 
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translation have placed impetus on performing global or systems level analyses of miRNAs to 
uncover the full detail of their regulatory function, and therefore methods that offer high levels of 
multiplexing will be of great value to these efforts. Furthermore, recent reports describing the 
value of miRNAs as diagnostic biomarkers for a range of human diseases make the development 
of point-of-care analysis methods incredibly important. In these applications, metrics such as 
time-to-result, sample consumption, and assay cost will be key drivers for technology 
development. As has historically been the demonstrated, transformative biological discoveries 
are often tied to the development of new technological capabilities. The small size of miRNAs 
(and other small RNA molecules) challenges conventional biomolecular analysis methodologies 
and new innovations in miRNA detection will likely play a unique role in enabling future 
biological breakthroughs. 
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2.7 Figures 
 
Figure 2.1. Schematic description of a RT-PCR assay for a target miRNA. Stem-loop 
primers, are first hybridized to the miRNA followed by reverse transcription. The 
resulting transcript is then quantitated using conventional real-time PCR, using a TaqMan 
probe.  Figure adapted from reference 83. 
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Figure 2.2. Schematic diagram of the enzymatic ligation-based real-time PCR assay for 
measurement of mature miRNAs. In the presence of the target miRNA, two stem-loop 
probes, each of which is partially complementary to the target, brought into close 
proximity via hybridization with the miRNA. T4 ligase is then used to attach the probes 
together, forming an extended primer than is amenable to real-time PCR-based 
quantitation. Figure adapted from reference 85. 
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Figure 2.3.  Schematic of the RNA-primer, array-based Klenow enzyme (RAKE) assay. 
Hybridized miRNA bound to specially designed capture probes both shields the capture probe 
from enzymatic degradation, but also serves as a primer for strand extension, during which a 
biotinylated nucleotide is introduced. Following extension, the microarray is stained with 
fluorescent streptavidin and imaged to determine the relative amount of miRNA present in the 
original sample. Figure adapted from reference 96. 
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Figure 2.4. (a) Optical and scanning electron micrograph (inset) showing an array of ten 
silicon nanowire field effect transistors. (b) Schematic showing the interaction between a 
charged nucleic acid and a nanowire field effect transistor. When functionalized with 
peptide nucleic acids (PNAs) the nanowires can be used to sensitively detect miRNAs as 
the charge accompanying miRNA hybridization modulates the current flowing through 
the nanowire due to a gating effect. Figure adapted from references 103,129. 
  
A
B. 
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Figure 2.5. Fan and co-workers developed a miRNA detection scheme based upon 
polymerization of a conductive polymer across a microscale electrode gap. Aniline 
selectively interacts with the negatively charged backbone of the miRNA hybridized to 
PNA capture probes, which have uncharged backbones. The addition of oxidative 
reagents then leads to the formation of conductive polyaniline and the resistance drop 
across the electrode gap is proportional to the amount of hybridized miRNA. Figure 
adapted from reference 104.  
  
72 
 
 
 
Figure 2.6. Schematic diagram illustrating the fabrication and operatin of arrays of novel 
nanostructured electrodes useful for ultrasensitive miRNA detection. The high surface 
area of the electrode structure allows sensitive detection of miRNAs via a novel redox 
reporter system that provides tremendous gain for each target binding event. Figure 
adapted from reference 106. 
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Figure 2.7. Surface plasmon resonance imaging is a promising technique for the 
detection of miRNAs in an array format. High sensitivity was achieved by Fang and 
coworkers, who used poly(A) polymerase and poly(T)-coated gold nanoparticles to 
greatly amplify the SPR response for miRNA binding events. Figure adapted from 
reference 124. 
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Figure 2.8. Arrays of silicon photonic microring resonators can be used to quantitate 
miRNAs. (a) Schematic illustration of the hybridization of miRNA onto a modified 
microring, which leads to a shift in the resonance wavelength supported by the integrated 
microcavity. (b) Scanning electron micrograph showing an array of microring resonators. 
A zoomed in view of a single sensing element is shown in the inset. Figure adapted from 
reference 128. 
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Chapter 3 – Multiplexed Detection and Label-Free Quantitation of microRNAs using 
Arrays of Silicon Photonic Microring Resonators 
 
This chapter has been reproduced from the original paper, titled “Multiplexed Detection and 
Label-Free Quantitation of microRNAs using Arrays of Silicon Photonic Microring 
Resonators” (Qavi, A.J.; Bailey, R.C.; Angewandte Chemie International Edition, 2010, 49, 
27, 4608-4611, DOI: 10.1002/anie.201001712).   It has been reproduced here with 
permission from John Wiley & Sons, Inc.  The original document can be accessed online at 
<http://onlinelibrary.wiley.com/doi/10.1002/anie.201001712/abstract>. 
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3.1 Abstract 
Microrings for microRNAs! A label-free method has been developed for the sensitive 
detection of microRNAs utilizing arrays of silicon photonic microring resonators. This simple 
and modularly multiplexable method for the direct profiling of microRNA within 10 minutes 
meets a number of challenges faced by current methodologies in this area. 
3.2  Introduction 
MicroRNAs (miRNAs) are short (19 to 24 nucleotides), single-stranded, non-protein-coding 
RNAs that are powerful transcriptional and post-transcriptional regulators of gene expression. 
Unlike small interfering RNAs (siRNAs), miRNAs are genomically encoded and play key 
roles in a range of normal cellular processes, including proliferation, apoptosis, and 
development.1-4 Not surprisingly, miRNAs have also been implicated in a number of 
diseases, including cancer,5-8 neurodegenerative disorders,9-11 and diabetes,12-14 and represent 
promising biomarker candidates for informative diagnostics. Despite their increasingly well-
understood importance in gene regulation, the development of sensitive analytical techniques 
for the quantitation of multiple miRNAs has lagged behind. Furthermore, current 
methodologies for miRNA expression analysis are not applicable to a clinical setting where 
sample sizes are limited and assay cost and time-to-result is of tremendous importance. 
 In contrast to most nucleic acid analysis technologies that advantageously utilize the 
polymerase chain reaction (PCR) to increase the amount of the target sequence, miRNAs are 
not easily amplified on account of their small size, which prohibits standard primer 
hybridization.15 Although creative approaches that enable reverse transcriptase-PCR 
amplification have been developed,16-18 many conventional miRNA analyses are prone to 
sequence-biased amplification or hindered by the need for large amounts of sample. The most 
widely reported miRNA analysis technique, Northern blotting, requires substantial amounts 
of starting material, is extremely laborious, and is not amenable to large-scale multiplexing.19 
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Recently, a number of new miRNA analysis methods have been reported that feature high 
sensitivity, but often at the expense of assay simplicity and scalability, multiplexing 
capability, or rapid analysis time.20-27 
In this paper, we report a label-free, direct hybridization assay enabling the 
simultaneous detection of multiple different miRNAs from a single sample using 
commercially fabricated and modularly multiplexable arrays of silicon photonic microring 
resonators. Using complementary single-stranded DNA capture probes, we are able to rapidly 
(10 min) quantitate down to ~150 fmol of miRNA and show the ability to discriminate 
between single nucleotide polymorphisms within the biologically important let-7 family of 
miRNAs. We also demonstrate the applicability of this platform for quantitative, multiplexed 
expression profiling by determining the concentration of four miRNAs from within a 
clinically-relevant sample size of a cell line model of glioblastoma with minimal sample 
preparation. 
Microring resonators are a promising class of refractive index-sensitive devices that 
have recently been applied to monitoring chemical reactions and biomolecular binding 
events.28-36 Light coupled via an adjacent linear waveguide is strongly localized around the 
circumference of the microring under conditions of optical resonance, as defined by the 
cavity geometry and the surrounding refractive index environment. Given a defined 
microring structure, the resonance wavelength is sensitive to changes in the local refractive 
index, in this case the hybridization of miRNAs to complementary ssDNAs on the surface, as 
illustrated in Figure 3.1a. Monitoring the shift in resonance wavelength after exposure to the 
sample of interest allows determination of the solution-phase analyte concentration. 
We have previously described the use of silicon-on-insulator (SOI) microring 
resonators for the sensitive detection of proteins.28-31,37 A wavelength-tuneable laser centered 
at 1560 nm is coupled into on-chip waveguides that interrogate the microrings and determine 
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resonance wavelengths. The sensor chips, each containing 32 individually-addressable 30 µm 
diameter microrings, are coated with a fluoropolymer cladding layer that is selectively 
removed over the active sensing elements using reactive ion etching. Figure 3.1b shows a 
small portion of the sensor array, and the inset highlights a single microring and its adjacent 
linear interrogation waveguide. 
3.3 Experimental 
3.3.1  Nucleic Acid Sequences  
All synthetic nucleic acid probes were obtained from Integrated DNA Technologies 
(Coralville, IA). DNA capture probes were HPLC purified while all synthetic RNA 
sequences were RNase-free HPLC purified. The sequences used are summarized in  
Table 3.1. 
3.3.2 Fabrication of Silicon Photonic Microring Resonators and Measurement 
Instrumentation 
Microring resonator arrays were designed in collaboration with Genalyte, Inc. (San Diego, 
CA). Devices were fabricated on 8" silicon-on-insulator (SOI, 200 nm thick top-layer Si) 
wafers by the silicon foundry at LETI (Grenoble, France), and the entire wafer was spin-
coated with a fluoropolymer cladding material. Individual sensors were then revealed by 
photolithography and reactive ion etching. Substrates used in sensing experiments contained 
thirty-two 30 µm diameter microrings, and the 6 x 6 mm chip was diced from the 8" wafers 
by Grinding and Dicing Services, Inc. (San Jose, CA). Microrings were optically interrogated 
via input and output diffractive grating couplers at either end of linear waveguides that run 
adjacent to each individual microring.  
The instrumentation used to measure shifts in microring resonance frequency was 
designed in collaboration with and built by Genalyte, Inc. and has been previously 
described.[1-2] Sensor chips are loaded into a custom cell with microfluidic flow channels 
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defined by a 0.010" thick laser-cut Mylar gasket (fabricated by RMS Laser; El Cajon, CA) 
that is aligned over top of the array and compressed between an aluminum chip holder and a 
Teflon lid. Solutions are flowed over the chip at controlled rates using an 11 Plus syringe 
pump (Harvard Apparatus; Holliston, MA) operated in withdraw mode. 
3.3.3 Chemical and Biochemical Modification of Silicon Photonic Microring Resonator 
Surfaces    
Chips were immersed in Piranha solution[3] (3:1 solution of 16 M H2SO4:30 wt% H2O2) and 
rinsed thoroughly with Millipore H2O prior to functionalization. A 2% (v/v) solution of 3-
aminopropyltriethoxysilane (APTES, Gelest; Morrisville, PA) in 95% ethanol was flowed 
over the sensor surface at 7.5 µL/min for at least 30 min, followed by a rinse in 95% ethanol.  
 The addition of the silane to the sensor surface was monitored in real time and is 
shown in Figure 3.2. The initial increase in signal is attributed to the large bulk index shift 
caused by the 2% APTES solution. The net addition of silane to the sensor surface can be 
seen after rinsing with 95% EtOH, and gives a response of ~120 pm, indicating the addition 
of a layer of silane to the surface. 
The chips were subsequently immersed in a solution consisting of 0.1 mg 
succinimidyl 5-hydrazinonicotinate acetone hydrazone (S-HyNic, Solulink; San Diego, CA), 
20 µL N,N-dimethylformamide (DMF, Fisher), and 480 µL Dulbecco’s Phosphate Buffered 
Saline, pH 7.4 (PBS, Sigma), and allowed to recirculate across the sensor surface for at least 
4 h at a rate of 7.5 µL/min, shown in Figure 3.3. The net shift produced by the addition of S-
HyNic is ~175 pm. 
 The DNA capture sequences were buffer exchanged in PBS pH 7.4 using a Vivaspin 
500, 5000 MWCO (Sartorius; Aubagne, France) spin column three times to remove any 
residual ammonium acetate present in the sample that would interfere with subsequent 
conjugation. The DNA capture strands were reacted with a solution of 1 mg succinimidyl 4-
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formylbenzoate (S-4FB, Solulink) in 100 µL DMF and 400 µL PBS, pH 7.4 overnight. The 
DNA sequences were then buffer exchanged in PBS, pH 6.0, using a Vivaspin 500 spin 
column. The covalent attachment of the DNA capture probes as monitored in real time is 
shown in Figure 3.4. 
3.3.4 miRNA Detection  
Solutions containing the miRNA of interest were flowed over the sensor surface at a rate of 
7.5 µL/min for 10 min for a total analysis volume of 75 µL. The sensors were subsequently 
rinsed with PBS, pH 7.4, to ensure that the binding of the target miRNA was specific. All 
synthetic miRNA targets were suspended in PBS, pH 7.4 and the concentrations verified 
using a NanoDrop 1000 UV-Vis spectrometer (Thermo Scientific). 
3.3.5 Enzymatic Regeneration of Sensor Surfaces  
The sensor surface was regenerated for further miRNA detection experiments using RNase 
H, an enzyme that selectively cleaves DNA-RNA heteroduplexes. 10 units of RNase H (USB 
Corporation) were suspended in a solution of 20 mM Tris-HCl (pH 7.5), 20 mM KCl, 10 mM 
MgCl2, 0.1 mM EDTA, and 0.1 mM dithiothreitol and flowed over the sensor surface over 30 
min at a rate of 7.5 µL/min. The surface was subsequently rinsed with PBS, pH 7.4, after 
which it could be reused for additional miRNA binding experiments. If sequence-specific 
binding of the target miRNA did not occur, addition of RNase H to the sensor surface elicited 
a step wise response, as shown in Figure 3.5. Figure 3.6 shows the repeated regeneration of 
microrings on a single chip. It is important to note that the maximum signal elicited after 
every regeneration approaches ~20 pM, indicating not only complete regeneration of the 
sensor surface, but that the sensor response is not degrading. 
3.3.6 Detection of a Single Base Mismatch 
Two sets of three microrings on a single sensor chip were functionalized with ssDNA capture 
probes complementary to the miRNAs let-7b and let-7c.  Solutions containing either 1 µM 
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let-7b or 1 µM let-7c in PBS, pH 7.4, were flowed across the sensor surface at a rate of 10 
µL/min.  As apparent in Figure 3.7a-b, it is difficult to distinguish between the target 
sequence and SNP.  The experiments were repeated, but all solutions were in 50% (v/v) 
Formamide in PBS, pH 7.4 to increase the stringency of adsorption-hybridization.   Figures 
3.7c-d show the high sequence specificity of each set of microrings towards their respective 
capture probes. 
3.3.7 Isolation and Detection of Small RNAs from U87 MG Cells 
The U87 MG (glioma) cell line was obtained from the American Type Culture Collection 
(HTB-14, ATCC) and cultured according to manufacturer’s instructions. Upon reaching 
confluence, the cells were trypsinized with Trypsin-0.5% EDTA (Gibco) and spun at 500 rpm 
for 5 min to form a pellet. The cells were counted with a hematocytometer (Reichert) prior to 
lysis. The pellet was resuspended in 700 µL of Qiazol Lysis Reagent (Qiagen), and the total 
small RNAs were extracted using both the miRNeasy Mini Kit (Qiagen) and RNeasy 
MinElute Cleanup Kit (Qiagen). Residual organic solvents introduced during the extraction 
process were removed using a SpeedVac SC100 (Savant). Prior to experiments, the small 
RNA extracts were resuspended in PBS, pH 7.4 and the concentration monitored using a 
NanoDrop 1000 UV-Vis spectrometer (Thermo Scientific). 
 The commercially available miRNA separation kits from Qiagen state that small 
RNAs <200 nucleotides are extracted during this process.  To confirm this with our findings, 
we ran analytical PAGE, shown in Figure 3.8.  RNA fractions were extracted from 3 x 107 
HeLa cells utilizing the commercially available Qiagen kits previously described and 
analyzed using TBE polyacrylamide gel electrophoresis with 15% T resolving slab gels.  For 
this, 20 µL of the fractions were combined with 5 µL of blue/orange gel loading buffer 
(Promega, Madison, WI), of which 5 µL were loaded onto individual lanes of the slab gel 
along with the appropriate standards.  Gels were stained using 1 x 10-4% (v/v) ethidium 
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bromide solution for 10 min, and scanned using a Molecular Imager Gel Doc System (Biorad, 
Hercules, CA) 
Lane A indicates an Invitrogen 10 bp Lane Marker, with significant markers labeled.  
Lane B shows the “small” RNA extracts (<200 nucleotides) obtained from 3 X 107 HeLa 
cells, while Lane C shows the larger RNA extracts (>200 nucleotides) from the same HeLa 
cells used for Lane B.  Consistent with the reported values, it is evident that the extraction 
process we utilize removes most RNAs larger than 200 nucleotides.  Lane D shows the total 
RNA extracted from 3 x 107 HeLa cells without separation into the respective sample sizes.  
We believe this lane is significantly darker due to the limited number of purification steps 
employed in the extraction methodology.  Lane E serves as a control, with 1 nmol of 
synthetic miRNA let-7c. 
3.3.8 Quantitative Detection of a Single miRNA 
We generated a 6-point linear calibration curve for miR-21 in PBS pH 7.4 prior to the small 
RNA extract measurements, as shown in Figure 3.9.  Fitting parameters for the linear fit can 
be found in Tables A1.1-A1.3.  From this curve, we determined the concentration of miR-21 
in our small RNA extract sample to be 34.7 nM, corresponding to ~31,300 copies of miR-21 
per U87 cell. 
3.3.9 Multiplexed Quantitation of Four miRNAs 
Microrings were functionalized as previously detailed, with the exception that solutions 
containing ssDNA capture probes were hand-spotted onto the sensor surface and allowed to 
react overnight.  Each set of microrings was calibrated separately to account for differences 
in signal response for each target miRNA.  The miRNAs miR-21, miR-24-1, and let-7c were 
calibrated using solutions of synthetic miRNAs at concentrations of 250 nM, 62.5 nM, 16 
nM, 4 nM, and 0 nM.  Because of the low response of miR-133b, 2-fold dilutions were 
utilized (1000 nM, 500 nM, 250 nM, 125 nM, 62.5 nM, and 0 nM).  Prior to measurements, 
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the sequence specificity of each capture probe was tested to ensure the lack of non-specific 
adsorption (similar to the results shown in Figure 3.13). 
3.3.10 Data Processing 
All data was corrected for temperature and instrumental drift by subtracting relative shifts 
from a series of reference microrings not exposed to solution. All data was fitted and graphed 
using OriginPro8 (OriginLab Corporation). 
To calculate the initial slope of the miRNA binding, we fit a modified Langmuir 
Binding Isotherm as described by: 
( )( )0( ) 1 B t tS t A e− −= −
     [3.1] 
The initial slope of the binding isotherm is given by the derivative of Equation 3.1 evaluated 
at t = t0 : 
dS AB
dt
=  
An average of the initial slopes was taken over a number of sensors, n, for each 
concentration. As a general rule, concentrations greater than 250 nM, the first 5 min of 
collected data was used to obtain a fit, while for concentrations less than or equal to 250 nM, 
10 min was used. For concentrations 16 nM or lower, a linear fit was used to approximate the 
initial slope.  Higher concentrations would be fit using a linear function if the sensor response 
for that target probe was sufficiently low. The fitting parameters used for all measurements 
are included in Tables A1.1 to A1.15. 
3.3.11 Determination of Uncertainties for Multiplexed miRNA Quantitation  
For calculating the uncertainty in the measurements of miRNA from the U87 MG extracts, 
two approaches were taken. For miR-21, miR-24-1, and miR-133b, the standard deviation of 
the mean of each of the individual measurements was used (sample size of n = 5, 3, and 4, 
respectively).  For let-7c, due to the limited sample size, the error for the measurement from 
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U87 extracts was calculated by propagating the error generated from the linear calibration 
curve, shown in Figure 3.10d.  The parameters used in the propagation of error can be found 
in Table A.1.16.   
3.3.12 Parameters for Data Fitting 
The parameters used in data fits can be found in Section A1 of the Appendix. 
3.4 Results/Discussion 
The first step in modifying sensors to detect particular miRNAs is to covalently modify the 
native oxide-coated surface of the silicon microrings with single-stranded DNAs 
complementary to the target(s) of interest. After appropriate derivitization, the shifts in 
resonance wavelength accompanying hybridization of miRNA to the microrings can be 
followed in real time, as shown in Figure 3.11. At t = 15 min, a 2 µM solution of miR-24-1 is 
flowed over the sensors and its hybridization to complementarily functionalized microrings 
elicits a shift of ~ 40 pm in the resonance wavelength. Returning to PBS buffer at t = 45 min 
gives an immediate increase in resonance peak shift on account of differences in bulk 
solution refractive index. The opposite shift (a negative change in bulk refractive index) 
occurs for the injection of miRNA solution, but is largely counteracted by the hybridization 
of miRNA. 
To confirm the hybridization, we introduced a solution containing RNase H, an 
enzyme that selectively cleaves DNA:RNA heteroduplexes, at t = 60 min. The rapid increase 
in resonance wavelength corresponds to a bulk refractive index change, but the enzymatic 
activity of RNase H dissociating the duplex quickly leads to a decrease in relative peak shift. 
Control experiments without hybridized miRNA or with DNA:DNA duplexes show a stepped 
response that reflects only the bulk index change to and from the RNase H-containing 
solution, but without the net decrease corresponding to heteroduplex cleavage. Returning the 
microring to RNase H buffer and then PBS buffer confirms the hybridization of miRNAs to 
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the ssDNA capture strands and also demonstrates that the sensor surfaces can be regenerated. 
Utilizing this RNase H protocol, we have found that sensors can reproducibly respond to 
miRNA hybridization after more than twenty regeneration cycles. 
Exposure of microrings to different solutions of miR-24-1 varying from 2 µM to 1.95 
nM reveals a concentration-dependent response, as shown in Figure 3.12a. Rather than 
utilize the absolute wavelength shift, which saturates as miRNAs hybridize to all of the 
available ssDNA capture probes, we determine the rate at which the resonance peak changes 
immediately after target introduction and use the initial slope response for quantitation. 
Advantages of this approach include generation of a linear sensor calibration curve and 
greatly reduced assay time (~10 min), which is significantly faster than waiting for the 
system to establish binding equilibrium, a concentration-dependent period that can take many 
hours. Figure 3.12b shows the linear relationship between the initial slope of sensor 
response, determined via fitting of the real time resonance wavelength shift data, and the 
concentration of miR-24-1. 
 A significant challenge for all nucleic acid analyses that is particularly important for 
miRNAs is the ability to distinguish single base differences in sequence. Therefore, we 
developed an isothermal method of distinguishing single base differences between two 
members of the biologically important let-7 family of miRNAs by performing hybridizations 
in the presence of formamide, which is a chaotropic agent that competes for hydrogen 
bonding sites. Under normal hybridization conditions (no formamide) the miRNA isoforms 
let-7b and let-7c, which differ only by a single base change at position 17, both bind to the 
non-specific DNA capture probe designed to be perfectly complementary to the other 
sequence (Figure 3.7). However, when hybridization is performed in a 50% (v/v) formamide 
solution, the single base difference is easily distinguished. 
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A key advantage of the microring resonator sensing platform is its potential for high-
level multiplexing. SOI microring resonators are fabricated using scalable semiconductor-
processing techniques that enable a large number of sensors to be incorporated and 
individually interrogated on the same chip. Utilizing microarray spotting or other patterning 
methodologies, each ring can be functionalized with a unique capture agents (cDNAs, 
antibodies, etc.), allowing many different biomolecules to be simultaneously quantitated. 
To demonstrate the multiplexing capability of our platform, we constructed a four-
component array by differentially functionalizing microrings on the same chip with unique 
ssDNAs complementary to four dissimilar miRNAs. Figure 3.13 shows the real time shift in 
resonance wavelength for 4 sets of microrings, each functionalized with a different ssDNA, 
during the sequential introduction of miR-133b, miR-21, miR-24-1, and let-7c. Sequence-
specific responses are observed at appropriate microrings only when the complementary 
miRNA solution is exposed to the sensor array. Small changes in resonance wavelengths 
arising from differences in bulk refractive index are observed at time points where solutions 
are switched, but in each case the sequence-specific response is clearly discernable above 
baseline.  
Furthermore, we simultaneously determined the expression levels of the same four 
miRNAs extracted from U87 MG cells, an established model for grade IV gliomas, including 
glioblastoma and astrocytoma.38,39 The entire small RNA content from 5×107 U87 cells was 
extracted using a commercial purification kit and flowed over a sensor surface with 
microrings functionalized with ssDNA capture probes complementary to the target miRNAs.  
Each microring was individually calibrated to account for differences in signal response 
between target miRNAs (Figure 3.10).  The initial slope of sensor response upon addition of 
the U87 small RNA sample was measured and the concentration of each target miRNA in 
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solution determined (miR-21: 18.9 ± 3 nM, miR-24-1: 3.3 ± 0.2 nM, miR-133b: 60 ±20 nM, 
let-7c: 4 ± 3 nM).   
Given the drive towards even smaller sample sizes, future work with this platform 
will focus heavily on improvements in sensitivity.  One method for improving might include 
the incorporation of higher affinity oligo capture probes, such as locked nucleic acids (LNA) 
or peptide nucleic acids (PNA).  Previous studies have shown that both classes of synthetic 
oligos increase the specificity as well as sensitivity of miRNA assays.26,40   Another approach 
might include the implementation of sequence-independent, secondary amplification 
techniques to increase the total mass bound to our sensor surfaces. Two candidate methods 
include the RNA-primed array-based Klenow enzyme assay (RAKE) or Poly(A) polymerase 
enzymatic amplification, both of which utilize enzymes to specifically add nucleotides to the 
3’ end of miRNAs hybridized to the sensor surface, after which additional amplification steps 
can be included to further boost the amount of bound mass.21,41   
The emergence of miRNAs as important regulators of gene expression and as 
valuable disease biomarkers places an impetus on developing next-generation detection 
methodologies. Particularly valuable will be those that can operate under the sample size 
limitations and time-to-result requirements of clinical analyses. Furthermore, multiplexed 
analyses in which a significant fraction of the “miRNA-ome,” predicted to be comprised of 
~1000 miRNAs for humans,42 can be simultaneously analyzed will prove exceedingly 
important in deciphering the complex regulatory action of these molecules. In pursuit of these 
needs, we have developed a new platform for the sensitive, sequence-specific, and label-free 
quantitation of miRNAs using direct hybridization to arrays of ssDNA-functionalized silicon 
photonic microring resonators. We demonstrate the ability to quantitate the expression level 
of multiple miRNAs from clinically relevant sample volumes within a 10-minute data 
acquisition time using a pre-calibrated sensor array. Future efforts will be directed towards 
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improving sensor limits of detection as well as increasing levels of multiplexing by 
interfacing microring resonator arrays with microarray spotting technologies for rapid 
encoding of many unique sensing elements. 
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3.5 Tables and Figures 
 
Table 3.1. Sequences of DNA capture probes and miRNAs used. All sequences are  
written 5’ to 3’. 
 
 Sequence DNA Capture Probe 
hsa miR-21 UAGCUUAUCAGACUGAUGUUGA NH2 – (CH2)12 – 
TCAACATCAGTCTGATAAGCTA 
hsa miR-24-1 UGGCUC AGUUCAGCAGGAACAG NH2 – (CH2)12 – 
CTGTTCCTGCTGAACTGAGCCA 
hsa miR-
133b 
UUUGGUCCCCUUCAACCAGCUA NH2 – (CH2)12 – 
TAGCTGGTTGAAGGGGACCAAA 
hsa let-7b UGAGGUAGUAGGUUGUGUGGUU NH2 – (CH2)12 – 
AACCATACAACCTACTCCCTCA   
hsa let-7c UGAGGUAGUAGGUUGUAUGGUU NH2 – (CH2)12 – 
AACCATACAACCTACTACCTCA   
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Figure 3.1.  (a) Each microring sensor is functionalized with a capture sequence of DNA 
(black). The sequence-specific hybridization of the target miRNA (red) causes a shift in the 
wavelength required to achieve optical resonance. (b) Scanning electron micrograph showing 
six microrings on a sensor array chip. The inset shows a single microring and its 
corresponding linear access waveguide revealed within an annular opening in the 
fluoropolymer cladding layer. 
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Figure 3.2.  Addition of a 2% (v/v) solution of APTES in 95% EtOH to 3 separate 
microrings.  
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Figure 3.3.  Addition of S-HyNic to 3 microrings previously functionalized with APTES. 
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Figure  3.4.  Addition of an S-4FB conjugated ssDNA capture strand to 3 rings 
functionalized with S-HyNic. 
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Figure 3.5. Comparison of the response of 3 microrings towards RNase H (a) with target 
miRNA bound to the surface versus (b) no target miRNA bound to the surface. 
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Figure 3.6. Sequential hybridization with miR-24-1 and regeneration of a set of microrings 
via RNase H cleavage of the bound miRNA. 
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Figure 3.7. Two sets of microrings have been functionalized with an ssDNA capture probe 
complementary to either let-7b (black) or let-7c (red).  Upon addition of (a) 1 µM let-7b or 
(b) 1 µM let-7c in PBS, pH 7.4, both sets of sensors respond in a similar fashion.  However, 
if a 50% (v/v) solution of formamide in PBS, pH 7.4 is utilized (c) and (d), there is a high 
sequence specificity for the microrings towards their respective target probe. 
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Figure 3.8. Analytical PAGE containing various RNA extracts and synthetic probes. Lane A:  
Invitrogen 10 bp Lane Marker, Lane B:  Small RNA Extracts (<200 nucleotides), Lane C:  
Large RNA Extracts (>200 nucleotides), Lane D:  Total RNA Extracts, Lane E:  Synthetic 
miRNA spike.   
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Figure 3.9. Linear calibration curve for miR-21 (■) and detection from 5×107 U87 MG 
glioma cells (▲).  Linear calibration curve for buffer samples:  Initial Slope = 
0.0075(Concentration nM) + 0.07617, R2 = 0.9902. 
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Figure 3.10. Overlay of the concentration-dependent response for each set of functionalized 
microrings as well as the corresponding linear calibration curves generated from each 
overlay.  Microrings functionalized with ssDNA capture probes complementary to  (a) miR-
21 (b)  miR-24-1 (c) miR-133b (d) let-7c.  The concentrations used in creating the curve 
overlay as well as the linear calibration curve are summarized in Tables S8 through S15.  The 
linear calibration curves as well as the respective R2
 
value are as follows:  (a)  miR-21, Initial 
Slope = 0.01338(Concentration nM) + 0.09252, R2 = 0.9988 (b)  miR-24-1, Initial Slope = 
0.03848(Concentration nM) + 0.5265, R2 = 0.9869 (c)  miR-133b, Initial Slope = 
0.00342(Concentration nM) + 0.05202, R2 = 0.9888 (d)  let-7c, Initial Slope = 
0.35905(Concentration nM) – 1.23157, R2 = 0.9980. 
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Figure 3.11.  Real time measurement in shift of microring resonance wavelength during the 
hybridization of 2 µM miR-24-1 to three separate microring resonators. The resulting 
heteroduplex is subsequently dissociated by the enzyme RNase H, yielding a regenerated 
sensor surface. 
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Figure 3.12.  (a) Response of a single microring to the binding of miR-24-1 as a function of 
concentration (2 µM to 7.8 nM decreasing top-to-bottom via 2-fold dilutions). The dotted 
lines designate the fitted curves used to calculate the initial slope of the target miRNA 
binding. The response of only a single ring is shown for clarity. Responses for miRNA 
concentrations of 3.91 and 1.95 nM are omitted for clarity, but are resolvable from the zero 
concentration response. (b) Average response of microring resonators as a function of miR-
24-1 concentration. Error bars represent ± 1 standard deviation for at least nine independent 
measurements at each concentration. 
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Figure 3.13.  Sequence-specific detection of four unique miRNAs on a single chip as the 
miRNA complementary to the ssDNA on the microring is sequentially introduced into the 
flow chamber. Microrings were functionalized with complementary ssDNAs against (top to 
bottom) miR-133b, miR-21, miR-24-1, and let-7c. miRNA solutions were all 1 µM in PBS. 
Asterisks () denote time points where the solution over the sensors was changed to PBS 
buffer. In some cases, small changes in resonance wavelength are observed due to small 
differences in bulk solution refractive index.  Each set of rings is offset from the baseline 
wavelength for clarity. 
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Chapter 4 – Anti-DNA:RNA Antibodies and Silicon Photonic Micoring Resonators:  
Increased Sensitivity for Multiplexed microRNA Detection 
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4.1  Abstract 
In this paper, we present a method for the ultrasensitive detection of microRNAs (miRNAs) 
utilizing an antibody that specifically recognizes DNA:RNA heteroduplexes, using a silicon 
photonic microring resonator array transduction platform. Microring resonator arrays are 
covalently functionalized with DNA capture probes that are complementary to solution phase 
miRNA targets. Following hybridization on the sensor, the anti-DNA:RNA antibody is 
introduced and binds selectively to the heteroduplexes, giving a larger signal than the original 
miRNA hybridization due to the increased mass of the antibody, as compared to the 22 
oligoribonucleotide. Furthermore, the secondary recognition step is performed in neat buffer 
solution and at relatively higher antibody concentrations, facilitating the detection of miRNAs of 
interest.  The intrinsic sensitivity of the microring resonator platform coupled with the 
amplification provided by the anti-DNA:RNA antibodies allows for the detection of microRNAs 
at concentrations as low as 10 pM (350 attomoles). The simplicity and sequence generality of 
this amplification method position it as a promising tool for high-throughput, multiplexed 
miRNA analysis, as well as a range of other RNA based detection applications. 
4.2 Introduction 
MicroRNAs (miRNAs) comprise a class of small, noncoding RNAs that are incredibly important 
regulators of gene translation.1,2 Although the exact mechanisms of miRNA action are still being 
elucidated, they are known to play an important regulatory role in a number of biological 
functions, including cell differentiation and proliferation,3-7 developmental timing,8-11 neural 
development,12 and apoptosis.13 Given their importance in such transformative processes, it is 
not surprising that aberrant miRNA levels are found to accompany many diseases, such as 
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diabetes,14 cancer,15-17 and neurodegenerative disorders,18,19 and thus these small RNAs have 
been proposed as informative targets for both  diagnostic and therapeutic applications.20 
Despite their critical role in cellular processes and promise as biomarkers, the short 
sequence lengths, low abundance, and high sequence similarity of miRNAs all conspire to 
complicate detection using conventional RNA analysis techniques, such as Northern blotting, 
reverse transcriptase polymerase chain reaction (RT-PCR), and cDNA microarrays.21 Numerous 
approaches have been employed to adapt these methods to the specific challenges of miRNA 
analysis, and while offering increased measurement performance, many suffer from significant 
complexity. 22-29 The analysis of miRNAs is further complicated by the complex nature by which 
miRNAs affect translation, wherein multiple miRNA sequences can be required to regulate a 
single mRNA and/or a particular miRNA may regulate multiple mRNAs.30,31 Given this 
complexity, robust, multiplexed methods of miRNA analysis that feature high target specificity, 
sensitivity and dynamic range will be essential to fully unraveling the biological mechanisms of 
miRNA function, and may also find utility in the development of robust in vitro diagnostic 
platforms. 
Microring optical resonators are an emerging class of sensitive, chip-integrated 
biosensors that have recently been demonstrated for the detection of a wide range of 
biomolecular targets.32-37  These optical microcavities support resonant wavelengths that are 
highly sensitive to biomolecule binding-induced changes in the local refractive index. In 
particular, the combined high Q-factor and small footprint of microring resonators make them an 
attractive choice for both sensitive and multiplexed biosensing. Most relevant to this report, we 
recently demonstrated the direct, label-free detection of miRNAs with a limit of detection of 150 
fmol.33 While this is sufficient for many miRNA applications, we were interested in developing 
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methods to further extend the sensitivity without adding undue complexity or introducing 
sequence-specific bias to the assay, which would compromise the generality and multiplexing 
capabilities of the platform. 
Monoclonal and polyclonal antibodies recognizing RNA:RNA and DNA:RNA duplexes 
have been previously developed and utilized in hybridization based assays for the detection of 
nucleic acid targets including viral nucleic acids and E.coli small RNA.38-43 Of particular 
relevance here is an anti-DNA:RNA antibody, named S9.6, which specifically recognizes 
RNA:DNA heteroduplexes and has been utilized to detect RNA in a conventional fluorescence-
based microarray format.44-47 
In this paper, we combine the utility of the S9.6 anti-DNA:RNA antibody with the 
appealing detection capabilities of silicon photonic microring resonators to demonstrate the 
sensitive detection of mammalian miRNAs. Importantly, the S9.6 binding response is 
significantly larger than that observed for the miRNA itself, allowing the limit of detection to be 
lowered by ~3 orders of magnitude, down to 350 attomoles. We apply this approach to the 
multiplexed quantitation of four miRNA targets both from standard solutions as well as the total 
RNA extract from mouse brain tissue. These results indicate that this strategy is appealing for the 
multiplexed detection of miRNAs in a simple and reasonably rapid assay format that does not 
require RT-PCR amplification schemes. 
Importantly, during the preparation of this manuscript, Šípová and co-workers reported a 
similar S9.6 miRNA detection assay on a grating-coupled surface plasmon resonance platform. 48 
Focusing on the detection of single miRNA, the authors report a similar limit of detection, 
further highlighting the broad utility of the S9.6 antibody in PCR-less assay formats.  
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4.3  Experimental 
4.3.1  Materials 
The silane, 3-N-((6-(N'-Isopropylidene-hydrazino))nicotinamide)propyltriethyoxysilane (HyNic 
Silane), and succinimdyl 4-formyl benzoate (S-4FB) were purchased from SoluLink. PBS was 
reconstituted with deionized water from Dulbecco’s Phosphate Buffered Saline packets 
purchased from Sigma-Aldrich (St. Louis, MO), and the buffer pH adjusted to pH 7.4 (PBS-7.4) 
or pH 6.0 (PBS-6) with sodium hydroxide or hydrochloric acid. A 20X saline-sodium phosphate-
EDTA buffer (SSPE) was purchased from USB Corp. for use in a high stringency hybridization 
buffer. All other reagents were purchased from Fisher, unless otherwise noted, and used as 
received. 
4.3.2  Fabrication of Silicon Photonic Microring Resonators and Measurement Instrumentation 
The fabrication of sensor chips and operational principles of the measurement instrumentation 
have been previously reported.34,49 Briefly, sensor substrates, each containing 32 uniquely-
addressable microring resonators within a 6x6 mm footprint, were fabricated at a commercial-
scale silicon foundry on 8” silicon-on-insulator wafers using conventional deep-UV 
photolithography and dry etching methods, before being diced into individual chips. After 
immobilization of DNA capture probes (described below), the sensor chips are loaded into a 
biosensor scanner (Genalyte, Inc.), and the wavelengths of optical resonance of the entire array 
of microring elements are monitored in near real-time using an external cavity laser, integrated 
control hardware, and data acquisition software. 
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4.3.3 Nucleic Acid Sequences 
All synthetic nucleic acids were obtained from Integrated DNA Technologies. DNA capture 
probes were HPLC purified prior to use, while synthetic RNA probes were RNase Free HPLC 
purified. The sequences of all nucleic acid strands used in this work are listed in Table 4.1. 
4.3.4  Modification of ssDNA Capture Probes 
DNA capture probes, synthesized with amines presented on the 5' end of the sequence, were 
resuspended in PBS-7.4 and then buffer exchanged three times with a new PBS-7.4 solution 
utilizing Vivaspin 500 Spin columns (MWCO 5000, Sartorius) to remove residual ammonium 
acetate from the solid phase synthesis. A solution of succinimidyl-4-formyl benzoate (S-4FB, 
Solulink) in N,N-dimethylformamide was added in 4-fold molar excess to the DNA capture 
probe, and allowed to react overnight at room temperature. The 4FB-DNA solution was 
subsequently buffer exchanged three additional times into PBS-6 to remove any unreacted S-
4FB. 
4.3.5 Chemical and Biochemical Modification of Silicon Photonic Microring Resonator Surfaces 
Prior to functionalization, sensor chips were cleaned in a freshly-prepared Piranha solution (3:1 
solution of 16 M H2SO4:30% wt H2O2) for 1 min, and subsequently rinsed with copious amounts 
of water. (Warning: Piranha solutions can react explosively with trace organics—use with 
caution!) Sensor chips were then sonicated for 7 min in isopropanol, dried with a stream of N2, 
and stored until further use. 
To attach DNA capture probes, sensor chips were immersed in a 1 mg/mL solution of 
HyNic Silane in ethanol for 30 min, rinsed and sonicated for 7 min in absolute ethanol, and dried 
with a stream of N2. Small aliquots (15 µL) of 4FB-modified-DNA were then carefully deposited 
onto the chips so as to cover only specific sets of microrings, and the solution droplets incubated 
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overnight in a humidity chamber. Prior to hybridization experiments, the substrates were 
sonicated in 8 M urea for 7 min to remove any non-covalently immobilized capture probe. 
4.3.6 Addition of Target miRNA to Sensor Surface 
Target miRNA solutions were suspended in a high stringency hybridization buffer, consisting of 
30% formamide, 4X SSPE, 2.5X Denhardt’s solution (USB Corporation), 30 mM 
ethylenediaminetetraacetic acid, and 0.2% sodium dodecyl sulfate. Aliquots (35 µL) of target 
miRNA solutions were recirculated across the sensor surface at a rate of 24 µL/min for 1 hr 
utilizing a P625/10K.133 miniature peristaltic pump (Instech). Solutions were directed across to 
the surface via a 0.007” Mylar microfluidic gasket sandwiched between a Teflon cartridge and 
the sensor chip. Gaskets were laser etched by RMS Laser in various configurations to allow for 
multiple flow patterns. 
4.3.7 Surface Blocking and Addition of S9.6 
Following hybridization of the target miRNA to the sensor array, the surface was blocked with 
Starting Block™ (PBS) Blocking Buffer (Thermo Scientific) for 30 min at 10 µL/min, as 
controlled with a 11 Plus syringe pump (Harvard Apparatus) operated in withdraw mode, 
followed by rinsing with PBS-7.4 with 0.05% Tween for 7 min at 30 µL/min. Following surface 
blocking, a 2 µg/mL solution of S9.6 in PBS-7.4 with 0.05% Tween was flowed across the 
sensor surface for 40 min at a rate of 30 µL/min. 
4.3.8 Generation and Purification of the S9.6 Antibody 
The S9.6 antibody was harvested from the medium from cultured HB-8730 cells, a mouse 
hybridoma cell line obtained from the American Type Culture Collection (ATCC). Cells were 
cultured according to manufacturer instructions and the S9.6 antibody was purified using protein 
G by the Immunological Resource Center in the Carver Biotechnology Center at the University 
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of Illinois at Urbana-Champaign. The purified antibody was aliquoted at 0.94 mg/mL in PBS-
7.4, and stored at -20oC until use. 
4.3.9 Data Analysis 
To utilize the S9.6 response for quantitative purposes, we used the net sensor response after 40 
min of exposure to a 2 µg/mL solution of S9.6. Control rings functionalized with a non-
complementary DNA capture probe were employed to monitor non-specific hybridization-
adsorption of the target miRNA as well as the non-specific binding of the S9.6 antibody. The 
signal from temperature reference rings (rings buried underneath a polymer cladding layer on the 
chip) was subtracted from all sensor signals to account for thermal drift. 
Calibration data over a concentration range from 10 pM to 40 nM, with the exception of 
miRNA miR-16 (in which the 40 pM and 10 pM points were not obtained), was fit to the logistic 
function: 
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where A1 is the initial value limit, A2 is the final value limit, and c and p describe the center and 
power of the fit, respectively.  The data used for fitting the logistic curve as well as the 
associated fitting parameters can be found in the Appendix, Section A2. 
4.3.10 miRNA Expression Levels in Mouse Tissue 
50 µg of total mouse brain RNA (Clontech) was diluted 1:5 with hybridization buffer and 
recirculated overnight prior to amplification with S9.6. The net sensor response after 40 min 
exposure to 2 µg/mL S9.6 was calibrated to each miRNA to account for variable Tm values and 
any secondary structure that would influence the hybridization kinetics.  
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4.4 Results/Discussion 
A schematic of the S9.6 assay is shown in Figure 4.1a. The microrings are initially 
functionalized with ssDNA capture probes complementary to the target miRNAs of interest. A 
solution containing the miRNA is flowed across the sensor surface, after which the surface is 
blocked to prevent non-specific protein adsorption, and subsequently exposed to the S9.6 
antibody. Representative real-time shifts in the resonance wavelength for three DNA-modified 
microrings first to the hybridization of a complementary miRNA and then the S9.6 anti-
DNA:RNA antibody are shown in Figure 4.1b. Notably, we do not observe any significant 
response when S9.6 is flowed across a surface containing only single-stranded DNA capture 
probes or double stranded DNA duplexes, confirming the specificity of this amplification 
strategy (Figure 4.2). 
Apparent from the data shown in Figure 4.1b is an unusual kinetic binding response for 
the S9.6 antibody binding to the DNA:RNA heteroduplex-presenting surface. Rather than 
display classical Langmuir-type behavior in which the rate of binding is fastest initially, the 
measured response appears sigmoidal, with the rate of binding actually increasing for the first 
10-15 minutes, after which the curves begins to level off. Suspecting either a steric or 
cooperative binding explanation, we varied the concentration of DNA capture probe immobilized 
onto sensors, incubated complementary miRNA at saturating concentrations, and then performed 
S9.6 enhancement. Since the amount of underlying DNA was varied, the sensors supported 
different saturation levels of miRNA hybridization, but saturation was always reached by 
flowing a very high (40 nM) solution of the target across the surface prior to blocking and 
introducing S9.6. Interestingly, the shape of the S9.6 binding response varied as a function of the 
underlying DNA capture probe loading, as shown in Figure 4.3, transitioning from sigmoidal, at 
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high relative DNA loadings, to the expected logarithmic response. We preliminarily attribute this 
behavior to steric crowding on the surface at high capture probe densities, but this inhibition is 
relaxed for subsequent S9.5 binding events—particularly in the case where multiple S9.6s bind 
to a single DNA:miRNA heteroduplex, as described in greater detail below. Although we do not 
yet fully understand the mechanism of this binding interaction, we do observe that the highest 
capture probe densities result in the largest observed S9.6 responses over all target miRNA 
concentrations measured at a fixed 40 minute time point. Therefore, for the purposes of sensitive 
detection, rather than kinetic analysis, we chose to functionalize our sensors with the highest 
achievable levels of capture probes.  
After the initial verification of S9.6 binding and amplification potential, we sought to 
better understand the applicability and limitations of the antibody. In particular, one interesting 
aspect of the antibody was the large signal amplification we observed upon S9.6 binding to our 
sensor surfaces, especially under non-saturating conditions. As shown in Figure 4.1b, the net 
sensor shift for the hybridization-adsorption of a 100 nM solution of miR-24-1 (a concentration 
that will saturate binding sites) onto the sensor surface is ~80 pm. The S9.6 response for 
amplification is ~520 pm, limited by steric crowding of the antibody. However this secondary 
amplification becomes even more dramatic at lower miRNA conditions, increasing the response 
over 60-fold (Figure 4.4). Since the miRNA and antibody differ in mass by a factor of 
approximately 21, this suggests that ~3 S9.6 antibodies can bind to a single DNA:miRNA 
duplex.  
To confirm our hypothesis that a single DNA:RNA heteroduplex could be bound by 
multiple S9.6 antibodies, we functionalized a sensor surface with a ssDNA capture probe that 
was complementary to 10- and 20-mer RNA test sequences. As seen in Figure 4.5, the primary 
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hybridization response for the 20-mer RNA sequence is almost exactly twice as large as for the 
10-mer. The observed S9.6 binding response is again larger for the 20-mer target, but the 
response is ~2.5 times that of the 10-mer, suggesting that two and sometimes three S9.6 
antibodies can bind to the 20-mer target. Experiments performed with a 40-mer test RNA 
sequence confirm that multiple S9.6 antibodies can bind to single heteroduplexes, and also reveal 
that longer strand responses are accompanied by more complex steric binding considerations. 
These results, while preliminary, suggest that the S9.6 binding epitope is on the order of 6 base 
pairs in size, which is considerably smaller than the 15 nucleotide epitope previously proposed.44 
Importantly, the small size of the epitope allows multiple S9.6 antibodies to bind to single 
DNA:miRNA heteroduplexes, which in turn allows for greater signal amplification.  
To demonstrate the quantitative utility of this signal enhancement scheme, we performed 
S9.6 experiments for sensor arrays exposed to different concentrations of four different perfectly 
complementary target miRNAs. The resulting calibration curves for each of the target miRNAs 
were generated using synthetic miRNAs in buffer on separate chips, and quantitated based on the 
net S9.6 binding response measured after 40 minutes (Figure 4.6). The concentration dependent 
responses were obtained over 3 orders of magnitude down to a concentration of 10 pM (350 
amol). One exception to this is miR-16, which only gave consistent measurements down to 160 
pM. While the reason for this difference is not yet fully understood, we preliminarily attribute it 
to specific secondary structures of the miRNA target and capture probe. A key advantage of S9.6 
for miRNA detection is the fact that it is a universal recognition element, in contrast to sequence-
specific RT-PCR primers, and thus the addition of a single reagent can be used to enhance 
detection for all miRNA species being interrogated. This is especially valuable for multiplexed 
detection platforms, such as the arrays of microring resonators used herein. Sensor chips can 
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therefore be derivatized to present multiple, sequence-specific capture probes specific to multiple 
miRNAs, exposed to the sample of interest, and the signal for each target can be simultaneously 
enhanced in a single step with the addition of S9.6.  
As a proof-of-concept, we functionalized discrete regions of four sensor arrays with 
different ssDNA capture probes that were perfectly complementary towards miR-16, miR-21, 
miR-24, and miR-26a. Sensor chips were then exposed to solutions containing only one of the 
target miRNAs at 40 nM, rinsed, blocked, and exposed to S9.6. This process was repeated for 
each of the four target miRNAs, each on its own chip, and the compiled responses are shown in 
Figure 4.7. Each column in the figure represents a different sensor array incubated with a 
specific target sequence. Taken together, it is clear that the S9.6 antibody does not introduce any 
cross-talk even at high target concentrations, and that the specificity of complementary probe 
hybridization, as reinforced through the use of a high stringency buffer, is reflected in the 
enhanced S9.6 assay.  
To demonstrate the applicability of the S9.6 amplification methodology to the analysis of 
a relevant biological system, we simultaneously examined the relative expression profiles of the 
four aforementioned miRNAs in mouse total brain RNA. We chose to utilize mouse brain RNA 
due to the previously reported relative expression levels of many miRNAs. Two of the sequences 
have been found to be highly overexpressed in the mouse brain relative to other tissues, while the 
others are expressed at lower levels.22,50-53 We analyzed the expression of the four miRNAs in 
total mouse brain RNA, and after calibration and accounting for the 5-fold dilution in 
hybridization buffer, original expression levels were determined to be 3.12 ± 1.60 nM, 0.60 ± 
0.39 nM, 0.56 ± 0.25 nM, and 4.87 ± 2.72 nM for miR-16, miR-21, miR-24-1, and miR-26a, 
respectively (Figures 4.8a and 4.9). The overexpression of miR-16 and miR-26a relative to miR-
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21 and miR-24-1 is consistent with previous literature reports across a number of different 
profiling techniques, and is well within the variation observed between those studies, as shown in 
Figure 4.8b.  
While slightly beyond the scope of this manuscript, we also investigated the utility of the 
S9.6 signal enhancement strategy for locked-nucleic acid (LNA)-containing DNA:miRNA 
heteroduplexes. LNAs are non-natural nucleotide analogs of DNA that contain a 2'-O, 4'-C-
methylene bridge which confer added rigidity to the resulting duplex.54 Importantly, it has been 
previously shown that the incorporation LNAs into DNA capture probes can increase both the 
selectivity and sensitivity of miRNA hybridization assays.55 We found that the S9.6 antibody can 
bind to LNA-containing DNA capture sequences, albeit with a slightly lower efficiency, 
compared to an equally miRNA-saturated ssDNA(only)-modified sensor surface (Figure 4.10). 
Although the bulk of the miRNA detection experiments described herein utilized purely DNA-
based capture probes, we feel as though the demonstrated amenability of the S9.6 signal 
enhancement strategy to LNA-containing capture probes may be of future utility for small RNA 
detection. 
4.5 Conclusion 
The recently understood role of miRNAs in maintaining biological homeostatis and the plethora 
of disease states resulting from their disregulation has heightened the need for sensitive, 
multiplexed, high-throughput technologies for their analysis.  In particular, the ease by which an 
assay can be performed affects its acceptance and utilization by other researchers. We have 
demonstrated a simple, highly sensitive method for the multiplexed detection of miRNAs 
utilizing an anti-DNA:RNA antibody with arrays of silicon photonic microring resonators. The 
simplicity of the assay, the ability to simultaneously read-out multiple miRNAs in a single 
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amplification step, and the potential to utilize the antibody in complex media make the 
methodology extremely appealing. 
 Future work will focus on applying this methodology towards deciphering the role of 
miRNAs in myriad biological systems. We will also explore ways to further increase the 
amplification provided by S9.6 by conjugating the antibody with high molecular weight tags, 
such as nanoparticles and silica beads. The ability to utilize S9.6 with LNA capture probes also 
provides the potential for incorporating highly stringent and specific capture probes with this 
assay, possibly improving its performance characteristics in biologically complex samples. 
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4.6 Tables and Figures 
 
Table 4.1. Sequences of synthetic nucleic acids in described experiments. Bases in bold indicate 
the substitution of a locked nucleic acid.  
 
 Sequence 
hsa miR-16 5'-UAGCAGCACGUAAAUAUUGGCG-3' 
hsa miR-21 5'-UAGCUUAUCAGACUGAUGUUGA-3' 
hsa miR-24-1 5'-UGGCUCAGUUCAGCAGGAACAG-3' 
hsa miR-26a 5'-UUCAAGUAAUCCAGGAUAGGCU-3' 
DNA Capture 
Probe  
for hsa miR-16 
5'-NH2 – (CH2)12 – ATC GTC GTG CATTTATAACCGC-3' 
DNA Capture 
Probe  
for hsa miR-21 
5'-NH2 – (CH2)12 – ATCGAATAGTCTGACTACAACT-3' 
DNA Capture 
Probe  
for hsa miR-24-1 
5'-NH2 – (CH2)12 – CTGTTCCTGCTGAACTGAGCCA-3' 
DNA Capture 
Probe  
for hsa miR-26a 
5'-NH2 – (CH2)12 – AAGTTCATTAGGTCCTATCCGA-3' 
10mer RNA 5'-AAAGGUGCGU-3' 
20mer RNA 5'-AAAGGUGCGUUUAUAGAUCU-3' 
40mer DNA 
Modular Capture 
Probe 
5'-NH2 – (CH2)12 – 
TAGTTGCTGCAACCTAGTCTAGATCTATAAACGCACCTTT-3' 
LNA Capture 
Probe  
for hsa miR-24-1 
5’-NH2 – (CH2)12 – CTGTTCCTGCTGAACTGAGCCA-3’ 
 
  
126 
 
Figure 4.1. (a) Schematic of the S9.6 amplification assay, in which an DNA-modified microring 
is sequentially exposed to complementary miRNA followed by the S9.6 antibody. (b) Signal 
responses from 3 separate microrings corresponding to the schematic in (a) illustrate the 
heightened sensitivity achieved via the S9.6 antibody. 
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Figure 4.2.  Specificity of S9.6 binding only to DNA:RNA heteroduplexes. Sensor rings were 
functionalized with cDNA complementary to miR-16, and incubated with one of the following: 
40nM miR-16, 40 nM DNA analogue of miR-16, or buffer only. Real time response of S9.6 
amplification towards the resulting single stranded DNA (red), a DNA:DNA duplex (blue), and a 
DNA:RNA heteroduplex (black) illustrate the minimal nonspecific adsorption properties of the 
antibody. 
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Figure 4.3. Capture probe density plot, showing the S9.6 response to varied ssDNA capture 
probe concentrations with a constant miR-24-1 target concentration (40 nM). The binding 
transition from cooperative binding to Langmuir binding kinetics is evident as steric limitations 
are relaxed as the concentration of capture probe deposition solutions is lowered below 125 nM. 
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Figure 4.4.  Binding Response and S9.6 Amplification of a 1 nM miR-24-1 Target.   a) A 1 nM 
solution containing miR-24-1 is flowed across sensor rings functionalized with a perfectly 
complementary DNA capture probe giving a measureable signal, but one that is approaching the 
noise floor of the assay. b)  A solution containing 2 µg/mL of the S9.6 antibody is then flowed 
across the bound heteroduplexes and a much larger and more easily measured response. 
Although the S9.6 response is not yet at equilibrium after 40 minutes of binding, it is clear that 
the amount of amplification is significantly larger than that expected based upon a 1:1 binding 
interaction. The bound miRNA (~7 kDa) is approximately 21 times smaller than the S9.6 
antibody (~150 kDa), but the observed amplification factor is at least a factor of 60, suggesting 
that multiple S9.6 antibodies can bind to each surface-bound heteroduplex.  
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Figure 4.5. (a) Microrings functionalized with a 40-mer ssDNA capture probe were incubated 
with 100 nM solutions of 10-mer and 20-mer RNA targets complementary to the 3' end of the 
capture probe, revealing a length dependent signal response. As expected, the hybridization of 
the 20-mer results in a signal that is approximately two times larger than for the 10-mer. (b) The 
subsequent S9.6 amplification response on the DNA:RNA heteroduplexes consisting of the 20-
mer RNA also shows a larger response than the 10-mer heteroduplex, further supporting the 
notion that multiple (2-3) S9.6 antibodies can bind to a single bound miRNA. Experiments 
performed with a 40-mer test RNA sequence (not shown) confirm that multiple S9.6 antibodies 
can bind to single heteroduplexes, and also reveal that longer strand responses are accompanied 
by more complex steric binding considerations. 
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Figure 4.6. (a) Overlay of the signal responses achieved for each concentration of target 
miRNA. Concentrations utilized were 40 nM, 10 nM, 2.56 nM, 640 pM, 160 pM, 40 pM, 10 pM, 
and a blank (with the exception of miR-16, which did not contain the 40 pM and 10 pM 
calibration points). (b) Calibration curves for the S9.6 response for miR-16, miR-21, miR-24-1, 
and miR-26a. Plots were constructed from the relative shifts at 40 min. The red curves represent 
the logistic fits to the data points. Error bars represent ±1 standard deviation for between 4 and 
12 independent measurements at each concentration. 
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Figure 4.7. Simultaneous amplification of a panel of 4 miRNA targets (columns) hybridized to 
four complementary capture probes (rows). A panel of 4 chips was functionalized towards all 
four miRNA, and a single 40 nM target solution was introduced to each, followed by 2 µg/mL 
S9.6. Only those channels containing complementary capture probes and target miRNAs elicit an 
S9.6 response, allowing multiplexed miRNA analysis. 
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Figure 4.8. (a) Comparison of the concentrations for each of the four target miRNAs in total 
mouse brain RNA. Five-fold sample dilution and individual calibration plots were taken into 
account to calculate the final concentrations. (b) Microring resonator-based relative miRNA 
expression profiles, normalized to miR-26a expression levels, correlate well with literature 
results from a variety of detection techniques. Both the technique-to-technique variability and 
incomplete expression profiles of currently accepted techniques highlight the need for highly 
multiplexed and accurate profiling methods. 
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Figure 4.9.  Binding response of S9.6 to Mouse Brain Total RNA.  Microrings previously 
functionalized with 4 different capture probes complementary to different miRNA of interest 
were incubated with mouse brain total RNA overnight. After a blocking step the microrings are 
subsequently exposed to S9.6 in buffer. The resulting shift is then quantitated via calibration 
plots for each miRNA. 
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Figure 4.10. Sensor rings were functionalized with either cDNA complementary to miR-24-1 or 
an LNA analogue of the DNA capture probe.  A solution of 40 nM miR-24-1 was flowed over 
the entire chip.  The real time response of the S9.6 amplification towards each of the 
heteroduplex pairs is shown above.  While the LNA:RNA heteroduplex (red) elicits a response to 
the S9.6 amplification, the response is lower than seen with an DNA:RNA heteroduplex (black). 
However, the fact that S9.6 can recognize LNA:RNA heteroduplexes should prove to be quite 
useful as LNAs have previously been demonstrated to be  higher affinity capture probes for 
miRNA detection applications, compared to DNA. 
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Chapter 5 – Isothermal Discrimination of Single-Nucleotide Polymorphisms via Real-Time 
Kinetic Desorption and Label-Free Detection of DNA using  
Silicon Photonic Microring Resonator Arrays 
 
This chapter has been reprinted (adapted) with permission from “Isothermal Discrimination of 
Single-Nucleotide Polymorphisms via Real-Time Kinetic Desorption and Label-Free Detection 
of DNA using Silicon Photonic Microring Resonator Arrays” (Qavi, A.J.; Mysz, T.M.; Bailey, 
R.C.; Anal. Chem., 2011, 83, 6827-6833).  Copyright 2011 American Chemical Society.  The 
original document can be accessed online at <http://pubs.acs.org/doi/abs/10.1021/ac201659p>. 
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5.1 Abstract 
We report a sensitive, label-free method for detecting single-stranded DNA and discriminating 
between single nucleotide polymorphisms (SNPs) using arrays of silicon photonic microring 
resonators. In only a 10 minute assay, DNA is detected at sub-picomole levels with a dynamic 
range of three orders of magnitude. Following quantitation, sequence discrimination with single 
nucleotide resolution is achieved isothermally by monitoring the dissociation kinetics of the 
duplex in real-time using an array of SNP-specific capture probes. By leveraging the multiplexed 
capabilities of the microring resonator platform, we successfully generate multiplexed arrays to 
quickly screen for the presence and identity of SNPs and show the robustness of this 
methodology by analyzing multiple target sequences of varying GC content. Furthermore, we 
show that this technique can be used to distinguish both homozygote and heterozygote alleles. 
5.2 Introduction 
With the sequencing of the human genome effectively complete, the development of high 
throughput and rapid DNA detection methods has become a major focus of research as the 
biomedical community seeks to translate genomic insight into clinical improvements in patient 
care. For example, DNA detection is an essential element of genetic screening,1 disease 
diagnosis,2,3 forensic analysis,4,5 single-nucleotide polymorphism (SNP) profiling,6,7 and drug 
quality control.8 Many traditional analysis tools involve fluorescent and/or enzymatic tags for 
detection, which can provide versatility and sensitivity. However, the requirement for labeled 
biomolecules can introduce limitations in terms of reagent cost and slower analysis times, and 
may also introduce signal bias into measurements. Label-free technologies represent alternative 
means for detecting a range of biomolecules, including DNA, enabling quantitative, multiplexed 
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measurements and real time kinetic analysis of binding events without requiring additional assay 
reagents or sample pre-treatment (i.e., labeling).9 
Microcavity optical resonators have emerged as an interesting class of devices that are 
well suited to label-free biomolecular quantitation.10 These biosensors, which include 
microspheres,11,12  microtoroids,13 microcapillaries,14,15 and microrings,16-19 support spectrally 
narrow optical resonances that are exceptionally responsive to binding-induced changes in the 
refractive index environment at the cavity surface. The relationship between refractive index and 
resonance wavelength is given by: 
effrnm piλ 2=  
where m is an integer value, λ is the wavelength, r is the radius of the resonant cavity, and neff is 
the effective refractive index of the optical mode. Therefore, the resonance wavelengths shift to 
longer or shorter values as molecular binding or unbinding, respectively, modulates the local 
refractive index, as shown in Scheme 5.1. 
On account of their scalable and cost-effective fabrication via commercially validated 
semiconductor processing methods, microring resonators are particularly well-suited for high 
volume, multiplexed diagnostic applications. We have recently developed a versatile biosensing 
platform in which an array of silicon-on-insulator microring resonators can be simultaneously 
interrogated in near real time, and have demonstrated the ability to quantitatively a range of 
biomolecular targets in both single16,18 and multiplexed formats.17,19 
In this paper, we report the rapid and label-free detection of DNA down to a detection 
limit of 195 femtomoles (1.95 nM) utilizing arrays of silicon photonic microring resonators. 
More importantly, we show the ability to distinguish single nucleotide polymorphisms by 
monitoring in real-time the desorption rates of mismatch DNA from the sensor surfaces.  By 
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leveraging the multiplexed nature of our sensing platform, we can screen multiple DNA 
interactions simultaneously, allowing for a high-throughput method of SNP identification.  The 
rapid time-to-result and intrinsic scalability of this semiconductor-based platform makes it a 
promising technology for sensitive and specific detection of DNA. 
5.3 Experimental  
5.3.1 Materials.  
All synthetic DNA probes were obtained from Integrated DNA Technologies. DNA capture 
probes were HPLC purified and target sequences were desalted. DNA capture probes contained a 
C12 linker and a randomly generated 18-mer DNA sequence to act as a spacer between the 
recognition sequence and the sensor surface. Phosphate buffered saline (PBS), with a standard 10 
mM phosphate ion concentration, was reconstituted from Dulbecco’s phosphate buffered saline 
packets purchased from Sigma-Aldrich (St. Louis, MO) and adjusted to pH 7.4.  
5.3.2 Fabrication of Silicon Photonic Microring Resonators and Measurement Instrumentation.  
Details on the fabrication of the sensor arrays and measurement instrumentation, from Genalyte, 
Inc., have been previously described.16,20 Briefly, the 6 x 6 mm sensor substrates contained 32 
uniquely addressable microrings that were thirty micrometers in diameter. The sensor array was 
assembled into flow chamber with two ~1.5 µL microfluidic channels. All measurements were 
made at room temperature (~25°C). 
5.3.3 Chemical and Biochemical Functionalization of Sensor Surfaces.  
Sensor chips were first immersed in Piranha solution (3:1 solution of 16 M H2SO4:30% wt H2O2) 
for 1 min and subsequently rinsed copiously with Millipore H2O. (Caution: Piranha solutions 
are extremely hazardous and can explode in contact with trace amounts of organics!) A solution 
of 1 µg/mL of 3-N-((6-(N′-Isopropylidene-hydrazino))nicotinamide)propyltriethoxysilane 
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(HyNic Silane, Solulink Inc.) in 100% EtOH was introduced to the sensor surface at a flow rate 
of 10 µL/min for 90 min. The sensors were subsequently rinsed with 100% ethanol to remove 
any residual HyNic Silane not covalently bound to the surface. The deposition of the HyNic 
Silane was monitored in real-time, and is shown in Figure 5.1. 
The DNA capture sequences were buffer exchanged in PBS using a Vivaspin 500, 5000 
MWCO (Sartorius) spin column. The solution was centrifuged three times at 10000 rpm to 
remove any residual ammonium acetate present in the sample that would interfere with 
subsequent conjugation steps. The 5′-aminated DNA capture strands were treated with 
succinimidyl 4-formylbenzoate (S-4FB, Solulink, Inc.) with at least a 4-fold molar excess.  The 
DNA capture strands and S-4FB were allowed to react overnight, after which the solution was 
centrifuged three times in 5000 MWCO spin columns at 10000 rpm to remove any residual S-
4FB that did not react with the capture probes. The S-4FB modified ssDNA capture probes were 
flowed across the sensor surface, where they were covalently attached only to areas immediately 
surrounding and including microrings, with the rest of the substrate masked by an inert cladding 
layer. The covalent attachment of the DNA capture probes was monitored in real-time to ensure 
covalent attachment to the sensor surface, as shown in Figure 5.2. 
5.3.4 DNA Detection and Surface Regeneration 
All synthetic DNA targets (sequences listed in Table 5.1) were suspended in PBS. The 
concentration of the target DNA solutions were verified using a NanoDrop 1000 UV-Vis 
spectrometer (Thermo Scientific). Solutions containing the DNA target of interest were flowed 
across the sensor surface for 10 min at 10 µL/min. The sensors were subsequently rinsed with 
PBS to ensure hybridization of the target probe. In order to regenerate the sensors for further 
experiments, the surface was exposed to 8 M Urea for 90 min at a flow rate of 10 µL/min. The 
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surface was subsequently rinsed with Millipore H2O for at least 30 min at a flow rate of 10 
µL/min, after which the sensors could be used for further experiments.  As shown in Figures 5.3 
and 5.4, repeated regeneration cycles do not significantly affect signal response. 
5.3.5 Non-Complementary Sequence Specificity   
To evaluate the specificity of the sensors towards the hybridization of non-complementary 
sequences, a single sensor chip was functionalized with two ssDNA capture probes, A and B 
(Table 5.1).  The entire sensor surface was initially exposed to a 1 µM solution of A′ (the target 
probe complementary to A), followed by a quick rinse with PBS and then a 1 µM solution of B′ 
(the target probe complementary to B).  The results, shown in Figure 5.5, demonstrate no 
appreciable cross-reactivity between the two sequences. 
5.3.6 Detection of a Single Nucleotide Polymorphism 
Microrings were functionalized with ssDNA Capture Probe A and subsequently exposed to 
solutions containing either the complementary ssDNA Sequence A′ or single-base mismatch 
DNA sequence (Table 5.2) for 20 min at a flow rate of 20 µL/min. While continuously 
measuring the relative shifts in resonance wavelength, the sensor was then rinsed with PBS for 
30 min at the same flow rate, during which the desorption of the target sequences were observed.  
5.3.7 Multiplexed Detection and Identification of Single Nucleotide Polymorphisms.   
Microring sensors were functionalized as previously mentioned, with the exception that S-4FB 
modified ssDNA capture probes for each of the 4 possible DNA targets (Table 5.3 and Table 
5.4) were hand-spotted onto a single sensor chip and allowed to incubate overnight. A 1 µM 
solution of each target DNA sequence in PBS was flowed across the sensor surface for 20 min at 
a rate of 30 µL/min.  The sensors were subsequently exposed to a solution of PBS for 30 min, at 
a flow rate of 30 µL/min, and finally regenerated for further experiments as described above. The 
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results of these experiments are summarized in Table A3.6 and Table A3.8, while the 
normalized desorption responses are shown in Figure 5.8 and Figure 5.12. Experimental 
parameters for detecting SNP heterozygotes were identical, except that the target solution 
contained two target probes, each at a concentration of 1 µM. The results of these experiments 
are summarized in Figure 5.14, Figure 5.15, and Table A3.10. 
5.3.8 Determination of DNA Melting Temperatures.  
Prior to measurements, the concentrations of total DNA solutions were adjusted to 4 µM. All 
probes were annealed by heating to 95oC followed by cooling at 10oC prior to absorbance 
measurements. The absorbance of every capture and target probe combination, summarized in 
Tables S3 and S4, were measured at λ = 260 nm as a function of temperature with a UV-2561 PC 
UV Recording Spectrometer (Shimadzu). Absorbance readings were taken at every ~0.5oC from 
10oC to 95oC, with 1 min stabilization periods between temperatures. From each of the spectra 
(Figure 5.9 and Figure 5.11), the Tm of each target sequence towards each capture probe was 
determined using LabSolutions – Tm Analysis software, and are summarized in  
Tables A3.6 and A3.8.  
5.3.9 Data Processing.   
All data was corrected for temperature drift by subtracting relative shifts from a series of 
reference microrings that were not exposed to solution. Any linear instrumental drift was 
corrected for by subtracting linear fits from data points collected in PBS. All data was fitted and 
graphed using OriginPro8 (OriginLab Corporation). To calculate the initial slope of the DNA 
binding, we used a modified 1:1 Langmuir Binding Isotherm, as described by: 
 = 1 − 
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To determine the initial slope of the binding response, the first derivative of the previous 
equation was evaluated at t = t0, yielding: 
	
	 = 
 
For concentrations greater than 15.6 nM, the first 10 min of the sensor response was fit to 
the Langmuir binding isotherm, prior to taking the derivative of the function. At concentrations 
15.6 nM or lower, a linear fit over the initial 10 min was sufficient. The data used in the fitting of 
the adsorption-hybrdization responses is compiled in Tables A3.2, A3.3, A3.4. 
To determine the desorption rates, the sensor response over 30 min were fit to: 
 = 	 
where A represents the maximum response of the microring during adsorption-hybridization and 
B is the desorption rate, kd. The parameters used in fitting desorption rates can be in found in 
Tables A3.5 and A3.7, and are summarized in Tables A3.6 and A3.8 respectively. 
For illustrative purposes, the desorption responses of the microrings in Figure 5.7, 
Figure 5.8, and Figure 5.12 were normalized at the point at which the solution was switched 
back to PBS . 
5.4 Results/Discussion 
To validate the applicability of the microring resonator platform for DNA detection, an array of 
microrings was covalently modified with a single 5′-aminated DNA capture probe (strand A). 
Solutions containing a 15-mer complement (strand A′) over a concentration range from 1 µM to 
1.95 nM were then flowed across the entire array. As shown in Figure 5.6a, upon hybridization, 
the resonance wavelengths of the microrings shifted to longer wavelength, and the amount of 
shift was  a function of DNA target concentration. Following hybridization, an 8 M aqueous 
solution of urea, a chaotropic reagent that destabilizes the hydrogen bonding networks of DNA 
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duplexes, was flowed across the sensor chip in order to release the target probe and regenerate 
the surface. Repeated exposures to the same concentration showed no loss of device 
performance, indicating complete regeneration as well as the robust nature of the sensing 
platform (Figures 5.3 and 5.4). 
To demonstrate the quantitative utility of the platform for DNA concentration 
determination, we constructed a sensor calibration plot based upon the data in Figure 5.6a. Since 
we are interested in minimizing assay time, we employed an analysis method in which we use 
the initial slopes of the sensor response, as opposed to saturation or fixed time point shifts, as the 
sensor output.16,19  To determine the sensor slope, the real-time target binding data is fit with an 
exponential function, and the derivative determined at time zero. A plot of sensor initial slope 
versus concentration, Figure 5.6b, yields a linear calibration curve, which is convenient not only 
from the standpoint of quantitation, but also suggests that analyses can be achieved at very short 
assay times, since the slope above background is determined within the first ten minutes of 
hybridization. Using this approach, we demonstrated a detection limit of 1.95 nM, which 
corresponds to only 195 fmol of target DNA given the 100 µL sample volume of analysis. This 
detection limit is comparable to those reported using surface plasmon resonance in a direct 
hybridization format.21-23 Nonetheless, we are currently investigating methods to improve the 
limit of detection, which include enzymatic amplification strategies24 as well as improved 
microfluidic sample delivery that will allow for further reduced sample volumes. 
While there are certainly instances where ultimate sensitivity is important, the widespread 
use of the polymerase chain reaction (PCR) prior to analysis via hybridization has lessened the 
significance of extremely low DNA detection limits for many applications. Given this, sequence 
specificity is perhaps the most important attribute to design into emerging DNA analysis 
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technologies. Target specificity is of particular concern when using label-free techniques since 
only a single analyte recognition event is responsible for the observed response. In contrast, 
sandwich-type assays require two target-specific recognition events for detection. We first 
evaluated specificity of our microring resonator platform by functionalizing portions of the 
sensor array with two unique capture probes, strands A and B, and find that there was absolutely 
no cross reactivity between their completely non-complementary 15-mer target sequences 
(Figure 5.5).   
However, a much more important and clinically-relevant challenge is the discrimination 
of SNPs. A common approach to SNP discrimination relies upon determining the relative 
amount of bound target DNA when measured at different temperatures.25-29 Since imperfect 
duplexes are energetically less stable than perfectly complementary duplexes, SNPs can be 
thermally dissociated (melted) at lower temperatures. Increasing the temperature across the 
duplex melting temperature, Tm, allows SNPs to be resolved due the differential amount of 
hybridized probe at equilibrium. Differences in Tm can be further resolved by either the addition 
of chaotropric reagents or by engineering constructs which take advantage of collective melting 
effects.30 Another approach to discriminating between SNPs involves enzymatic recognition of 
duplex mismatches. Enzymatic processes can be extremely selective, but biases towards 
particular sequences limit the generality of these methods.31-33 
As an alternative to equilibrium-based measurements, we reasoned that differences in the 
energetic stability of perfectly and imperfectly paired strands would be evident in the duplex 
interaction kinetics. Given our access to real-time interaction data, we felt that a kinetic-based 
assay would be advantageous since it does not require changing the temperature and also 
eliminates the need for any additional chemical or biochemical reagents. Previously, Suter and 
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co-workers showed an ability to discriminate between multiple base mismatches on the basis of 
differential adsorption rates between a capture probe and a solution phase target.15  However, the 
rate of adsorption onto a surface depends both upon the on “rate,” kon, and well as the 
concentration of analyte in solution, among other factors such as diffusion. Therefore, in order to 
rigorously discriminate SNPs, the exact target concentration needs to be known and held 
constant across multiple analyses—simultaneous concentration and sequence determination 
cannot be accomplished. By contrast, the rate at which a species desorbs from the surface, in the 
absence of additional target, depends solely on the dissociation rate constant, koff, with no 
dependence upon concentration.34 Dissociation rate constants have previously been used to 
assess the specificity of DNA duplexes, but in this report koff was calculated from a series of 
equilibrium measurements made sequentially at different temperatures.35 
To test the premise that desorption rate can be directly measured using microring 
resonators and used to determine the complementarity of the hybridized duplex via 
measurements made only at a single temperature, we flowed a room temperature solution of 
strand A′ as well as solutions containing the three possible SNPs at nucleotide position 8 (from 
the 5′ end of the target strands) over a microring functionalized with strand A. Clearly the length 
of the sequence and position of the SNP within the sequence will affect the relative stability of 
the resulting mismatched duplexes. Only a single sequence length and SNP position, in the 
center of the duplex, were investigated herein to establish the feasibility of kinetic desorption 
based discrimination. Further design and optimization would be required for a more diverse set 
of SNP sequences. Figure 5.7 shows the normalized association and dissociation responses of 
both the perfectly complementary strand A′ as well as 3 different SNP sequences. While there is 
only a slight difference in the adsorption of the sequences, which again is concentration 
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dependent, a clear difference is observed in the rate of strand desorption after returning the 
solution to pure buffer (no DNA). Furthermore, beyond simply discriminating between perfectly 
and imperfectly paired sequences, visual inspection reveals that the desorption rates track with 
the measured duplex melting temperatures, with faster dissociations observed for lower Tms. 
The relative desorption rates of each of the SNP sequences can be justified given the 
structures of each of the mismatches. The perfectly complementary sequence A′ contains a 
thymidine at position 8 (from the 5′ end of the target strand), forming two hydrogen-bonds with 
the adenosine of the DNA capture probe. The SNPs containing adenosine and cytosine at the 
same position, which have the fastest desorption rates, can only form a single hydrogen-bond 
with the adenosine on the capture probe, resulting in their decreased stability. Furthermore, the 
SNP containing adenine is slightly less stable than the duplex with a cytosine due to sterically 
repulsive purine-purine base pairing. By comparison, the SNP containing guanosine, which has 
the slowest desorption rate of the SNP sequences, can still form two hydrogen bonds with 
adenine; however purine-purine basepairing still destabilizes the duplex over the perfectly 
complementary sequence. 
As a demonstration of the platform’s ability to rapidly screen and identify SNPs, we 
functionalized a single sensor chip with four separate ssDNA capture probes, each varying by a 
single nucleotide at position 8 (from the 3′ end of the capture strand). The perfect complement to 
each of the capture probes was flowed across the entire sensor surface sequentially and the 
desorption rates measured for every combination of capture probe and target DNA. Figure 5.8 
shows the normalized desorption response for each combination, with each column representing 
a single hybridization/desorption cycle on the array of microring resonators. Each column in the 
figure represents a single target strand flowed across the entire array, which has complementary 
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strands varying by only a single nucleotide. By comparing the differential desorption rates of a 
single target sequence from the entire array of microrings, each presenting a different sequence 
that is perfectly complementary to one of the possible SNPs, we can rapidly identify the perfect 
complementary pair as the slowest desorption rate in each column. 
In order to provide a more quantitative framework to rationalize these observations, we 
empirically determined the melting temperatures for each of the sixteen pairwise interactions 
interrogated in Figure 5.8. Importantly, Tm is a good estimate for relative duplex stability that 
can easily be determined by simply measuring the UV absorbance at 260 nm as a function of 
temperature, with the absorbance increasing upon duplex dissociation.36 We then plotted the 
natural logarithm of the measured desorption rate versus Tm, which is a proxy for duplex 
stability, and found a linear dependence, consistent with the Arrhenius equation, as shown in 
Figure 5.11. While melting temperatures provide a convenient and widely accessible method to 
visualize this effect, future efforts will incorporate more rigorous studies of duplex 
thermodynamics involving isothermal titration calorimetry.37,38 
To further demonstrate the utility of this approach, we repeated the SNP screening 
experiment above utilizing a series of DNA capture and target probes with increased G-C 
content, as described in Table 5.4.  The increased G-C content of these probe sets globally 
increases the Tm for all duplexes (both perfectly complementary and SNP duplexes), significantly 
complicating the observation of strand desorption at room temperature. However, we were able 
to isothermally observe differential melting of perfectly complementary and SNP duplexes by 
the simple addition of 10% formamide to the PBS buffer.  Formamide is a commonly utilized 
chaotropic reagent that destabilizes base pairing interactions due to competitive hydrogen 
bonding, effectively lowering the melting temperature of all duplexes. By utilizing this higher 
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stringency buffer during desorption measurements we were able to again identify SNP 
sequences, with the slowest rates of dissociation for a given probe strand always corresponding 
to the perfectly complementary duplex as seen in Figure 5.12 (and summarized in Tables A3.7 
and A3.8).   
Another important area in the detection of SNPs is the ability to detect heterozygotes, 
where one allele carries a SNP not present in the other allele. In this case, both copies of the 
allele would be present within the same genomic sample, meaning that there would be two gene 
sequences that differ by only a single nucleotide. To demonstrate this capability, we 
functionalized a single sensor chip with four capture probes as in Figure 5.8. However, instead 
of flowing a single target DNA across the sensor surface, we flowed two target sequences 
simultaneously (both at the same concentration) to simulate the presence of a heterozygote allele. 
In this case there are two perfectly complementary capture probes on the sensor array and both 
alleles were clearly identified by the two slowest desorption rates, as shown in Figure 5.15, as 
opposed to the homozygous sample which has only a single complementary duplex combination. 
The relative desorption rates of the two capture sequences that are mismatched to both allele 
combinations remain similar in magnitude; however the capture probe presenting the guanine 
shows a dramatic lowering of the desorption rate for the simulated heterozygous allele, as it is 
now perfectly complementary to the cytosine-containing target probe. The ability to detect 
multiple SNP sequences is a distinct advantage of the array-based microring resonator platform 
as many different capture strands can be arrayed onto the multiplexable sensor chip with only 4N 
sensors needed to definitively identify N SNPs from within a sample.  
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5.5 Conclusions 
In this manuscript, we have demonstrated the label-free detection of DNA utilizing arrays 
of silicon photonic microring resonators down to a limit of detection of 195 femtomoles (1.95 
nM). Additionally, by taking advantage of the modular multiplexing capability of the platform 
we show the ability to distinguish between and even determine the identity of SNPs based upon 
the relative rates of desorption as measured isothermally and in real-time.  We have shown that 
this method can be applied to sequences with higher melting temperatures by incorporating 
probes with increased G-C content and demonstrate that this approach is well-suited for 
detecting heterozygote SNP alleles as well. While this proof-of-principle demonstration utilized 
short synthetic oligonucleotides, this methodology could translate to longer sequences by 
performing the dissociation analysis under conditions that uniformly destabilize duplex 
interactions, such as a static elevated temperature or in the presence of a low concentration of a 
chaotropic agent. Finally, we believe that the ability to simultaneously provide both quantitative 
information on target concentration and sequence specificity in a highly multiplexable assay 
format make this an attractive methodology for a range of existing and emerging DNA analysis 
challenges. 
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5.6 Tables and Figures 
Table 5.1. Probe sequences utilized in DNA detection and repeated regeneration experiments 
(shown in Figure 5.3, Figure 5.4, Figure 5.5, and Figure 5.6).  
Strand Sequence 
A 5′-NH2 – (CH2)12 – GGTAGTACAGCATATTGGAAAGTGTATAAGATT-3′ 
A′ 3′-TTTCACATATTCTAA-5′ 
B 5′-NH2 – (CH2)12 – AGAATGCAGGGCCTCACGTTACCCTACCACATA-3′ 
B′ 3′-AATGGGATGGTGTAT-5′ 
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Table 5.2. Sequences for the DNA capture and target sequences (perfectly complementary A′ 
and three SNPs) utilized in the single-plexed SNP assay (as seen in Figure 5.7).  Highlighted 
bases in the target probes indicate the presence of a SNP. 
Strand Sequence 
A 5′-NH2 – (CH2)12 – GGTAGTACAGCATATTGGAAAGTGTATAAGATT-3′ 
A′ 3′-TTTCACATATTCTAA-5′ 
A′ SNP: T to A 3′-TTTCACAAATTCTAA-5′ 
A′ SNP: T to C 3′-TTTCACACATTCTAA-5′ 
A′ SNP: T to G 3′-TTTCACAGATTCTAA-5′ 
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Table 5.3. Sequences for low G-C Content DNA probes (used in Figure 5.8, Figure 5.9, Figure 
5.10, and Figure 5.11).  X and Y = A, T, C, or G.   
Strand Sequence 
Capture Probe 5′-NH2 – (CH2)12 – GGTAGTACAGCATATTGGAAAGTGTXTAAGAAT-3′ 
Target Probe 3′-TTTCACAYATTCTAA-5′ 
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Table 5.4. Sequences for high G-C Content DNA probes (used in Figure 5.12 and Figure 5.13).   
X and Y = A, T, C, or G.   
Strand Sequence 
Capture Probe 5′-NH2 – (CH2)12 – ATTAAAAAATAATTATAGCTTGATGXTCTGTTG-3′ 
Target Probe 3′-GAACTACYAGACAAC-5′ 
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Scheme 5.1.  (a)  Microring resonators presenting single-stranded DNA capture probes can be 
used to detect the hybridization of complementary target probes and dissociation of the resulting 
duplex can be used to identify single nucleotide sequence mismatches. (b) The wavelength of 
optical resonances supported by microrings is responsive to hybridization and duplex melting 
events. c) Shifts in resonance wavelength are measured in real-time, allowing access to binding 
and unbinding kinetics, which are used both for quantitation and SNP identification. 
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Figure 5.1. Addition of 1 mg/mL HyNic-Silane solution to 12 microring sensors.  Each trace 
represents a different microring sensor.  The net shift of ~300 pm after rinsing the surface with 
100% ethanol indicates the covalent attachment of the HyNic Silane to the microring surfaces. 
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Figure 5.2. Addition of an S-4FB modified ssDNA capture probe to a set of 12 microrings 
functionalized with a HyNic-Silane layer.  
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Figure 5.3. Repeated real time shifts in resonance wavelength from 5’ ssDNA modified 
microrings responding to a 1 µM complementary target sequence. The surface-bound duplexes 
were dissociated with 8 M urea to regenerate the surface prior to the next hybridization cycle. 
For clarity, the regeneration step has been omitted due to a large bulk refractive index shift that 
goes off scale. Asterisks indicate the time points at which the solution was switched back to pure 
buffer (no DNA). 
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Figure 5.4. Repeated real time shifts in resonance wavelength from 5’ ssDNA modified 
microrings responding to a 1 µM complementary target sequence. The surface-bound duplexes 
were dissociated with 8 M urea to regenerate the surface prior to the next hybridization cycle. In 
contrast to Figure 5.3, the regeneration steps with 8 M Urea (the ~4000 pm increases in signal) 
are included.  The inset highlights an individual hybridization event. 
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Figure 5.5. Sequence specific response of two sets of microrings (3 per set) functionalized with 
DNA capture probes A (black) and B (red). Dotted lines indicate the addition of 1 µM of target 
DNA probes, A′ and B′.  Asterisks indicate the time points at which the solution was switched 
back to pure buffer (no DNA). 
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Figure 5.6. a) Overlay of the resonance wavelength shifts of a representative microring to 
several concentrations of target DNA. The dotted lines indicate the functions fit to the initial 
binding response from which the initial slope of the sensors was determined via differentiation. 
b) The plot of sensor initial slope versus target concentration yields a response relationship that 
is linear over an ~3 order of magnitude dynamic range. The inset is an expanded version of the 
same plot showing the lower concentration range. 
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Figure 5.7. Normalized hybridization and desorption responses of a single microring to sequence 
A′ and the three possible SNPs at position 8.  At t ~ 20 min the solution was switched to pure 
buffer. Although differences in strand hybridization rate are difficult to distinguish, the rate of 
desorption clearly reveals the perfect complement from the mismatched sequences. Furthermore, 
the order of desorption rates is correlated with duplex stability, as determined by measuring 
melting temperatures. 
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Figure 5.8. Using an array of differentially functionalized microrings, the identity of a particular 
SNP can be determined. Microrings were uniquely functionalized with one of four capture 
strands, each varying by only a single nucleotide at the same position within the sequence. Four 
different target sequences, each perfectly complementary to only one of the arrayed capture 
strands, were then individually flowed across the array and the desorption response monitored. In 
each case, the perfectly complementary interactions were observed as the slowest desorption 
rates within the column. By using an array of microring resonators it is therefore easy to not only 
establish that there is a SNP, but also precisely determine the identity of the mismatched 
nucleotide. 
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Figure 5.9. Multiplexed SNP assay containing the hybridization and desorption responses (non-
normalized) for each of the low G-C content DNA probes (described in Table 5.3).  While it is 
difficult to distinguish the perfectly complementary and SNP mismatch pairs based on their 
hybridization response, the clear difference in desorption responses allows for identification of 
the target.   The perfectly complementary duplexes, seen along the diagonal from the top left-to-
bottom right, have the lowest desorption rates in their respective columns. 
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Figure 5.10. Temperature vs. absorbance curves for each of the low G-C content capture and 
target probe combinations (listed in Table 5.3). 
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Figure 5.11. The natural log of desorption rates demonstrate a strong correlation with 
empirically determined solution phase duplex melting temperatures. 
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Figure 5.12. Normalized desorption response for each of the possible high G-C capture and 
target probe combinations in the multiplexed SNP assay (described in Table 5.4). In all cases, 
the desorption rate is slowest for the perfectly complementary duplexes, as observed from the top 
left-to-bottom right diagonal.   
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Figure 5.13. Temperature vs. absorbance curves for each of the high G-C content capture and 
target probe combinations (listed in Table 5.4). 
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Figure 5.14.  Normalized desorption response for each combination of target probes simulating a 
SNP heterozygote.  The capture and targets probes are the same as those utilized in the low G-C 
content experiments (described in Table 5.3).  The identity of the capture probe in each of the 
insets above is as follows:  X = A (black), X = T (red), X = G (blue), and X = C (green). In each 
case, the two perfectly complementary target and capture probe combinations show the two 
lowest desorption rate in each of the plots. 
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Figure 5.15. Comparison of the desorption rates in which a single target probe is flowed across 
the sensor surface (simulating a homozygous allele) with two target probes (simulating a 
heterozygote allele).  Upon additional of a second DNA target probe in the heterozygote 
experiment (Y = C), the desorption rate for the duplexes formed with the X = G capture probe 
drastically decreases, consistent with the observation that perfectly complementary duplexes 
have relatively low desorption rates.  The X = T capture probe has its respective target in both 
the homozygote and heterozygote case, and thus does not change significantly.  Each of the 
respective experiments were normalized relative towards the desorption rate of the X = C, Y = A 
duplex, a non-perfectly complementary pair for both simulated alleles.   
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6.1  Abstract 
In this chapter, we present our preliminary results towards a number of prospective amplification 
techniques that might further increase the sensitivity of the microring resonator platform towards 
detecting nucleic acids, without adversely affecting specificity or multiplexing capabilities. 
6.2  Introduction 
Previously, our lab demonstrated the ability to detect miRNAs as low as 150 fmol with label-free 
methods, and 350 amol with the utilization of an antibody against DNA:RNA heteroduplexes.  
While these limits of detection are sufficient for many biological applications, we would like to 
further improve our platform’s sensitivity, dynamic range, and robustness.  In part, this is 
motivated due to the fact that the expression of miRNAs can range from a few copies to over 
50,000 copies per cell.1  Additionally, by further increasing the sensitivity of platform, we can 
begin to utilize even smaller sample volumes, making the platform more amenable for clinical 
diagnostics. 
In this chapter, we present our preliminary results from four amplification methodologies 
that might be used as alternatives to the S9.6 assay presented in Chapter 4.  These methods 
include a nanoparticle-based amplification, the inclusion of poly-(A) polymerase, Duplex 
Specific Nuclease, or Horseradish Peroxidase. One limitation faced by many miRNA 
amplification techniques is the introduction of signal bias either through the addition of a label or 
an enzymatic process with a sequence-dependent bias.  Given the importance of a quantitative 
readout with our platform, one of the design criteria for these amplification techniques was that 
they be sequence independent – that is, the addition of an amplification step does not introduce a 
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bias.  Additionally, the amplification schemes are fairly straight-forward and amenable towards 
multiplexed detection capabilities of our sensors. 
6.3 Experimental 
6.3.1  Nucleic Acids 
All synthetic nucleic acids were obtained from Integrated DNA Technologies.  DNA probes 
were HPLC purified prior to arrival, and RNA probes were RNase-Free HPLC purified prior to 
arrival.   
6.3.2 Chemical and Biochemical Modification of Silicon Photonic Microring Resonator Surfaces 
Functionalization processes used on the microring sensors can be found in previous reports.2-4   
6.3.3 Modification of ssDNA Capture Probes 
Details on the modification of ssDNA capture probes used in these assays can be found in 
previous literature reports.2-4  
6.3.4 Addition of Target Nucleic Acids to Sensor Surface 
Target miRNA solutions were suspended in a high stringency hybridization buffer, consisting of 
30% formamide, 4X SSPE, 2.5X Denhardt’s solution (USB Corporation), 30 mM 
ethylenediaminetetraacetic acid, and 0.2% sodium dodecyl sulfate.   All primary hybridization of 
DNA and RNA sequences were conducted for 20 min at a flow rate of 30 µL/min.  Solutions 
were directed across to the surface via a 0.007” Mylar microfluidic gasket sandwiched between a 
Teflon cartridge and the sensor chip. Gaskets were laser etched by RMS Laser in various 
configurations to allow for multiple flow patterns. 
6.3.5 Fabrication of Silicon Photonic Microring Resonators and Measurement Instrumentation 
Details on the fabrication of microring resonator sensor chips as well as the measurement 
instrumentation can be found in previous literature reports.2,5 
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6.3.6 Biotinylation of S9.6 Antibody 
A NHS-based biotinylation kit was obtained from Thermo (EZ-Link NHS-PEG4-Biotin-No-
Weigh Format). The NHS-biotin was resuspended in Millipore H2O to a final concentration of 
20 mM upon arrival, and stored at -80oC. A 5-fold molar excess of this solution was added to the 
S9.6 antibody (1 mg/mL, in PBS, pH 7.4).  The mixture was allowed to incubate at room 
temperature for 2 hours.  Afterwards, the solution was buffered exchanged into PBS, pH 7.4, 
using a Zeba Spin Desalting Column, 7K MWCO (Thermo Scientific).  The columns were spun 
at 15,000xg for 1 min, three times in total.  The biotinylated S9.6 antibody was stored at -20oC 
until further use. 
6.3.7 Nanoparticle Preparation 
114 nm streptavidin coated beads (Bio-Adem Beads Streptavidin Plus, 114 nm) were purchased 
from Ademtech.  The beads were diluted in PBS, pH 7.4, + 0.05% Tween 20 (PBST) to a 
concentration of 250 µg/mL, and centrifuged for 5 min at 5,000xg.  The supernatant solution was 
removed, and the pellet resuspended at a concentration of 250 µg/mL  This process was repeated 
for a total of three times, after which the beads were diluted to a final concentration of 50 µg/mL. 
6.3.8 Poly-(A) Amplification 
Yeast Poly-(A) Polymerase (USB Corporation) was stored at -20oC upon arrival.  For 
experiments, 500 units of Poly-(A) Polymerase were resuspended in a solution of 5 mM ATP, 20 
mM Tris-Hcl, 60 mM KCl, 4 mM MnCl2, and 0.5 mM DTT, pH 7.1.  The poly-(A) solution was 
flowed over the chip surface for a total of 30 minutes at 30 µL/min. 
6.3.9 Duplex Specific Nuclease Amplification 
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Upon arrival, the lyophilized Duplex Specific Nuclease (Evrogen) was resuspended in a solution 
consisting of 50% glycerol and 50% DSN Storage Buffer, at a final concentration of 1 unit/µL.  
The enzyme was stored at -20oC until use.  
6.3.10 Horseradish Peroxidase 
The streptavidin-HRP conjugate (Abcam) was received at a concentration of 1 mg/mL.  The 
protein conjugate was aliquoted and stored at -20oC until use. 
 The 4-chloro-1-napthol (4CN) substrate was obtained from Sigma, and stored at -20oC 
until use.  The substrate was resuspended at a concentration of 2.8 mM with 81.54 µM H2O2 in a 
solution consisting of 2 mL methanol, 10 mL Tris-EDTA, pH 7.4 (unless otherwise stated).  Due 
to degradation of the substrate, the 4CN was resuspended immediately prior to use. 
6.4 Results/Discussion 
6.4.1.  Nanoparticle Amplification 
Because microring resonators are highly mass sensitive, the addition of nanoparticles to our S9.6 
assay (described previously in Chapter 4) is a logical progression.  Nanoparticles have been used 
by a number of refractive-index sensitive techniques as a means to increase sensitivity. In 
particular, SPRI based methods have utilized gold nanoparticles, as the coupling between 
plasmons generated on the gold sensor surface and the nanoparticles significantly increase the 
sensitivity.6  Additionally, our own research group has utilized magnetic particles in a three-step 
sandwich assay for the highly sensitive detection of C-reactive protein.7 
 In this assay, the S9.6 antibody is biotinylated and allowed to interact with DNA:miRNA 
heteroduplexes on the sensor surface, as previously seen in Chapter 4.  Subsequently, though, a 
solution of 114 nm streptavidin coated beads is flowed across the sensor surface, where it binds 
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to the biotinylated S9.6.  Theoretically, the binding of the beads should produce a large shift, 
increasing both our sensitivity and dynamic range. 
Unfortunately, we ran into a number of significant issues while working with 
nanoparticles.  First, the nanoparticle based amplification demonstrated an extremely limited 
dynamic range.  As seen in Figure 6.2, at miRNA concentrations at 40 pM and above, the 
nanoparticle signal response was relatively constant.  We suspect that this might be due to steric 
hindrances of the nanoparticles on the microring surface.  Most importantly, however, is the 
inconsistent fouling we observed with the streptavidin coated nanoparticles.  Figures 6.3a and 
6.3b show two separate nanoparticle amplification runs.  While the specific response (shown in 
black) corresponds well with the miRNA concentrations, the non-specific response for the two 
runs (shown in red) is vastly different, despite identical preparation between the sensor chips.  
This phenomena was seen across a wide variety of sensor chips, with the non-specific fouling 
varying anywhere between 0 pm to over 100 pm.  This highly variable non-specific fouling of 
the streptavidin coated nanoparticles ultimate hinders our sensitivity, and will need to be address 
before we can further push our limit of detection with this technique. 
6.4.2. Poly-(A) Polymerase Amplification 
Another potential method for improving our platform’s sensitivity is through the use of 
enzymatic amplification.  One enzyme in particular, poly-(A) polymerase, has been utilized 
previously Surface Plasmon Resonance Imaging (SPRI) for the highly sensitive detection of 
miRNAs.8 Poly-(A) polymerase catalyzes the addition of a poly-adenosine tail onto the 3’-OH of 
RNA.  Not only does the addition of the poly-(A) tail contribute to a larger signal due to the 
additional mass, but the Poly-(A) tail can be used to further enhance the signal by adding gold 
T30 ssDNA probes (which can be further amplified themselves). 
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To adapt this technique to the microring resonator platform, we followed a similar 
approach utilized by Fang and colleagues, shown schematically in Figure 6.4.  Instead of 
utilizing gold nanoparticles coated with a T30 DNA probe, however, we opted for a biotinylated 
T30 sequence, after which we could add streptavidin.  Figure 6.5 shows the amplification results 
from a typical experiment. 
There were a number of problems during the course of these experiments, however.  For 
one, the stability of the ATP was an issue, and we noticed significant degradation within the 
course of hours.  Additionally, the activity of Poly-(A)-Polymerase is highly sensitive towards 
temperature.  Slight differences in the ambient temperature created noticeable differences in the 
polymerase activity.  While we could introduce a peltier block to precisely control the sensor 
temperature (and thus reduce variability due to enzyme activity), new protocols will be necessary 
to help account for degradation of our dATP substrate. 
6.4.3. Duplex Specific Nuclease Amplification 
Duplex Specific Nuclease (DSN) is an interesting enzyme found exclusively in hepatopancreas 
of the Kamchatka Crab (Paralithodes camtschaticus).  DSN displays a strong preference for 
cleaving dsDNA and the DNA in DNA:RNA heteroduplexes, but not ssDNA.9  The unique 
ability to cleave only the DNA of a DNA:RNA heteroduplexes (the only enzyme that we are 
aware of having this specificity) makes the enzyme incredibly appealing towards miRNA 
detection.   
Our proposed amplification method is similar to that developed by Lee and colleagues for 
the highly sensitive detection of DNA.10  In this method, Exonuclease III, an enzyme that 
selectively cleaves DNA in the 3’ to 5’ direction, is utilized.  A target DNA binds to a capture 
probe on the sensor surface, which is immobilized with its 3’ end available.  Upon  
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hybridization, Exo III is free to cleave DNA from the 3’ direction.  Exo III removes the ssDNA 
capture probe from the sensor, releasing the target DNA back into solution, where it rehybridize 
to a new capture probe.  The enzymatic cleavage reaction can continue for a number of cycles 
until all of the surface immobilized capture probes are degraded. In this assay, the concentration 
of the target DNA is not gauged by the signal it generates when it initially hybridizes, but rather 
the rate at which the ssDNA capture probes on the sensor surface are degraded.   
We wanted to adapt a similar approach for use with DSN, in which the target molecule 
would be RNA instead of DNA.  In this modified format, shown in Figure 6.6.  DSN would 
specifically cleave the DNA capture probes in the DNA:RNA heteroduplexes, releasing the 
target RNAs back into solution where it would be available to hybridize to additional ssDNA 
capture probes.  We could then monitor the rate at which the surface capture probes are degraded 
to determine the concentration of target RNA. 
To ensure that the DSN enzyme was active, we initially began with DNA:DNA 
homoduplexes on our sensor surfaces.  Figure 6.7 shows that the enzyme activity drastically 
improves in the presence of divalent cations, as predicted in the literature. [cite].  Additionally, 
the enzyme shows a concentration dependent response for DNA targets (Figure 6.8). 
Unfortunately, we had incredibly limited success in utilizing the enzyme with DNA:RNA 
heteroduplexes.  Figure 6.9 compares the DSN response observed in the presence of a 
DNA:DNA homoduplex versus an DNA:RNA heteroduplex.  The limited activity in the 
presence of the heteroduplex is contrary to literature precedent,9,11 and despite our efforts, we 
were unable to elicit a significant response with DSN. 
6.4.4  Horseradish Peroxidase Amplification 
184 
 
Horse-Radish Peroxidase (HRP) is a 44 kDA glycoprotein that catalyzes the reductive cleavage 
of H2O2 in the presence of an electron donor.  It is commonly utilized in immunohistological 
staining, Western blots, and ELISAs, where its ability to form an insoluble, colored precipitate 
from a variety of substrates is used as a simple read-out mechanism.12 
Given the mass sensitivity of our platform, we were curious whether the use of HRP 
could significantly increase our sensitivity for detecting miRNAs while still maintaining a high 
degree of specificity and multiplexed capabilities.  A schematic of the proposed HRP 
amplification methodology is shown in Figure 6.10b.  In this layout, a solution containing the 
target miRNA of interest is flowed across the sensor surface, and allowed to hybridize to its 
corresponding ssDNA capture probe.  Afterwards, a solution of S9.6 antibody, conjugated to 
HRP, is flowed across the surface, where it can bind to DNA:RNA  heteroduplexes.  Finally, a 
solution containing the 4-chloro-1-naphthol substrate with H2O2 is flowed, where HRP converts 
it into its insoluble form. 
 For initial studies, we sought to determine the net effect of HRP catalyzed formation of 
precipitate on the rings, and simplified the experimental layout.  As shown in Figure 6.10a 
instead of utilizing miRNA targets and an S9.6-HRP conjugate, we instead opted for a 
biotinylated T30 target sequence of DNA, as well as a commercially available HRP-Streptavidin 
conjugate.  These changes were implemented in part because there will be differential binding 
kinetics between miRNA species, that will in turn affect the net HRP response.  Additionally, 
creating an active S9.6-HRP conjugate can be difficult – the activity of the conjugate depends 
largely on the type of linker chemistry used and the activity of the HRP to be conjugated. 
 The results from this modified experiment layout are shown in Figure 6.11.  While the 
specific binding of the T30-biotin and HRP-Streptavidin conjugate are fairly typical, the net shift 
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produced upon addition of the substrate solution is incredibly large (over 10,000 pm!).  Figure 
6.12 compares the net response from the label-free binding of 1 µM miRNA (hsa miR-24-1), the 
S9.6 amplification response to a 1 µM solution of miR-24-1, and the HRP-SA catalyzed 
formation of precipitate from 4-chloro-1-naphthol (with a prior exposure to 1 µM T30-biotin). 
One of the more unusual responses observed with the HRP-amplification methodology 
was the ability to detect DNA concentrations as low as 1 pM, a value we had previously been 
unable to observe with any other amplification technique.  The Langmuir Binding Isotherm can 
be described by: 
 = (1 + ) 
where θ represents of the relative surface coverage of the target probe, KAds is the Langmuir 
adsorption coefficient, and C  is the bulk concentration of the target.  At low concentrations (for 
our purposes, generally below 1 nM), this expression becomes: 
 =  
Assuming that the microrings have an available surface area of between 60 and 70 µm2 
(unpublished, data provided by Dr. Carey Gunn of Genalyte, Inc.), and that the KAds for a T30 
target probe is 2 x 107 M, at equilibrium, a 1 pM solution of target DNA would have between 60 
and 70 target strands of DNA bound to the surface of a single ring.  Figure 6.14 shows the 
response between a set of microrings exposed to a 1 pM solution of T30-biotin versus a set of 
rings not exposed to any target DNA.  Upon switching back to buffer, it is clear that the rings 
exposed to a 1 pM solution of DNA have a higher signal than the control rings.  Furthermore, the 
generation of precipitate onto the microring surfaces demonstrate different kinetics between the 
target response and the control. 
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We hypothesize that the significant increase in sensitivity is due to localized diffusion of 
the insoluble precipitate around the microring.  Figure 6.15 shows a single microring that has 
been etched out from a perfluoropolymer cladding layer.  The etched region likely has been 
functionalized identically to the microring, as the exposed oxide surface is amenable towards our 
linker chemistry.  This significantly increases the surface area over which DNA capture probes 
are present.  The etched region by itself adds an additional ~600 µm2 surface area that can be 
functionalized.  At equilibrium, this increases the number of bound target probes by about an 
order of magnitude, which might explain why the HRP based amplification is highly sensitive. 
We are incredibly optimistic about the HRP amplification methodology.  Future work 
will be necessary to begin to apply this amplification technique towards miRNAs, rather than the 
DNA system demonstration here.  Additionally, further characterization will be necessary to 
gauge the boost in sensitivity this technique receives from localized diffusion of the insoluble 
precipitate. 
6.5  Conclusions and Outlook 
The amplification techniques presented above have enormous potential for further boosting the 
sensitivity of the resonator platform without a loss of specificity or multiplexing capabilities.  
Future work will focus on resolving many of the issues currently plaguing these techniques, 
including the inconsistent non-specific fouling of nanoparticles, the run-to-run variability seen 
with the poly-(A) polymerase enzyme, and the inactivity of DSN towards DNA:RNA 
heteroduplexes.  We are especially optimistic towards the HRP-S9.6 amplification methodology, 
due to the relative success we have achieved with it, as well as the simplicity of the assay and the 
large signal it produces.  
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6.6 Figures 
 
Figure 6.1  Schematic of the nanoparticle-enhanced amplification assay for the detection of 
miRNAs.   
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Figure 6.2.  An overlay of the concentration dependent responses for binding of the streptavidin-
coated nanoparticles. 
  
  
Figure 6.3 Amplification responses upon 
coated beads for two separate runs.  The response for the control rings (red in both graphs) is 
highly variable, and representative for many of the experiments performed.
 
 
 
 
addition of a solution containing the streptavidin 
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Figure 6.4  Poly-(A) polymerase Amplification Scheme.  A target miRNA is flowed across the 
sensor surface, where it is allowed to hybridized as normal.  Poly-(A) polymerase recognizes the 
3’ OH of the target RNA, and catalyzes the addition of a Poly-(A) tail to the RNA.  Afterwards, a 
solution of T30-biotin is exposed to the sensor, where the probes hybridize with the miRNAs’ 
Poly-(A) tails.  Finally, streptavidin is flowed across the surface where it binds to the T30-biotin 
probes. 
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Figure 6.5  Poly-(A) polymerase amplification on a surface previously treated with 1 µM 
solution of hsa miR-24-1.  (a)  Addition of the poly(A) tail to the target miRNA.  (b) Addition of 
T30-biotin followed by streptavidin. 
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Figure 6.6 Duplex-Specific Nuclease (DSN) amplification scheme.  A target miRNA is allowed 
to hybridize with ssDNA capture probes covalently immobilized on the microring surface.  Upon 
addition of DSN, the DNA of the DNA:RNA heteroduplex is cleaved, while the target miRNA is 
released back into  solution where it can rehybridize with an additional capture probes, repeating 
the cycle. 
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Figure 6.7  Comparison of the DSN response on a DNA:DNA homoduplex across various 
running buffers.  
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Figure 6.8  Concentration dependent DSN response towards two separate concentrations of 
target DNA, 1 µM (black) and 1 nM (red). 
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Figure 6.9  Comparison of the DSN response between a DNA:DNA homoduplex (black) and a 
DNA:RNA heteroduplex (red).  The target DNA and RNA sequences utilized were identical to 
account for any differences in secondary structure or hybridization efficiency. 
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Figure 6.10  HRP Amplification Schemes.  (a)  HRP Amplification method utilizing a T30-biotin 
target probe, and an HRP-Streptavidin conjugate.  (b)  HRP Amplification method for miRNA 
detection.  In contrast to (a), this method uses S9.6-HRP conjugate. 
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Figure 6.11 HRP-based amplification scheme.  The microrings in red correspond to those 
exposed to a 1 µM solution of T30-biotin, while those in black acted as controls (not exposed to 
DNA, but with HRP-SA and the 4CN substrate flowed over).  The net response generated from 
the HRP catalyzed reduction of the 4CN substrate generates an enormous increase in signal. 
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Figure 6.12  Comparison of the signal response generated from the primary hybridization of 1 
µM solution of miR-24-1, the S9.6 amplification response from a 1 µM solution of miR-24-1, 
and the HRP-catalyzed amplification for 1 µM solution of target DNA. 
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Figure 6.13  Overlay of the HRP generated responses for varying concentrations of target DNA. 
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Figure 6.14  HRP amplification response for a 1 pM T30-biotin target DNA (black) vs. a set of 
control rings not exposed to target DNA (red). 
  
 Figure 6.15  False color SEM ima
corresponding linear waveguide etched away in a perfluoropolymer cladding layer.
from reference [2]. 
 
 
  
 
ge of a single microring sensor, showing a microring and 
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Appendix 
 
 
 
 
 
 
 
 
 
 
 
A.1 – Fitting Data from Chapter 3 
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Table A1.1. Parameters determined by fitting time-resolved hybridization data from experiments 
shown in Figure 3.12, and used to calculate initial slope for miRNA quantitation. 
Concentration (nM) A (pm) B (min-1) t0 (min) AB (pm/min) R2 χ2 
1000 18.3304 0.7224 0.0890 13.2419 0.9875 0.3052 
19.3955 0.7326 0.0897 14.2092 0.9942 0.1588 
19.1050 0.7248 0.1125 13.8473 0.9915 0.2322 
20.5667 0.7410 0.1056 15.2399 0.9926 0.2337 
19.3391 0.7872 0.1018 15.2238 0.9925 0.2044 
19.1180 0.8418 0.1165 16.0935 0.9963 0.0994 
15.0180 0.8346 0.0682 12.5340 0.9882 0.1832 
19.1952 0.8202 0.1103 15.7439 0.9962 0.1022 
20.3383 0.7554 0.0115 15.3635 0.9954 0.1229 
19.9259 0.7968 0.0974 15.8770 0.9964 0.1038 
20.6825 0.8118 0.1162 16.7901 0.9950 0.1462 
500 17.4127 0.4254 0.2607 7.4074 0.9923 0.1824 
17.9998 0.4512 0.2672 8.1215 0.9933 0.1690 
17.4365 0.4056 0.3316 7.0722 0.9931 0.1742 
18.7463 0.4482 0.2216 8.4021 0.9945 0.1441 
18.0550 0.4692 0.2602 8.4714 0.9901 0.2497 
18.8983 0.4650 0.1783 8.7877 0.9921 0.2025 
17.9943 0.4632 0.2880 8.3349 0.9919 0.2081 
15.3627 0.4464 0.1460 6.8579 0.9823 0.2971 
17.7767 0.4728 0.2876 8.4048 0.9940 0.1494 
19.0204 0.4134 0.2245 7.8630 0.9930 0.1932 
18.9443 0.4560 0.2211 8.6386 0.9936 0.1710 
19.7118 0.4842 0.2105 9.5445 0.9927 0.2071 
250 14.8407 0.2718 0.6889 4.0337 0.9974 0.0547 
15.6893 0.2706 0.6146 4.2455 0.9980 0.0438 
16.1561 0.2556 0.6292 4.1295 0.9961 0.08985 
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15.9504 0.2790 0.6333 4.4502 0.9978 0.05189 
15.6251 0.2886 0.6099 4.5094 0.9970 0.0677 
15.7822 0.2718 0.6635 4.2896 0.9968 0.0746 
15.4528 0.2940 0.6990 4.5431 0.9972 0.0663 
13.8295 0.2466 0.5480 3.4103 0.9917 0.1328 
16.0824 0.2664 0.5117 4.2844 0.9956 0.0982 
16.0872 0.2640 0.5823 4.2470 0.9974 0.0589 
16.3593 0.2748 0.5960 4.4955 0.9982 0.0428 
17.3339 0.2754 0.5337 4.7737 0.99822 0.0466 
125 11.7603 0.2076 0.7740 2.4414 0.99458 0.0623 
13.7709 0.1626 0.7538 2.2391 0.99629 0.0472 
11.7384 0.1776 1.1249 2.0847 0.99193 0.0923 
13.8351 0.1740 0.5800 2.4073 0.9937 0.0817 
12.9983 0.1704 1.0802 2.2149 0.9925 0.1000 
13.3629 0.1776 0.6989 2.3732 0.9956 0.0557 
12.6707 0.1680 1.1456 2.1287 0.9951 0.0617 
9.3580 0.1740 0.6834 1.6283 0.9638 0.2279 
14.3776 0.1506 0.8487 2.1652 0.9953 0.0624 
13.7480 0.1620 0.7666 2.2272 0.9968 0.0408 
13.4018 0.1734 0.8707 2.3239 0.9981 0.0257 
14.5707 0.1740 0.7949 2.5353 0.9967 0.0512 
62.5 10.6244 0.1314 -0.2411 1.3960 0.9889 0.0524 
11.2000 0.1242 -0.2890 1.3910 0.9921 0.0389 
12.9467 0.1008 -0.3739 1.3050 0.9934 0.0350 
10.8780 0.1470 -0.1026 1.5991 0.9890 0.0621 
10.1917 0.1266 -0.1493 1.2903 0.9975 0.0108 
12.4340 0.1068 0.0562 1.3280 0.9908 0.0525 
12.3261 0.1164 -0.1465 1.4348 0.9930 0.0412 
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11.5431 0.1212 0.1028 1.3990 0.9977 0.0129 
12.8515 0.1086 -0.0200 1.3957 0.9979 0.0128 
12.3749 0.1278 0.0184 1.5815 0.9981 0.0128 
12.5987 0.1062 0.0186 1.3380 0.9957 0.0249 
12.4754 0.1188 0.2849 1.4821 0.9985 0.0098 
31.3 9.0821 0.0924 -1.5784 0.8392 0.9702 0.0584 
7.4772 0.1044 0.6637 0.7806 0.9842 0.0369 
8.3390 0.1038 0.0756 0.8656 0.97934 0.0526 
8.1702 0.0978 0.5647 0.7990 0.9666 0.0852 
11.8468 0.0561 0.9714 0.6650 0.9923 0.0196 
7.7265 0.0990 1.2358 0.7649 0.9777 0.0582 
9.3189 0.0828 0.7890 0.7716 0.9838 0.0444 
7.6827 0.1044 0.7463 0.8021 0.9924 0.0189 
9.3772 0.0954 0.1328 0.8946 0.9930 0.0204 
10.5879 0.0822 0.1840 0.8703 0.9944 0.0174 
9.7083 0.0858 0.3855 0.8330 0.9855 0.0419 
13.2188 0.0591 0.5608 0.7818 0.9927 0.0237 
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Table A1.2. Fitting parameters used for linear fit of curves for Figure 3.12. 
Concentration 
(nM) 
Slope (pm/min) Slope Error 
(pm/min) 
Intercept (pm) Intercept Error 
(pm) 
R2 
15.6 0.3276 0.0101 -2.3147 0.06009 0.9630 
0.3408 0.0115 -2.4727 0.06807 0.9565 
0.3726 0.0101 -2.1197 0.05958 0.9717 
0.3732 0.0138 -2.8602 0.08168 0.9481 
0.4002 0.0168 -1.9750 0.09949 0.9341 
0.3738 0.0161 -1.4525 0.09506 0.9312 
0.4218 0.0141 -2.5997 0.08362 0.9571 
0.3888 0.0102 -2.1216 0.06019 0.9734 
0.4098 0.0126 -2.3807 0.07448 0.9637 
0.4434 0.0114 -2.6031 0.06777 0.9741 
0.4260 0.0124 -1.9453 0.07369 0.9669 
0.4398 0.0111 -2.5297 0.06573 0.9751 
7.81 0.1434 0.0153 -1.5874 0.09041 0.6855 
0.1446 0.0122 -2.3795 0.07243 0.7758 
0.1680 0.0118 -1.2172 0.07002 0.8342 
0.1800 0.0145 -1.6507 0.08603 0.7918 
0.1596 0.0062 -2.0479 0.03692 0.9425 
0.1680 0.0120 -2.8812 0.07119 0.8295 
0.1776 0.0089 -3.7961 0.05246 0.9091 
0.1680 0.0069 -3.5409 0.04079 0.9370 
0.1854 0.0070 -3.6311 0.04174 0.9454 
0.2028 0.0061 -2.9848 0.03611 0.9650 
0.1914 0.0115 -3.2666 0.06830 0.8729 
0.1950 0.0078 -3.3340 0.04642 0.9391 
3.91 0.0714 0.0113 -6.1317 0.06655 0.4935 
0.0630 0.0111 -5.5500 0.06516 0.4379 
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0.0912 0.0093 -5.6014 0.05499 0.7034 
0.0834 0.0135 -5.9079 0.07954 0.4819 
0.0882 0.0172 -6.6847 0.10150 0.3860 
0.0876 0.0125 -6.5737 0.07377 0.5460 
0.0768 0.0125 -6.8322 0.07374 0.4791 
0.0750 0.0086 -5.2708 0.05065 0.6527 
0.1044 0.0118 -6.8382 0.06972 0.6589 
0.0774 0.0085 -6.0464 0.04986 0.6725 
0.0786 0.0111 -6.0480 0.06535 0.5518 
0.0990 0.0067 -6.4356 0.03954 0.8443 
1.95 0.0203 0.0127 -3.6783 0.07465 0.0373 
0.0275 0.0122 -4.5638 0.07187 0.0921 
0.0161 0.0090 -5.3007 0.05302 0.0518 
0.0137 0.0100 -5.9737 0.05880 0.0218 
0.0231 0.0095 -6.1156 0.05579 0.1099 
0.0114 0.0074 -5.2066 0.04360 0.0331 
0.0385 0.0094 -5.2862 0.05494 0.2849 
0.0792 0.0083 -4.2859 0.04855 0.6951 
0.3276 0.0101 -2.31474 0.06009 0.9630 
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Table A.1.3. Summary of initial slopes determined from data in Figure 3.12. 
Concentration 
(nM) 
n Mean Initial 
Slope 
(pm/min) 
Standard Deviation 
of Mean (pm/min) 
1000 11 14.924 1.3048 
500 12 8.1588 0.7580 
250 12 4.2843 0.3415 
125 12 2.2308 0.2329 
62.5 12 1.4117 0.0996 
31.3 12 0.8056 0.0613 
15.6 12 0.3932 0.0371 
7.81 12 0.1737 0.0187 
3.91 12 0.0830 0.0117 
1.95 9 0.0264 0.0264 
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Table A1.4. Parameters utilized to obtain initial slopes for Figure 3.9. 
Concentration (nM) A (pm) B (min-1) t0 (min) AB (pm/min) R2 χ2 
500  35.7372 0.1062 -1.0324 3.7953 0.9985 0.0227 
41.7461 0.0888 -1.1557 3.7071 0.9979 0.0353 
35.2143 0.1092 -1.0806 3.8454 0.9994 0.0089 
33.6978 0.1134 -1.1930 3.8213 0.9959 0.0594 
25.9969 0.1566 -0.4625 4.0711 0.9799 0.3106 
30.5358 0.1146 -1.2187 3.4994 0.9949 0.0615 
32.6130 0.1158 -1.0579 3.7765 0.9965 0.0497 
29.3998 0.1170 -1.1224 3.4398 0.9982 0.0208 
27.3131 0.1302 -1.0953 3.5562 0.9961 0.0441 
27.5699 0.1260 -1.1119 3.4738 0.9979 0.0240 
30.5988 0.1254 -1.0910 3.8371 0.9980 0.0282 
31.7650 0.1152 -1.1707 3.6593 0.9958 0.0552 
250 29.7352 0.0840 -0.3651 2.4978 0.9784 0.5020 
32.4556 0.0702 -0.4280 2.2784 0.9851 0.3242 
31.2093 0.0756 -0.6168 2.3594 0.9845 0.3318 
30.2408 0.0720 -0.6222 2.1773 0.9851 0.2830 
27.6688 0.0726 -0.5686 2.0088 0.9851 0.2399 
31.7725 0.0630 -0.5285 2.0017 0.9863 0.2437 
27.5956 0.0786 -0.3929 2.1690 0.9852 0.2704 
24.3972 0.0852 -0.4897 2.0786 0.9830 0.2631 
24.2382 0.0834 -0.5013 2.0215 0.9851 0.2204 
28.1771 0.0828 -0.5812 2.3331 0.9839 0.3141 
26.2073 0.0912 -0.6136 2.3901 0.9805 0.3658 
62.5 1159.9180 0.0005 -5.0480 0.5217 0.9674 0.0794 
1063.9160 0.0005 -5.0298 0.5099 0.9740 0.0601 
988.5157 0.0005 -4.6262 0.5256 0.9815 0.0452 
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1015.5430 0.0005 -4.2126 0.4991 0.9635 0.0817 
866.6546 0.0005 -4.8044 0.4638 0.9650 0.0675 
998.6122 0.0004 -4.5603 0.4414 0.9569 0.0760 
1103.3430 0.0004 -5.2575 0.4683 0.9512 0.0974 
1627.8500 0.0003 -2.9358 0.4747 0.9556 0.0912 
1277.5000 0.0003 -3.7730 0.4413 0.9630 0.0650 
825.65950 0.0005 -4.4010 0.4226 0.9710 0.0462 
1276.5150 0.0004 -4.5337 0.5075 0.9596 0.0941 
1089.8670 0.0005 -4.6400 0.4991 0.9689 0.0694 
5.3072 0.0792 -0.1792 0.0070 0.7281 0.2551 
6.1784 0.0678 0.0819 0.0070 0.9625 0.0309 
351.6043 0.0008 -0.2600 0.0050 0.9228 0.0636 
344.5752 0.0009 -1.2063 0.0050 0.9152 0.0722 
7.4146 0.0449 0.3918 0.0055 0.9481 0.0349 
1.9535 0.1926 0.5341 0.0063 0.7551 0.0868 
1031.5580 0.0003 -0.1899 0.0057 0.9694 0.0315 
1461.592 0.0002 0.7684 0.0057 0.9768 0.0242 
7.2864 0.0389 -1.3353 0.0047 0.9123 0.0409 
791.4512 0.0003 -0.8374 0.0042 0.9148 0.0501 
 
 
 212 
 
Table A1.5. Fitting parameters used for linear fit of curves for Figure 3.9. 
Concentration 
(nM) 
Slope (pm/min) Slope Error 
(pm/min) 
Intercept (pm) Intercept Error 
(pm) 
R2 
15.6 0.1848 0.0109 0.4969 0.0636 0.8474 
0.1752 0.0091 1.0502 0.0535 0.8761 
0.1644 0.0073 1.0132 0.0430 0.9060 
0.1158 0.0109 0.8656 0.0640 0.6809 
0.1536 0.0167 0.1667 0.0979 0.6170 
0.1464 0.0098 0.6654 0.0575 0.8098 
0.1344 0.0113 0.5500 0.0661 0.7304 
0.1284 0.0115 0.9609 0.0671 0.7055 
0.1578 0.0099 0.6970 0.0577 0.8313 
0.1788 0.0078 0.5159 0.0456 0.9104 
0.1650 0.0093 0.9589 0.0544 0.8581 
0.1812 0.0091 0.7596 0.0531 0.8850 
3.91 0.1254 0.0107 2.3556 0.0635 0.7153 
0.1368 0.0083 1.4173 0.0493 0.8325 
0.1506 0.0091 0.8795 0.0538 0.8354 
0.0810 0.0108 0.8607 0.0636 0.5080 
0.1284 0.0089 -0.1265 0.0528 0.7924 
0.1050 0.0121 2.7856 0.0719 0.5767 
0.1254 0.0112 0.7215 0.0664 0.6976 
0.1014 0.0081 0.4506 0.0479 0.7437 
0.1140 0.0091 0.6359 0.0540 0.7413 
0.1152 0.0105 1.1623 0.0624 0.6860 
0.1146 0.0070 0.6115 0.0414 0.8313 
0.1020 0.0072 1.2194 0.0426 0.7876 
0.977 0.0364 0.0042 0.6928 0.0248 0.5882 
0.0304 0.0086 1.0396 0.0506 0.1819 
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0.0369 0.0047 1.2797 0.0278 0.5367 
0.0391 0.0103 1.2119 0.0604 0.2066 
0.0340 0.0102 0.8730 0.0603 0.1619 
0.0350 0.0072 1.2771 0.0430 0.2980 
0.0361 0.0061 0.6505 0.0360 0.3955 
0.0319 0.0082 0.5369 0.0483 0.2145 
0.0343 0.0047 0.9248 0.0274 0.5068 
0.0499 0.0064 1.1280 0.0376 0.5371 
0.0464 0.0081 1.2465 0.0480 0.3773 
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Table A1.6. Summary of initial slopes used with Figure 3.9. 
Concentration 
(nM) 
n Mean Initial 
Slope 
(pm/min) 
Standard Deviation 
of Mean (pm/min) 
500 12 3.7069 0.1879 
250 11 2.2105 0.1723 
62.5 12 0.4813 0.0342 
15.6 12 0.1572 0.0222 
3.91 12 0.1167 0.0184 
0.977 11 0.0373 0.0059 
34.7 
(U87 sample) 
 
10 0.3363 0.0563 
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Table A1.7. Fitting parameters used for miR-21 in creating Figure 3.10. 
Concentration (nM) A (pm) B (min-1) t0 (min) AB (pm/min) R2 χ2 
250 45.9895 0.0012 0.2035 3.3112 0.9988 0.0580 
44.8255 0.0013 0.1715 3.4964 0.9987 0.0664 
36.4333 0.0016 -0.0187 3.4976 0.9985 0.0640 
44.4945 0.0014 0.1395 3.6574 0.9980 0.1092 
45.1088 0.0012 0.1788 3.2749 0.9977 0.1127 
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Table A1.8. Linear fitting parameters used for miR-21 in creating Figure 3.10. 
Concentration 
(nM) 
Slope (pm/min) Slope Error 
(pm/min) 
Intercept (pm) Intercept Error 
(pm) 
R2 
62.5 0.8466 0.0094 -0.4375 0.0551 0.9924 
0.8274 0.0079 -0.7058 0.0465 0.9943 
0.9708 0.0116 -0.2174 0.0681 0.9912 
0.8562 0.0104 -0.2454 0.0612 0.9909 
16 
 
0.3876 0.0108 0.3252 0.0632 0.9527 
0.3156 0.0148 0.0999 0.0865 0.8767 
0.3480 0.0102 0.2312 0.0597 0.9477 
0.4122 0.0126 0.0002 0.0735 0.9439 
4 0.1452 0.0095 -0.0718 0.0560 0.7886 
0.1668 0.0074 -0.2422 0.0436 0.8904 
0.1410 0.0087 -0.2568 0.0509 0.8092 
0.1758 0.0096 -0.3792 0.0564 0.8438 
0 0.1170 0.0098 -0.2282 0.0574 0.6828 
-0.0351 0.0102 -0.3942 0.0595 0.1436 
-0.0351 0.0102 -0.3942 0.0595 0.1436 
0.1020 0.0138 -0.1436 0.0808 0.4512 
0.1830 0.0128 0.3425 0.0748 0.7572 
U87 Extracts 0.3264 0.0136 0.2812 0.0794 0.9042 
0.3462 0.0135 0.2559 0.0789 0.9148 
0.3030 0.0136 1.1366 0.0791 0.8909 
0.3774 0.0138 0.2276 0.0804 0.9248 
0.3768 0.0172 0.5251 0.1006 0.8868 
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Table A1.9. Fitting parameters used for miR-24-1 in creating Figure 3.10. 
Concentration (nM) A (pm) B (min-1) t0 (min) AB (pm/min) R2 χ2 
250 35.7566 0.2544 0.4177 9.0965 0.9912 0.9405 
39.1514 0.2616 0.3873 10.2420 0.9922 0.9861 
40.0524 0.2664 0.3830 10.6700 0.9929 0.9476 
62.5 51.5285 0.0630 -0.2267 3.2463 0.9986 0.0687 
71.7060 0.0506 -0.3713 3.6299 0.9985 0.1059 
16 16.4367 0.0864 0.0378 1.4201 0.9947 0.0415 
16.1445 0.0966 -0.1803 1.5596 0.9946 0.0447 
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Table A1.10. Linear fitting parameters used for miR-24-1 in creating Figure 3.10. 
Concentration 
(nM) 
Slope (pm/min) Slope Error 
(pm/min) 
Intercept (pm) Intercept Error 
(pm) 
R2 
4 0.3210 0.0106 -0.1616 0.0622 0.9342 
0.3390 0.0092 0.1501 0.0536 0.9553 
0.4308 0.0083 -0.0809 0.0484 0.9769 
0 0.1746 0.0089 -0.0985 0.0522 0.8541 
0.0912 0.0093 0.3033 0.0544 0.5921 
U87 0.6630 0.0196 0.3480 0.1143 0.9494 
0.6510 0.0237 0.8627 0.1385 0.9249 
0.6444 0.0272 0.4428 0.1586 0.9020 
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Table A1.11. Fitting parameters used for miR-133b in creating Figure 3.10. 
Concentration (nM) A (pm) B (min-1) t0 (min) AB (pm/min) R2 χ2 
1000 23.7211 0.0024 -0.4255 3.3447 0.9936 0.1500 
25.4116 0.0024 -0.2652 3.6593 0.9974 0.0742 
28.5229 0.0020 0.0030 3.4399 0.9985 0.0510 
500 12.2894 0.1230 0.2592 1.5116 0.9890 0.0747 
13.6434 0.1194 0.1157 1.6290 0.9903 0.0749 
9.8968 0.1782 -0.0006 1.7636 0.9869 0.0723 
9.6384 0.1770 0.1517 1.7060 0.9863 0.0720 
250 10.2407 0.1038 0.0295 1.0630 0.9951 0.0179 
14.2668 0.0768 -0.2376 1.0957 0.9920 0.0383 
9.2043 0.1356 -0.1145 1.2481 0.9832 0.0631 
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Table A1.12. Linear fitting parameters used for miR-133b in creating Figure 3.10. 
Concentration 
(nM) 
Slope (pm/min) Slope Error 
(pm/min) 
Intercept (pm) Intercept Error 
(pm) 
R2 
125 0.3510 0.0075 -0.0334 0.0438 0.9720 
0.4212 0.0089 0.3150 0.0519 0.9727 
0.3936 0.0078 -0.2994 0.0457 0.9756 
0.3966 0.0101 0.0073 0.0587 0.9610 
62.5 0.1596 0.0060 -0.0810 0.0351 0.9205 
0.2802 0.0109 0.0296 0.0636 0.9155 
0.2184 0.0081 -0.2432 0.0474 0.9222 
0.2004 0.0084 0.1222 0.0489 0.9035 
0 0.0756 0.0106 0.2871 0.0629 0.4304 
0.0834 0.0130 -0.4574 0.0767 0.3826 
0.0428 0.0079 -0.0182 0.0467 0.3036 
0.0672 0.0113 -0.0486 0.0671 0.3431 
0.0303 0.0085 0.3069 0.0504 0.1513 
U87 Extracts 0.1914 0.0093 0.4090 0.0552 0.8732 
0.2424 0.0086 0.1756 0.0511 0.9279 
0.2334 0.0068 0.1414 0.0405 0.9502 
0.3774 0.0112 0.3154 0.0665 0.9486 
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Table A1.13. Fitting parameters used for let-7c in creating Figure 3.10. 
Concentration (nM) A (pm) B (min-1) t0 (min) AB (pm/min) R2 χ2 
250 99.8489 0.9210 0.1610 91.9608 0.9871 7.0883 
99.8210 0.8640 0.0553 86.2454 0.9834 7.8936 
62.5 73.7193 0.2550 0.3589 18.7984 0.9943 2.4102 
77.3021 0.2496 0.2603 19.2946 0.9988 0.5425 
16 24.1302 0.1542 0.3216 3.7209 0.9962 0.1287 
24.4991 0.1518 0.3216 3.7190 0.9976 0.0789 
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Table A1.14. Linear fitting parameters used for miR-133b in creating Figure 3.10. 
Concentration 
(nM) 
Slope (pm/min) Slope Error 
(pm/min) 
Intercept (pm) Intercept Error 
(pm) 
R2 
4 1.3590 0.0139 0.0610 0.0811 0.9937 
1.2930 0.0141 0.5107 0.0824 0.9928 
0 0.0340 0.0068 -0.1717 0.0417 0.2638 
0.0242 0.0099 -0.0783 0.0611 0.0687 
U87 Extracts 0.3432 0.0086 0.3375 0.0508 0.9632 
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Table A1.15. Summary of Initial Slopes utilized in generating Figure 3.10. 
Concentration 
(nM) 
n Mean Initial Slope 
(pm/min) 
Standard Deviation of 
Mean (pm/min) 
miR-21 
250 5 3.4475 0.1560 
62.5 4 0.8753 0.0648 
16 4 0.3659 0.0427 
4 4 0.1572 0.0168 
0 5 0.0664 0.0975 
U87 Extracts 5 0.3460 0.0323 
miR-24-1 
250 3 10.0028 0.8136 
62.5 2 3.4381 0.2713 
16 2 1.4898 0.0986 
4 3 0.3636 0.0589 
0 2 0.1329 0.0590 
U87 Extracts 3 0.6528 0.0094 
miR-133b 
1000 3 3.4813 0.1317 
500 4 1.6526 0.0944 
250 3 1.1356 0.0988 
125 4 0.3906 0.0252 
62.5 4 0.2147 0.0434 
0 5 0.0599 0.0225 
U87 Extracts 4 0.2612 0.0806 
let-7c 
250 2 89.1031 4.0414 
62.5 2 19.0465 0.3509 
16 2 3.7199 0.0013 
4 2 1.3260 0.0467 
0 2 0.0291 0.0069 
U87 Extracts 1 0.3432 0 
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Table A1.16.  Paramters for the linear calibration curves generated for the quantification of 
miRNAs from cell extracts. 
 Slope 
(pm/min*nM) 
Standard 
Error 
(pm/min*nM) 
Intercept 
(pm/min) 
Standard 
Error 
(pm/min) 
Adjusted R2 
miR-21 0.0134 0.0002 0.0925 0.0270 0.9988 
miR-24-1 0.0385 0.0022 0.5265 0.2553 0.9869 
miR-133b 0.0034 0.0002 0.0520 0.0767 0.9888 
let-7c 0.3591 0.0080 -1.2316 0.9197 0.9980 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 225 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A.2 – Fitting Data from Chapter 4 
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Table A2.1 Concentration dependent S9.6 amplification response for miR-16 used to generate 
the logistic calibration curves in Figure 4.6b. 
Concentration (nM) Average Shift (∆pm) Std. Dev. (∆pm) n 
0 -4.64 4.68 12 
0.16 66.18 21.83 12 
0.64 126.11 37.45 12 
2.56 223.50 36.98 10 
10 511.15 20.74 10 
40 667.82 11.69 6 
0 -4.64 4.68 12 
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Table A2.2 Parameters for the Logistic Fit for miR-16. 
Parameter Value Standard Error 
A1 -4.0539 6.796 
A2 822.8484 109.171 
c 5.8116 2.767 
p 0.7680 0.176 
 
  
 228 
 
 
Table A2.3 Concentration dependent S9.6 amplification response for miR-21 used to generate 
the logistic calibration curves in Figure 4.6b. 
Concentration (nM) Average Shift (∆pm) Std. Dev. (∆pm) n 
0 -20.94 1.9 12 
0.01 9.37 1.9 6 
0.04 17.82 1.7 12 
0.16 67.17 4.7 7 
0.64 95.50 13.0 8 
2.56 328.41 23.9 7 
10 552.00 8.0 10 
40 600.51 4.9 6 
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Table A2.4  Parameters for the Logistic Fit for miR-21. 
Parameter Value Standard Error 
A1 -12.1120 9.077 
A2 678.1462 74.949 
c 2.2328 1.381 
p 0.7644 0.146 
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Table A2.5  Concentration dependent S9.6 amplification response for miR-24-1 used to generate 
the logistic calibration curves in Figure 4.6b. 
Concentration (nM) Average Shift (∆pm) Std. Dev. (∆pm) n 
0 -35.74 2.2 11 
0.01 8.67 11.3 11 
0.04 40.14 7.2 10 
0.16 87.22 18.2 10 
0.64 239.20 18.6 12 
2.56 403.70 32.6 12 
10 537.54 6.4 10 
40 618.88 20.2 11 
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Table A2.6 Parameters for the Logistic Fit for miR-24-1. 
Parameter Value Standard Error 
A1 -35.3977 2.131 
A2 724.6116 44.479 
c 1.6138 0.458 
p 0.6075 0.041 
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Table A2.7  Concentration dependent S9.6 amplification response for miR-26a used to generate 
the logistic calibration curves in Figure 4.6b. 
Concentration (nM) Average Shift (∆pm) Std. Dev. (∆pm) n 
0 1.82 10.7 10 
0.01 13.80 13.6 10 
0.04 88.15 24.6 5 
0.16 141.02 21.4 11 
0.64 185.42 23.1 9 
2.56 285.05 18.4 4 
10 569.54 14.5 8 
40 608.64 19.1 11 
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Table A2.8 Parameters for the Logistic Fit for miR-26a. 
Parameter Value Standard Error 
A1 9.2209 28.277 
A2 753.8020 182.286 
c 3.2261 2.848 
p 0.6939 0.275 
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A.3 – Fitting Data from Chapter 5 
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Table A3.1. Desorption Rates and Melting Temperature for A′ (perfect complement) and three 
SNPs to the ssDNA capture probe A (shown in Figure 5.7). 
 
Target Sequence Desorption 
Rate (s-1) 
Standard 
Deviation (s-1) 
n Desorption 
Rate Relative 
to A′ 
Melting 
Temperature 
(oC) 
A′ (perfect 
complement) 
8.0901 x 10-5 3.924 x 10-6 5 1.00 45.65 
A′ SNP: T to A 2.3225 x 10-3 2.766 x 10-4 4 28.71 32.51 
A′ SNP: T to C 1.4733 x 10-3 6.51 x 10-5 3 18.21 35.09 
A′ SNP: T to G 2.1130 x 10-4 9.14 x 10-6 3 2.61 40.90 
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Table A3.2. Parameters used in fitting a 1:1 kinetic Langmuir Binding Isotherm from 
experiments used in generating the calibration curve for DNA detection (seen in Figure 5.6). 
 
Concentration 
(nM) 
A (pm) B (min-1) to (min) AB 
(pm/min) 
R2 χ2 
1000 23.2179 0.0117 0.2938 16.2293 0.9550 2.5920 
22.1725 0.0161 0.2019 21.3521 0.9744 1.2027 
24.9700 0.0127 0.2486 19.0870 0.9704 1.8645 
23.0623 0.0142 0.2397 19.6491 0.9626 2.0316 
23.9485 0.0140 0.2191 20.0736 0.9693 1.7264 
23.5724 0.0144 0.2194 20.3524 0.9729 1.4762 
24.6268 0.0172 0.1866 25.3410 0.9753 1.3862 
22.7337 0.0164 0.1978 22.3290 0.9721 1.3685 
21.6393 0.0170 0.1935 22.0591 0.9733 1.1774 
500 35.1112 0.0076 0.3846 16.0528 0.9150 10.3994 
30.2040 0.0050 0.3465 8.9706 0.9622 2.2036 
29.8253 0.0055 0.3478 9.8066 0.9630 2.3126 
28.5734 0.0061 0.2847 10.4922 0.9662 2.0348 
27.6611 0.0061 0.3265 10.0908 0.9624 2.1851 
9.4990 0.0210 0.2877 11.9459 0.1883 38.5315 
23.9500 0.0060 0.3221 8.6220 0.9614 1.6613 
27.3758 0.0063 0.3525 10.3316 0.9595 2.4211 
20.1431 0.0063 0.3672 7.6503 0.9592 1.3431 
20.2007 0.0072 0.3036 8.6903 0.9619 1.3128 
250 21.4016 0.0031 0.2794 3.9422 0.9931 0.1995 
24.4589 0.0042 0.2869 6.1783 0.9920 0.3615 
21.0796 0.0032 0.3396 4.0093 0.9830 0.5038 
25.3695 0.0033 0.2722 5.0688 0.9955 0.1906 
27.1243 0.0034 0.3391 5.5659 0.9936 0.3247 
22.9953 0.0041 0.2187 5.6430 0.9853 0.5649 
23.2678 0.0038 0.1875 5.3051 0.9832 0.6318 
20.5398 0.0037 0.1498 4.5105 0.9898 0.2859 
125 30.4027 0.0018 0.4528 3.2105 0.9782 0.8067 
29.8156 0.0020 0.3039 3.5779 0.9842 0.6260 
36.0050 0.0018 0.2909 3.7805 0.9825 0.8689 
26.5448 0.0024 0.3326 3.8065 0.9830 0.6370 
22.3475 0.0026 0.2758 3.4192 0.9861 0.3852 
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Table A3.3. Parameters used in linear fits for time resolved hybridization data from experiments 
used in generating the calibration curve for DNA detection (seen in Figure 5.6). 
 
Concentration 
(nM) 
Slope 
(pm/min) 
Slope Error 
(pm/min) 
Intercept 
(pm) 
Intercept 
Error (pm) 
R2 
62.5 0.7074 0.0078 0.2764 0.0450 0.9873 
0.6438 0.0083 -0.3764 0.0477 0.9829 
0.5472 0.0069 -0.1487 0.0400 0.9833 
0.7194 0.0129 -0.3512 0.0748 0.9668 
0.6030 0.0092 -0.0949 0.0530 0.9761 
0.6138 0.0105 -0.2690 0.0609 0.9697 
0.7260 0.0063 -0.2625 0.0362 0.9922 
0.7944 0.0073 -0.0999 0.0423 0.9911 
0.7794 0.0076 -0.4657 0.0441 0.9899 
0.5232 0.0069 -0.1767 0.0397 0.9821 
0.5874 0.0070 -0.6068 0.0406 0.9851 
31.3 0.1692 0.0058 0.0503 0.0335 0.8894 
0.1848 0.0061 0.1070 0.0353 0.8963 
0.3720 0.0088 -0.1940 0.0510 0.9436 
0.2202 0.0090 0.2629 0.0525 0.8469 
0.4818 0.0091 -0.3665 0.0528 0.9633 
0.3744 0.0085 -0.0463 0.0496 0.9472 
0.2214 0.0052 -0.0749 0.0299 0.9451 
0.1998 0.0114 -0.4766 0.0663 0.7399 
0.1692 0.0038 -0.2047 0.0222 0.8443 
15.6 0.1272 0.0074 0.7174 0.0430 0.7374 
0.2766 0.0097 1.3964 0.0568 0.8838 
0.2874 0.0083 0.7696 0.0485 0.9187 
0.1350 0.0101 1.4250 0.0589 0.6264 
0.1524 0.0082 0.7544 0.0481 0.7626 
0.2484 0.0080 0.0174 0.0465 0.9015 
0.1212 0.0054 0.6109 0.0318 0.8225 
0.1302 0.0078 0.7056 0.0455 0.7240 
0.1614 0.0062 1.0438 0.0361 0.8650 
0.1092 0.0062 0.3297 0.0363 0.7431 
0.1116 0.0054 0.2704 0.0317 0.7980 
3.91 0.1056 0.0050 0.0125 0.0289 0.8081 
0.1290 0.0059 0.1598 0.0341 0.8181 
0.1314 0.0079 -0.0096 0.0458 0.7211 
0.1092 0.0050 0.0502 0.0290 0.8165 
0.0487 0.0082 0.0478 0.0477 0.2417 
0.1770 0.0066 0.0157 0.0382 0.8710 
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0.1200 0.0062 0.1171 0.0361 0.7768 
0.1062 0.0058 0.1918 0.0337 0.7567 
1.95 0.0978 0.0069 -0.0149 0.0401 0.6493 
0.0918 0.0063 0.0353 0.0367 0.6615 
0.0852 0.0067 -0.0555 0.0387 0.6008 
0.1056 0.0101 -0.1722 0.0587 0.5016 
0.0930 0.0072 -0.2189 0.0419 0.6028 
0.0870 0.0065 0.1075 0.0379 0.6217 
0.0750 0.0064 -0.0333 0.0372 0.5566 
0.0972 0.0071 0.0097 0.0410 0.6348 
0 0.0193 0.0085 -0.0822 0.0493 0.0377 
0.0519 0.0073 0.1256 0.0428 0.3120 
0.0774 0.0117 -0.3728 0.0679 0.2852 
-0.0077 0.0070 -0.1437 0.0409 0.0019 
-0.0190 0.0077 -0.1949 0.0449 0.0448 
0.0518 0.0131 -0.5543 0.0764 0.1191 
-0.0043 0.0055 -0.2833 0.0322 -0.0036 
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Table A3.4. Summary of Initial Slopes obtained from Tables A3.2 and A3.3, and used in 
generating the calibration curve in Figure 5.6b. 
 
Concentration (nM) n Mean Initial Slope 
(pm/min) 
Standard Deviation of 
Mean (pm/min) 
1000 9 20.7192 2.5167 
500 10 10.2653 2.3644 
250 8 5.0279 0.8066 
125 5 3.5589 0.2244 
62.5 11 0.6586 0.0921 
31.25 10 0.2573 0.1243 
15.63 11 0.1692 0.0677 
3.91 8 0.1159 0.0357 
1.95 8 0.0916 0.0093 
0 7 0.0242 0.0367 
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Table A3.5. Parameters used in fitting the desorption rates for the single-plexed SNP experiment 
and low G/C content multiplexed SNP experiments (represented in Figure 5.7 and Figure 5.8, 
respectively).  Note that the capture probe and target probes used in generating Figure 2 are the 
same as the capture probe X = A and the four target probes utilized in Figure 5.8. 
 
Capture 
Probe (X) 
Target 
Probe (Y) 
A Std. 
Error 
kd (s-1) Std. Error (s-
1) 
χ
2
 R2 
A T 59.9808 0.0374 8.0000 x 10-5 6.25 x 10-7 0.0690 0.9875 
59.9044 0.0360 7.4433 x 10-5 6.01 x 10-7 0.0642 0.9866 
59.2280 0.0353 8.2614 x 10-5 5.98 x 10-7 0.0613 0.9892 
58.7008 0.0452 8.3785 x 10-5 8.89 x 10-7 0.0860 0.9802 
55.5113 0.0254 8.3672 x 10-5 4.60 x 10-7 0.0318 0.9938 
A 43.3651 0.4259 2.2100 x 10-3 3.12 x 10-5 2.4231 0.9787 
43.3085 0.4161 2.0500 x 10-3 2.84 x 10-5 2.4792 0.9784 
45.1291 0.3927 2.3300 x 10-3 2.90 x 10-5 1.9649 0.9840 
50.3450 0.4168 2.7000 x 10-3 3.20 x 10-5 1.9214 0.9869 
C 40.7366 0.5213 1.4700 x 10-3 2.82 x 10-5 5.2014 0.9481 
41.1077 0.5890 1.4100 x 10-3 3.06 x 10-5 6.8542 0.9323 
41.7201 0.4936 1.5400 x 10-3 2.70 x 10-5 4.5022 0.9574 
G 52.6921 0.1210 2.0088 x 10-4 2.42 x 10-6 0.6421 0.9707 
56.5411 0.1077 2.1794 x 10-4 2.03 x 10-6 0.5017 0.9824 
60.0332 0.0667 2.1508 x 10-4 1.18 x 10-6 0.1926 0.9938 
T T 46.9323 0.1917 7.4303 x 10-4 5.86 x 10-6 1.0995 0.9885 
43.5835 0.3094 6.6835 x 10-4 9.74 x 10-6 3.0169 0.9599 
42.2102 0.2854 6.4301 x 10-4 9.14 x 10-6 2.6142 0.9620 
46.0296 0.2212 7.5725 x 10-4 6.95 x 10-6 1.4504 0.9845 
A 58.1095 0.0425 5.1759 x 10-5 7.17 x 10-7 0.0922 0.9606 
56.1172 0.0459 5.2053 x 10-5 8.03 x 10-7 0.1079 0.9516 
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55.4896 0.0678 5.0825 x 10-5 1.20 x 10-6 0.2349 0.8938 
C 48.6860 0.2429 6.4053 x 10-4 6.76 x 10-6 1.8971 0.9788 
44.5147 0.2029 5.8296 x 10-4 5.97 x 10-6 1.3795 0.9798 
43.7841 0.2518 6.0019 x 10-4 7.61 x 10-6 2.0980 0.9692 
G 54.9518 0.0935 3.2841 x 10-4 1.92 x 10-6 0.3454 0.9931 
52.7017 0.1044 3.0340 x 10-4 2.20 x 10-6 0.4394 0.9893 
49.5757 0.0915 3.0400 x 10-4 2.06 x 10-6 0.3378 0.9908 
53.5543 0.1021 3.0722 x 10-4 2.13 x 10-6 0.4189 0.9903 
G T 60.5901 0.0461 2.6405 x 10-4 8.31 x 10-7 0.0872 0.9980 
56.5829 0.1351 2.1486 x 10-4 2.55 x 10-6 0.7820 0.9720 
62.2761 0.1746 3.3760 x 10-4 3.19 x 10-6 1.1809 0.9825 
58.0323 0.1076 2.2639 x 10-4 1.99 x 10-6 0.4912 0.9844 
A 41.5170 0.1563 7.2476 x 10-4 5.31 x 10-6 0.7207 0.9901 
45.6663 0.2045 1.0100 x 10-3 7.50 x 10-6 1.0195 0.9910 
44.8127 0.2302 8.5350 x 10-4 7.83 x 10-6 1.4330 0.9851 
C 66.1746 0.0616 3.4314 x 10-5 9.11 x 10-7 0.1946 0.8712 
67.6445 0.0507 3.0317 x 10-5 7.31 x 10-7 0.1321 0.8913 
67.7671 0.0343 2.8791 x 10-5 4.94 x 10-7 0.0606 0.9420 
58.6339 0.0219 1.7525 x 10-5 3.62 x 10-7 0.0249 0.9180 
G 47.6778 0.1161 2.7170 x 10-4 2.67 x 10-6 0.5579 0.9806 
49.8770 0.2039 2.6792 x 10-4 4.48 x 10-6 1.7256 0.9454 
53.0895 0.0708 2.3703 x 10-4 1.44 x 10-6 0.2130 0.9926 
55.7501 0.1044 3.0160 x 10-4 2.09 x 10-6 0.4401 0.9903 
C T 54.3834 0.2920 2.0600 x 10-3 1.57 x 10-5 1.1434 0.9943 
53.0226 0.3283 2.0900 x 10-3 1.83 x 10-5 1.4258 0.9926 
 242 
 
52.4628 0.1978 2.2100 x 10-3 1.18 x 10-5 0.4904 0.9973 
A 45.4177 0.4669 3.2700 x 10-3 4.75 x 10-5 1.8873 0.9820 
44.5762 0.6203 3.5900 x 10-3 7.04 x 10-5 3.0297 0.9677 
42.9259 0.5980 3.2500 x 10-3 6.39 x 10-5 3.1202 0.9657 
43.1804 0.9199 2.9000 x 10-3 8.73 x 10-5 8.3020 0.9100 
C 48.8279 0.7200 2.1600 x 10-3 4.54 x 10-5 6.8380 0.9499 
53.7713 0.5631 2.7700 x 10-3 4.10 x 10-5 3.2660 0.9796 
52.2116 0.5903 2.6400 x 10-3 4.21 x 10-5 3.7754 0.9751 
G 72.2300 0.0493 3.8751 x 10-5 6.68 x 10-7 0.1227 0.9417 
73.8707 0.0345 3.5626 x 10-5 4.56 x 10-7 0.0602 0.9670 
76.0808 0.0309 3.5879 x 10-5 3.96 x 10-7 0.0482 0.9753 
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Table A3.6. Summary of the desorption rates and melting temperatures the single-plexed SNP 
experiment and low G/C content multiplexed SNP experiments (represented in Figure 5.7 and Figure 
5.8, respectively). Note that the capture probe and target probes used in generating Figure 5.7 are the 
same as the capture probe X = A and the four target probes utilized in Figure 5.8. 
Capture 
(X) 
Target 
(Y) 
Average 
Desorption 
Rate (s-1) 
Standard 
Deviation (s-1) 
n Melting 
Temperature 
(oC) 
Desorption Rate 
Relative to 
Perfect 
Complement 
A 
 
T 8.0901 x 10-5 3.924 x 10-6 5 45.649 1.00 
A 2.3225 x 10-3 2.766 x 10-4 4 32.512 28.71 
C 1.4733 x 10-3 6.51 x 10-5 3 35.086 18.21 
G 2.1130 x 10-4 9.14 x 10-6 3 40.904 2.61 
T T 7.0291 x 10-4 5.581 x 10-5 4 35.948 13.63 
A 5.1546 x 10-5 6.41 x 10-7 3 47.107 1.00 
C 6.0789 x 10-4 2.955 x 10-5 3 36.640 11.79 
G 3.1076 x 10-4 1.188 x 10-5 4 39.319 6.02 
G T 2.6072 x 10-4 5.539 x 10-5 4 40.547 9.40 
A 8.6275 x 10-4 1.429 x 10-4 3 36.597 31.10 
C 2.7737 x 10-5 7.195 x 10-6 4 49.050 1.00 
G 2.6956 x 10-4 2.641 x 10-5 4 40.507 9.72 
C T 2.1200 x 10-3 7.937 x 10-5 3 34.724 57.68 
A 3.2525 x 10-3 2.819 x 10-4 4 32.815 88.50 
C 2.5233 x 10-3 3.213 x 10-4 3 32.832 68.66 
G 3.6752 x 10-5 1.736 x 10-6 3 49.001 1.00 
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Table A3.7. Parameters used in fitting the desorption rates for the high G/C content multiplexed 
SNP experiments (shown in Figure 5.12). 
 
Capture 
Probe (X) 
Target 
Probe (Y) 
A Std. 
Error 
kd (s-1) Std. Error (s-
1) 
χ
2
 R2 
A T 
 
36.5112 0.0843 6.9985 x 10-5 2.287 x 10-6 0.3211 0.8280 
45.2542 0.0905 6.4423 x 10-5 1.975 x 10-6 0.3721 0.8453 
34.5208 0.0812 8.5017 x 10-5 2.347 x 10-6 0.2944 0.8709 
A 
 
21.6210 0.1605 2.2800 x 10-3 2.39 x 10-5 0.2921 0.9903 
23.6992 0.1849 2.3200 x 10-3 2.56 x 10-5 0.3811 0.9893 
19.8518 0.1652 2.4500 x 10-3 2.87 x 10-5 0.2881 0.9883 
18.6200 0.3270 3.1900 x 10-3 7.85 x 10-5 0.8643 0.9621 
16.4281 0.7016 4.5300 x 10-3 2.702 x 10-4 2.7675 0.8451 
C 
 
27.7352 0.1425 4.0216 x 10-4 6.04 x 10-6 0.6967 0.9593 
29.8968 0.2201 4.1647 x 10-4 8.72 x 10-6 1.6428 0.9231 
G 
 
25.9344 0.4676 4.0600 x 10-3 1.024 x 10-4 1.3764 0.9644 
19.0510 0.5036 4.2300 x 10-3 1.566 x 10-4 1.5281 0.9303 
26.3971 0.5436 4.6400  x 10-3 1.336 x 10-4 1.6175 0.9558 
29.6171 0.4470 2.5500 x 10-3 5.43 x 10-5 2.0233 0.9668 
T T 
 
31.7730 0.1042 2.3100 x 10-3 1.07 x 10-5 0.1202 0.9981 
30.2386 0.1017 2.2300 x 10-3 1.06 x 10-5 0.1183 0.9980 
A 
 
27.9358 0.1000 1.1670 x 10-4 3.63 x 10-6 0.4324 0.8416 
29.7215 0.1338 1.3201 x 10-4 4.60 x 10-6 0.7636 0.8083 
25.4645 0.1281 1.5149 x 10-4 5.19 x 10-6 0.6889 0.813 
24.9246 0.1302 1.5193  x 10-4 5.39 x 10-6 0.7111 0.8023 
21.7233 0.1674 1.9289 x 10-4 8.12 x 10-6 1.1354 0.7406 
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C 26.0607 0.1595 3.8309 x 10-4 7.13 x 10-6 0.8816 0.9384 
30.1670 0.1726 3.4969 x 10-4 6.54 x 10-6 1.0608 0.93735 
28.8019 0.1712 3.7037 x 10-4 6.87 x 10-6 1.0265 0.9384 
G 25.9663 0.1418 2.6900 x 10-3 2.06 x 10-5 0.1908 0.9954 
22.3761 0.1935 2.9600 x 10-3 3.59 x 10-5 0.3225 0.9895 
34.2597 0.1742 2.1700 x 10-3 1.56 x 10-5 0.3576 0.9953 
G T 28.6028 0.2136 8.6646 x 10-4 1.148 x 10-5 1.1121 0.9721 
31.4324 0.2302 9.0151  x 10-4 1.150 x 10-5 1.2615 0.9745 
28.2684 0.1602 8.5385 x 10-4 8.65 x 10-6 0.6312 0.9837 
32.7684 0.3199 1.1000 x 10-3 1.73 x 10-5 2.1423 0.9648 
A 20.5733 0.8378 3.9000 x 10-3 2.225 x 10-4 4.5556 0.8553 
26.8440 0.6627 3.4600 x 10-3 1.199 x 10-4 3.2271 0.9342 
20.1381 1.1911 4.7400  x 10-3 3.914 x 10-4 7.5126 0.7521 
18.2169 1.8206 6.0400 x 10-3 8.393 x 10-4 13.5905 0.4975 
14.2982 2.0124 7.8800 x 10-3 1.5400 x 10-3 12.4689 0.2228 
C 38.0782 0.1015 8.2129 x 10-5 2.659 x 10-6 0.4570 0.8315 
37.7280 0.0887 8.1424 x 10-5 2.333 x 10-6 0.3512 0.8626 
23.7650 0.0826 1.4477 x 10-4 3.56 x 10-6 0.2878 0.8952 
35.6760 0.0938 8.9138 x 10-5 2.619 x 10-6 0.3901 0.8564 
G 26.2781 0.3912 2.8800 x 10-3 6.02 x 10-5 1.3614 0.9710 
20.2104 0.7175 3.8500 x 10-3 1.914 x 10-4 3.3889 0.8828 
19.9839 0.5931 3.3100 x 10-3 1.380 x 10-4 2.7059 0.9091 
21.8720 0.7436 3.8400 x 10-3 1.827 x 10-4 3.6522 0.8911 
C T 31.2140 0.1611 2.9894 x 10-4 4.95 x 10-6 1.0918 0.9417 
31.6105 0.1812 2.5058 x 10-4 5.33 x 10-6 1.4474 0.9060 
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32.2294 0.1513 2.5705 x 10-4 4.38 x 10-6 1.0018 0.9380 
31.3304 0.2227 3.2632 x 10-4 6.94 x 10-6 2.0335 0.9075 
A 
 
18.1094 0.1812 9.5683 x 10-4 1.520 x 10-5 0.7978 0.9576 
24.5694 0.2769 8.3504 x 10-4 1.571 x 10-5 2.0418 0.9367 
17.8560 0.2268 9.4261 x 10-4 1.910 x 10-5 1.2630 0.9306 
15.6324 0.2030 1.2100 x 10-3 2.35 x 10-5 0.8368 0.9451 
12.4945 0.2381 2.6500 x 10-3 7.1233 x 10-5 0.5481 0.9438 
C 29.3149 0.1172 2.0788 x 10-4 3.62 x 10-6 0.6312 0.9354 
30.0669 0.1338 2.0151 x 10-4 4.01 x 10-6 0.8273 0.9167 
15.5254 0.1011 3.8019 x 10-4 6.59 x 10-6 0.3985 0.9377 
29.3023 0.1079 1.7628  x 10-4 3.27 x 10-6 0.5519 0.9270 
G 
 
31.6423 0.0856 9.6440 x 10-5 2.292 x 10-6 0.3771 0.8852 
20.0153 0.0911 1.3193 x 10-4 3.94 x 10-6 0.4116 0.8297 
23.1016 0.1209 1.4635 x 10-4 4.56 x 10-6 0.7137 0.8174 
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Table A3.8. Summary of the desorption rates and melting temperatures for each of the high G/C content 
probe combinations (Figure 5.12).  
Capture 
(X) 
Target 
(Y) 
Average 
Desorption 
Rate (s-1) 
Standard 
Deviation (s-1) 
n Melting 
Temperature 
(oC) 
Desorption Rate 
Relative to 
Perfect 
Complement 
A 
 
T 7.3142 x 10-5 1.0654 x 10-5 3 47.989 1.00 
A 2.9540 x 10-3 4.2622 x 10-4 5 37.473 40.39 
C 4.0931 x 10-4 1.0120 x 10-5 2 38.701 5.60 
G 3.8700 x 10-3 9.1305 x 10-4 4 41.719 52.91 
T T 2.2700 x 10-3 5.6569 x 10-5 2 37.923 15.23 
A 1.4900 x 10-4 2.8607 x 10-5 5 45.446 1.00 
C 3.6772 x 10-4 1.6857 x 10-5 3 36.840 2.47 
G 2.6067 x 10-3 4.0154 x 10-4 3 39.590 17.49 
G T 9.3045 x 10-4 1.1481 x 10-4 4 40.937 9.36 
A 5.2040 x 10-3 1.7901 x 10-3 5 41.542 52.37 
C 9.9364 x 10-5 3.0468 x 10-5 4 48.928 1.00 
G 3.4700 x 10-3 4.6726 x 10-4 4 43.435 34.92 
C T 2.8322 x 10-4 3.5847 x 10-5 4 35.896 2.27 
A 1.3189 x 10-3 7.5672 x 10-4 5 37.221 10.56 
C 2.4146 x 10-4 9.3486 x 10-5 4 35.220 1.93 
G 1.2491 x 10-4 2.5688 x 10-5 3 48.342 1.00 
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Table A3.9. Fitting parameters used in determining the desorption rates for SNPs with 
heterozygote alleles (seen in Figure 5.14). 
 
Capture 
Probe (X) 
Target 
Probes 
(Y) 
A Std. 
Error 
kd (s-1) Std. Error 
(s-1) 
χ
2
 R2 
A T, A 63.9413 0.0799 7.0754 x 10-5 1.233 x 10-6 0.2892 0.9441 
53.4259 0.0655 6.8792 x 10-5 1.209 x 10-6 0.1947 0.9433 
49.9496 0.0604 6.9896 x 10-5 1.194 x 10-6 0.1656 0.9462 
T 44.1643 0.1117 1.6038 x 10-4 2.61 x 10-6 0.5231 0.9509 
56.6922 0.1479 1.3451 x 10-4 2.66 x 10-6 0.9372 0.9291 
60.9121 0.1470 1.7027 x 10-4 2.50 x 10-6 0.8979 0.9597 
48.6977 0.1189 2.6579 x 10-4 2.66 x 10-6 0.5424 0.9811 
43.0696 0.1092 2.4976 x 10-4 2.74 x 10-6 0.4638 0.9773 
G 30.1717 0.1661 7.5961 x 10-4 7.93 x 10-6 0.7293 0.9819 
48.4226 0.1416 4.7571 x 10-4 3.57 x 10-6 0.6511 0.9898 
C 52.8133 1.3606 5.8900 x 10-3 2.123 x 10-4 7.9300 0.9379 
48.7450 1.5777 5.3800 x 10-3 2.440 x 10-4 11.7338 0.9062 
49.9744 1.6757 5.3100 x 10-3 2.497 x 10-4 13.4059 0.9001 
50.9883 1.7474 5.9200 x 10-3 2.839 x 10-4 13.0069 0.8979 
A T, C 57.0780 0.1329 7.4189 x 10-5 1.866 x 10-6 0.9782 0.8663 
51.0464 0.1347 8.5330 x 10-5 2.130 x 10-6 0.9929 0.8680 
T 55.0719 0.8906 2.4800 x 10-3 5.65 x 10-5 8.3316 0.9604 
51.0398 0.8500 2.5100 x 10-3 5.89 x 10-5 7.4890 0.9585 
47.3188 0.8931 2.5000 x 10-3 6.65 x 10-5 8.3078 0.9481 
G 52.5767 0.0838 1.1851 x 10-4 1.313 x 10-6 0.3712 0.9712 
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51.5859 0.0614 1.1308 x 10-4 9.8 x 10-7 0.2000 0.9823 
50.2226 0.0777 1.1919 x 10-4 1.27 x 10-6 0.3185 0.9732 
C 44.9880 2.4379 5.6700 x 10-3 4.292 x 10-4 26.4151 0.7430 
50.6008 2.4961 5.8600 x 10-3 4.041 x 10-4 26.7102 0.7783 
39.2606 2.8259 6.6100 x 10-3 6.628 x 10-4 30.1786 0.6028 
42.9966 3.0527 6.2800 x 10-3 6.218 x 10-4 37.1735 0.6123 
A T, G 65.3973 0.0716 1.0899 x 10-4 1.10 x 10-6 0.2249 0.9806 
60.0055 0.0785 1.2014 x 10-4 1.33 x 10-6 0.2675 0.9770 
56.5098 0.0608 1.2027 x 10-4 1.09 x 10-6 0.1605 0.9844 
60.8153 0.1066 9.3088 x 10-5 1.756 x 10-6 0.5060 0.9357 
T 50.8062 0.1886 7.6235 x 10-4 5.38 x 10-6 0.9417 0.9918 
43.4829 0.2937 9.6073 x 10-4 1.101 x 10-5 1.9980 0.9796 
50.0208 0.0792 9.5830 x 10-4 2.58 x 10-6 0.1454 0.9989 
48.5170 0.1079 1.2100 x 10-3 4.2 x 10-6 0.2301 0.9984 
G 48.7209 0.1185 4.4762 x 10-4 2.93 x 10-6 0.4671 0.9922 
49.5111 0.0521 4.4952 x 10-4 1.27 x 10-6 0.0903 0.9986 
52.3797 0.1326 4.7920 x 10-4 3.11 x 10-6 0.5716 0.9926 
C 53.0998 0.0917 1.0880 x 10-4 1.74 x 10-6 0.3688 0.9526 
40.5070 0.0785 7.1142 x 10-5 1.921 x 10-6 0.2798 0.8756 
56.0100 0.0893 6.5975 x 10-5 1.576 x 10-6 0.3635 0.9001 
60.3927 0.1142 6.9447 x 10-5 1.871 x 10-6 0.5920 0.8764 
58.8434 0.1964 7.5454 x 10-5 3.313 x 10-6 1.7423 0.7277 
A A, C 46.8757 1.4708 6.4000 x 10-3 2.829 x 10-4 8.7061 0.9128 
42.5288 0.7429 4.3800 x 10-3 1.082 x 10-4 3.2880 0.9555 
39.3734 0.8932 3.7700 x 10-3 1.211 x 10-4 5.5448 0.9163 
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45.3326 0.2811 5.1800 x 10-3 4.53 x 10-5 0.3963 0.9952 
T 46.1079 0.0832 1.1892 x 10-4 1.83 x 10-6 0.3007 0.9565 
55.3489 0.0908 9.2757 x 10-5 1.639 x 10-6 0.3663 0.9431 
62.2493 0.1092 1.1030 x 10-4 1.77 x 10-6 0.5219 0.9527 
52.2946 0.0741 1.6003 x 10-4 1.46 x 10-6 0.2303 0.9842 
47.0549 0.0879 1.4756 x 10-4 1.92 x 10-6 0.3272 0.9686 
G 29.2136 0.0844 9.0766 x 10-5 2.885 x 10-6 0.3173 0.8358 
50.2907 0.0577 6.0684 x 10-5 1.129 x 10-6 0.1522 0.9374 
48.7898 0.0517 5.9871 x 10-5 1.042 x 10-6 0.1221 0.9449 
C 36.1094 2.9464 1.1220 x 10-2 1.280 x 10-3 19.3269 0.5838 
23.1046 0.8353 3.8800 x 10-3 1.988 x 10-4 4.7003 0.7729 
37.7423 0.3068 7.2400 x 10-3 8.28 x 10-5 0.3333 0.9930 
34.5882 0.6143 7.2300 x 10-3 1.804 x 10-4 1.3389 0.9691 
28.4739 0.7676 4.9000 x 10-3 1.865 x 10-4 3.1294 0.8905 
A A, G 46.8060 0.1135 4.7501 x 10-4 2.96 x 10-6 0.4211 0.9929 
43.8659 0.0910 3.4670 x 10-4 2.36 x 10-6 0.2986 0.9914 
34.1311 0.1068 4.4851 x 10-4 3.77 x 10-6 0.3806 0.9871 
40.7340 0.1092 4.5968 x 10-4 3.25 x 10-6 0.3944 0.9909 
T 43.8045 0.0581 1.5629 x 10-4 1.37 x 10-6 0.1424 0.9854 
46.5544 0.0571 1.6229 x 10-4 1.27 x 10-6 0.1370 0.9883 
51.7000 0.0733 1.6764 x 10-4 1.47 x 10-6 0.2248 0.9853 
G 26.7882 0.0967 1.0800 x 10-3 6.3 x 10-6 0.2014 0.9951 
38.9356 0.0814 8.6504 x 10-4 3.21 x 10-6 0.1642 0.9978 
39.0394 0.1183 8.1733 x 10-4 4.52 x 10-6 0.3581 0.9950 
C 31.5048 0.0831 1.2158 x 10-4 2.67 x 10-6 0.3002 0.9134 
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50.5194 0.0630 6.6492 x 10-5 1.230 x 10-6 0.1809 0.9374 
33.8945 0.0411 4.1477 x 10-5 1.182 x 10-6 0.0787 0.8631 
44.3445 0.1151 6.1320 x 10-5 2.556 x 10-6 0.6076 0.7450 
45.1732 0.0450 5.4971 x 10-5 9.77 x 10-7 0.0931 0.9421 
42.1808 0.0519 7.2191 x 10-5 1.218 x 10-6 0.1224 0.9476 
A C, G 54.4163 0.2599 3.6747 x 10-4 5.51 x 10-6 2.3631 0.9594 
44.3384 0.2528 3.8975 x 10-4 6.66 x 10-6 2.1969 0.9479 
44.5219 0.2152 4.1516 x 10-4 5.72 x 10-6 1.5611 0.9658 
43.1168 0.2415 4.4798 x 10-4 6.75 x 10-6 1.9168 0.9595 
T 47.1016 0.1899 9.5673 x 10-4 6.55 x 10-6 0.8278 0.9930 
54.5349 0.1672 9.8071 x 10-4 5.05 x 10-6 0.6315 0.9960 
47.2464 0.1232 1.4200 x 10-3 5.5 x 10-6 0.2634 0.9982 
45.2700 0.1710 9.9526 x 10-4 6.28 x 10-6 0.6549 0.9942 
G 46.1395 0.1137 9.4366 x 10-5 2.467 x 10-6 0.5671 0.8834 
52.6328 0.0456 8.7428 x 10-5 8.66 x 10-7 0.0920 0.9816 
C 57.8145 0.0501 4.3575 x 10-5 8.48 x 10-7 0.1155 0.9325 
34.8381 0.0302 5.7019 x 10-5 8.52 x 10-7 0.0413 0.9591 
51.3347 0.0727 8.7245 x 10-5 1.413 x 10-6 0.2332 0.9522 
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Table A3.10. Summary of the desorption rates for each of the capture and target probe combinations 
used in profiling SNPs with heterozygote alleles (shown in Figure 5.14).   
Capture 
(X) 
Targets 
(Y) 
Average Desorption 
Rate (s-1) 
Standard 
Deviation (s-1) 
n 
A T, A 6.9814 x 10-5 9.84 x 10-7 3 
T 1.9614 x 10-4 5.804 x 10-5 5 
G 6.1766 x 10-4 2.0075 x 10-4 2 
C 5.6250 x 10-3 3.248 x 10-4 4 
A T, C 7.9760 x 10-5 7.878 x 10-6 2 
T 2.4967 x 10-3 1.53 x 10-5 3 
G 1.1693 x 10-4 3.35 x 10-6 3 
C 6.1050 x 10-3 4.223 x 10-4 4 
A T, G 1.1062 x 10-4 1.283 x 10-5 4 
T 9.7284 x 10-4 1.8340 x 10-4 4 
G 4.5878 x 10-4 1.771 x 10-5 3 
C 7.8163 x 10-5 1.7462 x 10-5 5 
A A, C 4.9325 x 10-3 1.1360 x 10-3 4 
T 1.2591 x 10-4 2.750 x 10-5 5 
G 7.0441 x 10-5 1.7607 x 10-5 3 
C 6.8940 x 10-3 2.8287 x 10-3 5 
A A, G 4.3248 x 10-4 5.821 x 10-5 4 
T 1.6207 x 10-4 5.68 x 10-6 3 
G 9.2079 x 10-4 1.56 x 10-6 3 
C 6.9672 x 10-5 2.7538 x 10-5 6 
A C, G 4.0509 x 10-4 3.460 x 10-5 4 
T 1.0882 x 10-3 2.218 x 10-4 4 
G 9.0897 x 10-5 4.906 x 10-6 2 
C 6.2613 x 10-5 2.2366 x 10-5 3 
 
